DRAMP_ID,Sequence,Hiden_Sequence,Original_Sequence,Sequence_Length,Name,Uniprot_Entry,Family,Source,Activity,Protein_Existence,Secondary_Structure,Structure_Description,PDB_ID,Comments,Target_Organism,Hemolytic_Activity,Linear/Cyclic,N_terminal_Modification,C_terminal_Modification,Special_Amino_Acid_and_Stapling_Position,Stereochemistry,Cytotoxicity,Pubmed_ID,Reference,Author,Title,Specific_Type,Nucleotide_Sequence,Full_Sequence,lfcMLE,padj,Workflow
DRAMP21468,KFFⓀKLKⓀAVKKGFKKFAKV,KFFKKLKKAVKKGFKKFAKV,KFFKKLKKAVKKGFKKFAKV,20,peptide 2 (derived from OH-CM6),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,Random coils in PBS.,"①All the peptides were random coils in PBS but displayed varied levels of α-helicity in the presence of 30 mM SDS. ②Other stapled peptides had an α-helix content ranging from 16 to 38%, but their antibacterial activity and proteolytic stability were quite similar.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.32216308] Gram-positive bacteria: Staphylococcus aureus (MIC99.9= 8 μg/mL), methicillin-resistant Staphylococcus aureus (MIC99.9= 4 μg/mL), Listeria monocytogenes (MIC99.9= 2 μg/mL);##Gram-negative bacteria: E.coli (MIC99.9= 16 μg/mL), Pseudomonas aeruginosa (MIC99.9= 8 μg/mL), clinically isolated drug-resistant E.coli (MIC99.9= 16 μg/mL)",[Ref.32216308] It has 1.9% hemolysis against human red blood cells at peptide concentration of 320 μg/mL,Cyclic (Stapled),Free,Amidation,①The Ⓚ (position: 4 and 8) in sequence indicates Nε-o-Ns-Nα-Fmoc-lysine before stapling. ②Ⓚ (4) and Ⓚ (8) are cross-linked by a (E)-but-2-enyl spacer employing the N-alkylation reaction.,L,No cytotoxicity information found in the reference,32216308,J Med Chem. 2020 Apr 23;63(8):4081-4089. doi: 10.1021/acs.jmedchem.9b02025. Epub 2020 Apr 8.,"Hong Li, Yuchen Hu, Qi Pu, Tong He, Qianyu Zhang, Wen Wu, Xuefeng Xia and Jinqiang Zhang",Novel Stapling by Lysine Tethering Provides Stable and Low Hemolytic Cationic Antimicrobial Peptides,Stapled AMP,,,,,
DRAMP21469,KFFⓀKLKKAVⓀKGFKKFAKV,KFFKKLKKAVKKGFKKFAKV,KFFKKLKKAVKKGFKKFAKV,20,peptide 3 (derived from OH-CM6),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,Random coils in PBS.,"①All the peptides were random coils in PBS but displayed varied levels of α-helicity in the presence of 30 mM SDS. ②Other stapled peptides had an α-helix content ranging from 16 to 38%, but their antibacterial activity and proteolytic stability were quite similar.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.32216308] Gram-positive bacteria: Staphylococcus aureus (MIC99.9= 8 μg/mL), methicillin-resistant Staphylococcus aureus (MIC99.9= 8 μg/mL), Listeria monocytogenes (MIC99.9= 8 μg/mL);##Gram-negative bacteria: E.coli (MIC99.9= 8 μg/mL), Pseudomonas aeruginosa (MIC99.9= 16 μg/mL), clinically isolated drug-resistant E.coli (MIC99.9= 32 μg/mL)",[Ref.32216308] It has 1.1% hemolysis against red blood cells at peptide concentration of 320 μg/mL,Cyclic (Stapled),Free,Amidation,①The Ⓚ (position: 4 and 11) in sequence indicates Nε-o-Ns-Nα-Fmoc-lysine before stapling. ②Ⓚ (4) and Ⓚ (11) are cross-linked by a (E)-but-2-enyl spacer employing the N-alkylation reaction.,L,No cytotoxicity information found in the reference,32216308,J Med Chem. 2020 Apr 23;63(8):4081-4089. doi: 10.1021/acs.jmedchem.9b02025. Epub 2020 Apr 8.,"Hong Li, Yuchen Hu, Qi Pu, Tong He, Qianyu Zhang, Wen Wu, Xuefeng Xia and Jinqiang Zhang",Novel Stapling by Lysine Tethering Provides Stable and Low Hemolytic Cationic Antimicrobial Peptides,Stapled AMP,,,,,
DRAMP21470,KFFKⓀLKKAVKⓀGFKKFAKV,KFFKKLKKAVKKGFKKFAKV,KFFKKLKKAVKKGFKKFAKV,20,peptide 4 (derived from OH-CM6),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,Random coils in PBS.,"①All the peptides were random coils in PBS but displayed varied levels of α-helicity in the presence of 30 mM SDS. ②Other stapled peptides had an α-helix content ranging from 16 to 38%, but their antibacterial activity and proteolytic stability were quite similar.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.32216308] Gram-positive bacteria: Staphylococcus aureus (MIC99.9= 8 μg/mL), methicillin-resistant Staphylococcus aureus (MIC99.9= 8 μg/mL), Listeria monocytogenes (MIC99.9= 4 μg/mL);##Gram-negative bacteria: E.coli (MIC99.9= 8 μg/mL), Pseudomonas aeruginosa (MIC99.9= 8 μg/mL), clinically isolated drug-resistant E.coli (MIC99.9= 32 μg/mL)",[Ref.32216308] It has 1.3% hemolysis against red blood cells at peptide concentration of 320 μg/mL,Cyclic (Stapled),Free,Amidation,①The Ⓚ (position: 5 and 12) in sequence indicates Nε-o-Ns-Nα-Fmoc-lysine before stapling. ②Ⓚ (5) and Ⓚ (12) are cross-linked by a (E)-but-2-enyl spacer employing the N-alkylation reaction.,L,No cytotoxicity information found in the reference,32216308,J Med Chem. 2020 Apr 23;63(8):4081-4089. doi: 10.1021/acs.jmedchem.9b02025. Epub 2020 Apr 8.,"Hong Li, Yuchen Hu, Qi Pu, Tong He, Qianyu Zhang, Wen Wu, Xuefeng Xia and Jinqiang Zhang",Novel Stapling by Lysine Tethering Provides Stable and Low Hemolytic Cationic Antimicrobial Peptides,Stapled AMP,,,,,
DRAMP21471,KFFKKLⓀKAVⓀKGFKKFAKV,KFFKKLKKAVKKGFKKFAKV,KFFKKLKKAVKKGFKKFAKV,20,peptide 5 (derived from OH-CM6),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,Random coils in PBS.,"①All the peptides were random coils in PBS but displayed varied levels of α-helicity in the presence of 30 mM SDS. ②Other stapled peptides had an α-helix content ranging from 16 to 38%, but their antibacterial activity and proteolytic stability were quite similar.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.32216308] Gram-positive bacteria: Staphylococcus aureus (MIC99.9= 8 μg/mL), methicillin-resistant Staphylococcus aureus (MIC99.9= 8 μg/mL), Listeria monocytogenes (MIC99.9= 2 μg/mL);##Gram-negative bacteria: E.coli (MIC99.9= 4 μg/mL), Pseudomonas aeruginosa (MIC99.9= 8 μg/mL), clinically isolated drug-resistant E.coli (MIC99.9= 16 μg/mL)",[Ref.32216308] It has 5.4% hemolysis against red blood cells at peptide concentration of 320 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓚ (position: 7 and 11) in sequence indicates Nε-o-Ns-Nα-Fmoc-lysine before stapling. ②Ⓚ (7) and Ⓚ (11) are cross-linked by a (E)-but-2-enyl spacer employing the N-alkylation reaction.,L,No cytotoxicity information found in the reference,32216308,J Med Chem. 2020 Apr 23;63(8):4081-4089. doi: 10.1021/acs.jmedchem.9b02025. Epub 2020 Apr 8.,"Hong Li, Yuchen Hu, Qi Pu, Tong He, Qianyu Zhang, Wen Wu, Xuefeng Xia and Jinqiang Zhang",Novel Stapling by Lysine Tethering Provides Stable and Low Hemolytic Cationic Antimicrobial Peptides,Stapled AMP,,,,,
DRAMP21472,KFFKKLKⓀAVKⓀGFKKFAKV,KFFKKLKKAVKKGFKKFAKV,KFFKKLKKAVKKGFKKFAKV,20,peptide 6 (derived from OH-CM6),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,Random coils in PBS.,"①All the peptides were random coils in PBS but displayed varied levels of α-helicity in the presence of 30 mM SDS. ②Other stapled peptides had an α-helix content ranging from 16 to 38%, but their antibacterial activity and proteolytic stability were quite similar.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.32216308] Gram-positive bacteria: Staphylococcus aureus (MIC99.9= 4 μg/mL), methicillin-resistant Staphylococcus aureus (MIC99.9= 4 μg/mL), Listeria monocytogenes (MIC99.9= 2 μg/mL);##Gram-negative bacteria: E.coli (MIC99.9= 8 μg/mL), Pseudomonas aeruginosa (MIC99.9= 8 μg/mL), clinically isolated drug-resistant E.coli (MIC99.9= 32 μg/mL)",[Ref.32216308] It has 2.9% hemolysis against red blood cells at peptide concentration of 320 μg/mL,Cyclic (Stapled),Free,Amidation,①The Ⓚ (position: 8 and 12) in sequence indicates Nε-o-Ns-Nα-Fmoc-lysine before stapling. ②Ⓚ (8) and Ⓚ (12) are cross-linked by a (E)-but-2-enyl spacer employing the N-alkylation reaction.,L,No cytotoxicity information found in the reference,32216308,J Med Chem. 2020 Apr 23;63(8):4081-4089. doi: 10.1021/acs.jmedchem.9b02025. Epub 2020 Apr 8.,"Hong Li, Yuchen Hu, Qi Pu, Tong He, Qianyu Zhang, Wen Wu, Xuefeng Xia and Jinqiang Zhang",Novel Stapling by Lysine Tethering Provides Stable and Low Hemolytic Cationic Antimicrobial Peptides,Stapled AMP,,,,,
DRAMP21473,KFFKKLKⓀAVKKGFⓀKFAKV,KFFKKLKKAVKKGFKKFAKV,KFFKKLKKAVKKGFKKFAKV,20,peptide 7 (derived from OH-CM6),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,Random coils in PBS.,"①All the peptides were random coils in PBS but displayed varied levels of α-helicity in the presence of 30 mM SDS. ②Other stapled peptides had an α-helix content ranging from 16 to 38%, but their antibacterial activity and proteolytic stability were quite similar.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.32216308] Gram-positive bacteria: Staphylococcus aureus (MIC99.9= 4 μg/mL), methicillin-resistant Staphylococcus aureus (MIC99.9= 16 μg/mL), Listeria monocytogenes (MIC99.9= 8 μg/mL);##Gram-negative bacteria: E.coli (MIC99.9= 8 μg/mL), Pseudomonas aeruginosa (MIC99.9= 16 μg/mL), clinically isolated drug-resistant E.coli (MIC99.9= 32 μg/mL)",[Ref.32216308] It has 2.6% hemolysis against red blood cells at peptide concentration of 320 μg/mL,Cyclic (Stapled),Free,Amidation,①The Ⓚ (position: 8 and 15) in sequence indicates Nε-o-Ns-Nα-Fmoc-lysine before stapling. ②Ⓚ (8) and Ⓚ (15) are cross-linked by a (E)-but-2-enyl spacer employing the N-alkylation reaction.,L,No cytotoxicity information found in the reference,32216308,J Med Chem. 2020 Apr 23;63(8):4081-4089. doi: 10.1021/acs.jmedchem.9b02025. Epub 2020 Apr 8.,"Hong Li, Yuchen Hu, Qi Pu, Tong He, Qianyu Zhang, Wen Wu, Xuefeng Xia and Jinqiang Zhang",Novel Stapling by Lysine Tethering Provides Stable and Low Hemolytic Cationic Antimicrobial Peptides,Stapled AMP,,,,,
DRAMP21474,KFFKKLKKAVⓀKGFⓀKFAKV,KFFKKLKKAVKKGFKKFAKV,KFFKKLKKAVKKGFKKFAKV,20,peptide 8 (derived from OH-CM6),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,Random coils in PBS.,"①All the peptides were random coils in PBS but displayed varied levels of α-helicity in the presence of 30 mM SDS. ②Other stapled peptides had an α-helix content ranging from 16 to 38%, but their antibacterial activity and proteolytic stability were quite similar.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.32216308] Gram-positive bacteria: Staphylococcus aureus (MIC99.9= 4 μg/mL), methicillin-resistant Staphylococcus aureus (MIC99.9= 4 μg/mL), Listeria monocytogenes (MIC99.9= 2 μg/mL);##Gram-negative bacteria: E.coli (MIC99.9= 8 μg/mL), Pseudomonas aeruginosa (MIC99.9= 8 μg/mL), clinically isolated drug-resistant E.coli (MIC99.9= 32 μg/mL)",[Ref.32216308] It has 2.7% hemolysis against red blood cells at peptide concentration of 320 μg/mL,Cyclic (Stapled),Free,Amidation,①The Ⓚ (position: 11 and 15) in sequence indicates Nε-o-Ns-Nα-Fmoc-lysine before stapling. ②Ⓚ (11) and Ⓚ (15) are cross-linked by a (E)-but-2-enyl spacer employing the N-alkylation reaction.,L,No cytotoxicity information found in the reference,32216308,J Med Chem. 2020 Apr 23;63(8):4081-4089. doi: 10.1021/acs.jmedchem.9b02025. Epub 2020 Apr 8.,"Hong Li, Yuchen Hu, Qi Pu, Tong He, Qianyu Zhang, Wen Wu, Xuefeng Xia and Jinqiang Zhang",Novel Stapling by Lysine Tethering Provides Stable and Low Hemolytic Cationic Antimicrobial Peptides,Stapled AMP,,,,,
DRAMP21475,KFFKKLKKAVKⓀGFKKFAⓀV,KFFKKLKKAVKKGFKKFAKV,KFFKKLKKAVKKGFKKFAKV,20,peptide 9 (derived from OH-CM6),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,Random coils in PBS.,"①All the peptides were random coils in PBS but displayed varied levels of α-helicity in the presence of 30 mM SDS. ②Other stapled peptides had an α-helix content ranging from 16 to 38%, but their antibacterial activity and proteolytic stability were quite similar.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.32216308] Gram-positive bacteria: Staphylococcus aureus (MIC99.9= 4 μg/mL), methicillin-resistant Staphylococcus aureus (MIC99.9= 8 μg/mL), Listeria monocytogenes (MIC99.9= 4 μg/mL);##Gram-negative bacteria: E.coli (MIC99.9= 8 μg/mL), Pseudomonas aeruginosa (MIC99.9= 16 μg/mL), clinically isolated drug-resistant E.coli (MIC99.9= 16 μg/mL)",[Ref.32216308] It has 5.4% hemolysis against red blood cells at peptide concentration of 320 μg/mL,Cyclic (Stapled),Free,Amidation,①The Ⓚ (position: 12 and 19) in sequence indicates Nε-o-Ns-Nα-Fmoc-lysine before stapling. ②Ⓚ (12) and Ⓚ (19) are cross-linked by a (E)-but-2-enyl spacer employing the N-alkylation reaction.,L,No cytotoxicity information found in the reference,32216308,J Med Chem. 2020 Apr 23;63(8):4081-4089. doi: 10.1021/acs.jmedchem.9b02025. Epub 2020 Apr 8.,"Hong Li, Yuchen Hu, Qi Pu, Tong He, Qianyu Zhang, Wen Wu, Xuefeng Xia and Jinqiang Zhang",Novel Stapling by Lysine Tethering Provides Stable and Low Hemolytic Cationic Antimicrobial Peptides,Stapled AMP,,,,,
DRAMP21476,KFFKKLKKAVKⓀGFKⓀFAKV,KFFKKLKKAVKKGFKKFAKV,KFFKKLKKAVKKGFKKFAKV,20,peptide 10 (derived from OH-CM6),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,①41% α-helical content in 30 mM SDS. ②Random coils in PBS,"①All the peptides were random coils in PBS but displayed varied levels of α-helicity in the presence of 30 mM SDS.  ②Stapled peptides 10 and 12 had a high content of α-helix of about 41 and 45%, respectively, respectively, which could partly explain their strong antibacterial activity and proteolytic resistance.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.32216308] Gram-positive bacteria: Staphylococcus aureus (MIC99.9= 4 μg/mL), methicillin-resistant Staphylococcus aureus (MIC99.9= 4 μg/mL), Listeria monocytogenes (MIC99.9= 2 μg/mL);##Gram-negative bacteria: E.coli (MIC99.9= 8 μg/mL), Pseudomonas aeruginosa (MIC99.9= 8 μg/mL), clinically isolated drug-resistant E.coli (MIC99.9= 32 μg/mL)",[Ref.32216308] It has 2.8% hemolysis against red blood cells at peptide concentration of 320 μg/mL,Cyclic (Stapled),Free,Amidation,①The Ⓚ (position: 12 and 16) in sequence indicates Nε-o-Ns-Nα-Fmoc-lysine before stapling. ②Ⓚ (12) and Ⓚ (16) are cross-linked by a (E)-but-2-enyl space employing the N-alkylation reactionr.,L,"[Ref.32216308] The cell survial of HEK 293T cell line induced by peptide 10 is 101.8%, 100.7%, 98.9%, 89.1% and 83.9%.",32216308,J Med Chem. 2020 Apr 23;63(8):4081-4089. doi: 10.1021/acs.jmedchem.9b02025. Epub 2020 Apr 8.,"Hong Li, Yuchen Hu, Qi Pu, Tong He, Qianyu Zhang, Wen Wu, Xuefeng Xia and Jinqiang Zhang",Novel Stapling by Lysine Tethering Provides Stable and Low Hemolytic Cationic Antimicrobial Peptides,Stapled AMP,,,,,
DRAMP21477,KFFKKLKKAVKKGFⓀKFAⓀV,KFFKKLKKAVKKGFKKFAKV,KFFKKLKKAVKKGFKKFAKV,20,peptide 11 (derived from OH-CM6),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,Random coils in PBS.,"①All the peptides were random coils in PBS but displayed varied levels of α-helicity in the presence of 30 mM SDS. ②Other stapled peptides had an α-helix content ranging from 16 to 38%, but their antibacterial activity and proteolytic stability were quite similar.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.32216308] Gram-positive bacteria: Staphylococcus aureus (MIC99.9= 8 μg/mL), methicillin-resistant Staphylococcus aureus (MIC99.9= 4 μg/mL), Listeria monocytogenes (MIC99.9= 2 μg/mL);##Gram-negative bacteria: E.coli (MIC99.9= 4 μg/mL), Pseudomonas aeruginosa (MIC99.9= 8 μg/mL), clinically isolated drug-resistant E.coli (MIC99.9= 16 μg/mL)",[Ref.32216308] It has 0.5% hemolysis against red blood cells at peptide concentration of 320 μg/mL,Cyclic (Stapled),Free,Amidation,①The Ⓚ (position: 15 and 19) in sequence indicates Nε-o-Ns-Nα-Fmoc-lysine before stapling. ②Ⓚ (15) and Ⓚ (19) are cross-linked by a (E)-but-2-enyl spacer employing the N-alkylation reaction.,L,No cytotoxicity information found in the reference,32216308,J Med Chem. 2020 Apr 23;63(8):4081-4089. doi: 10.1021/acs.jmedchem.9b02025. Epub 2020 Apr 8.,"Hong Li, Yuchen Hu, Qi Pu, Tong He, Qianyu Zhang, Wen Wu, Xuefeng Xia and Jinqiang Zhang",Novel Stapling by Lysine Tethering Provides Stable and Low Hemolytic Cationic Antimicrobial Peptides,Stapled AMP,,,,,
DRAMP21478,KFFKKLKKAVKⓀGFKⓀFAKV,KFFKKLKKAVKKGFKKFAKV,KFFKKLKKAVKKGFKKFAKV,20,peptide 12 (derived from OH-CM6),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,①45% α-helical content in 30 mM SDS. ②Random coils in PBS.,"①All the peptides were random coils in PBS but displayed varied levels of α-helicity in the presence of 30 mM SDS.  ②Stapled peptides 10 and 12 had a high content of α-helix of about 41 and 45%, respectively, respectively, which could partly explain their strong antibacterial activity and proteolytic resistance.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.32216308] Gram-positive bacteria: Staphylococcus aureus (MIC99.9= 4 μg/mL), methicillin-resistant Staphylococcus aureus (MIC99.9= 2 μg/mL), Listeria monocytogenes (MIC99.9= 4 μg/mL);##Gram-negative bacteria: E.coli (MIC99.9= 4 μg/mL), Pseudomonas aeruginosa (MIC99.9= 8 μg/mL), clinically isolated drug-resistant E.coli (MIC99.9= 8 μg/mL)",[Ref.32216308] It has 8.7% hemolysis against red blood cells at peptide concentration of 320 μg/mL,Cyclic (Stapled),Free,Amidation,"①The Ⓚ (position: 12 and 16) in sequence indicates Nε-o-Ns-Nα-Fmoc-lysine before stapling. ②Ⓚ (12) and Ⓚ (16) are cross-linked by a 1,2-bismethylenebenzene spacer employing the N-alkylation.",L,"[Ref.32216308] The cell survial of HEK 293T cell line induced by peptide 12 is 102.9%, 101.8%, 101.5%, 66.4% and 62.8%.",32216308,J Med Chem. 2020 Apr 23;63(8):4081-4089. doi: 10.1021/acs.jmedchem.9b02025. Epub 2020 Apr 8.,"Hong Li, Yuchen Hu, Qi Pu, Tong He, Qianyu Zhang, Wen Wu, Xuefeng Xia and Jinqiang Zhang",Novel Stapling by Lysine Tethering Provides Stable and Low Hemolytic Cationic Antimicrobial Peptides,Stapled AMP,,,,,
DRAMP21479,KFFKKLKKAVKⓀGFKⓀFAKV,KFFKKLKKAVKKGFKKFAKV,KFFKKLKKAVKKGFKKFAKV,20,peptide 13 (derived from OH-CM6),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,Random coils in PBS.,"①All the peptides were random coils in PBS but displayed varied levels of α-helicity in the presence of 30 mM SDS. ②Other stapled peptides had an α-helix content ranging from 16 to 38%, but their antibacterial activity and proteolytic stability were quite similar.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.32216308] Gram-positive bacteria: Staphylococcus aureus (MIC99.9= 4 μg/mL), methicillin-resistant Staphylococcus aureus (MIC99.9= 4 μg/mL), Listeria monocytogenes (MIC99.9= 4 μg/mL);##Gram-negative bacteria: E.coli (MIC99.9= 8 μg/mL), Pseudomonas aeruginosa (MIC99.9= 8 μg/mL), clinically isolated drug-resistant E.coli (MIC99.9= 32 μg/mL)",[Ref.32216308] It has 6.1% hemolysis against red blood cells at peptide concentration of 320 μg/mL,Cyclic (Stapled),Free,Amidation,"①The Ⓚ (position: 12 and 16) in sequence indicates Nε-o-Ns-Nα-Fmoc-lysine before stapling. ②Ⓚ (12) and Ⓚ (16) are cross-linked by a 1,3-bismethylenebenzene spacer employing the N-alkylation.",L,No cytotoxicity information found in the reference,32216308,J Med Chem. 2020 Apr 23;63(8):4081-4089. doi: 10.1021/acs.jmedchem.9b02025. Epub 2020 Apr 8.,"Hong Li, Yuchen Hu, Qi Pu, Tong He, Qianyu Zhang, Wen Wu, Xuefeng Xia and Jinqiang Zhang",Novel Stapling by Lysine Tethering Provides Stable and Low Hemolytic Cationic Antimicrobial Peptides,Stapled AMP,,,,,
DRAMP21480,KFFKKLKKAVKⓀGFKⓀFAKV,KFFKKLKKAVKKGFKKFAKV,KFFKKLKKAVKKGFKKFAKV,20,peptide 14 (derived from OH-CM6),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,Random coils in PBS.,"①All the peptides were random coils in PBS but displayed varied levels of α-helicity in the presence of 30 mM SDS. ②Other stapled peptides had an α-helix content ranging from 16 to 38%, but their antibacterial activity and proteolytic stability were quite similar.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.32216308] Gram-positive bacteria: Staphylococcus aureus (MIC99.9= 4 μg/mL), methicillin-resistant Staphylococcus aureus (MIC99.9= 4 μg/mL), Listeria monocytogenes (MIC99.9= 4 μg/mL);##Gram-negative bacteria: E.coli (MIC99.9= 8 μg/mL), Pseudomonas aeruginosa (MIC99.9= 8 μg/mL), clinically isolated drug-resistant E.coli (MIC99.9= 32 μg/mL)",[Ref.32216308] It has 6.8% hemolysis against red blood cells at peptide concentration of 320 μg/mL,Cyclic (Stapled),Free,Amidation,"①The Ⓚ (position: 12 and 16) in sequence indicates Nε-o-Ns-Nα-Fmoc-lysine before stapling. ②Ⓚ (12) and Ⓚ (16) are cross-linked by a 1,4-bismethylenebenzene spacer employing the N-alkylation.",L,No cytotoxicity information found in the reference,32216308,J Med Chem. 2020 Apr 23;63(8):4081-4089. doi: 10.1021/acs.jmedchem.9b02025. Epub 2020 Apr 8.,"Hong Li, Yuchen Hu, Qi Pu, Tong He, Qianyu Zhang, Wen Wu, Xuefeng Xia and Jinqiang Zhang",Novel Stapling by Lysine Tethering Provides Stable and Low Hemolytic Cationic Antimicrobial Peptides,Stapled AMP,,,,,
DRAMP21482,KKKKKKAAFⓍAWAⓍFAA,KKKKKKAAFXAWAXFAA,KKKKKKAAFAAWAAFAA,17,S-6K-F17,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",,①Random coils with only a small amount of helical structure in aqueous buffer. ②α-helix in SDS detergent micelles.,"①Similarly, the stapled peptide, S-6K-F17 is predominantly random coil in aqueous buffer with only a small amount of helical structure despite the presence of the staple - a feature likely due to the large stretch of non-helical Lys residues that flank the stapled portion of the sequence. ②As expected, in detergent micelles S-6K-F17 adopts a helical structure, paralleling the unstapled peptide.",Not found,Function: Antibacterial activity against Gram-negative bacteria. No experiments about antibacterial activity against Gram-positive bacteria are recorded.,[Ref.29275987] Gram-negative bacteria: E. coli (MIC= 1.0 μM),[Ref.29275987] MHC = 3.8 μM against human red blood cells. Note: Minimum hemolytic concentration (MHC) is the minimum peptide concentration at which red blood cells undergo > 2% hemolysis.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 10 and 14) in sequence indicates 2-(4'-pentenyl) alanine. ②Ⓧ (10) and Ⓧ (14) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,29275987,Bioorg Med Chem. 2018 Mar 15;26(6):1189-1196. doi: 10.1016/j.bmc.2017.10.020. Epub 2017 Oct 21.,"Tracy A Stone, Gregory B Cole, Huong Q Nguyen, Simon Sharpe, Charles M Deber",Influence of hydrocarbon-stapling on membrane interactions of synthetic antimicrobial peptides,Stapled AMP,,,,,
DRAMP21483,KKKKKKAGFⓍAWAⓍFGA,KKKKKKAGFXAWAXFGA,KKKKKKAAFAAWAAFAA,17,S-6K-F17-2G,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",,Lack of significant structure,"Substitutions with polar, known 'helix-breaker' Gly residues led to losses in helical character until finally the peptide containing 3 Gly and 1 Asn (S-6K-F17-3GN) shows a severe loss in helical structure",Not found,Function: Antibacterial activity against Gram-negative bacteria. No experiments about antibacterial activity against Gram-positive bacteria are recorded.,[Ref.29275987] Gram-negative bacteria: E. coli (MIC= 1.6 μM),[Ref.29275987] MHC = 15 μM against human red blood cells. Note: Minimum hemolytic concentration (MHC) is the minimum peptide concentration at which red blood cells undergo > 2% hemolysis.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 10 and 14) in sequence indicates 2-(4'-pentenyl) alanine. ②Ⓧ (10) and Ⓧ (14) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,29275987,Bioorg Med Chem. 2018 Mar 15;26(6):1189-1196. doi: 10.1016/j.bmc.2017.10.020. Epub 2017 Oct 21.,"Tracy A Stone, Gregory B Cole, Huong Q Nguyen, Simon Sharpe, Charles M Deber",Influence of hydrocarbon-stapling on membrane interactions of synthetic antimicrobial peptides,Stapled AMP,,,,,
DRAMP21484,KKKKKKAGFⓍAWGⓍFGA,KKKKKKAGFXAWGXFGA,KKKKKKAAFAAWAAFAA,17,S-6K-F17-3G,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",,Lack of significant structure,"Substitutions with polar, known 'helix-breaker' Gly residues led to losses in helical character until finally the peptide containing 3 Gly and 1 Asn (S-6K-F17-3GN) shows a severe loss in helical structure",Not found,Function: Antibacterial activity against Gram-negative bacteria. No experiments about antibacterial activity against Gram-positive bacteria are recorded.,[Ref.29275987] Gram-negative bacteria: E. coli (MIC= 4.2 μM),[Ref.29275987] MHC = 128 μM against human red blood cells. Note: Minimum hemolytic concentration (MHC) is the minimum peptide concentration at which red blood cells undergo > 2% hemolysis.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 10 and 14) in sequence indicates 2-(4'-pentenyl) alanine. ②Ⓧ (10) and Ⓧ (14) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,29275987,Bioorg Med Chem. 2018 Mar 15;26(6):1189-1196. doi: 10.1016/j.bmc.2017.10.020. Epub 2017 Oct 21.,"Tracy A Stone, Gregory B Cole, Huong Q Nguyen, Simon Sharpe, Charles M Deber",Influence of hydrocarbon-stapling on membrane interactions of synthetic antimicrobial peptides,Stapled AMP,,,,,
DRAMP21485,KKKKKKNGFⓍAWGⓍFGA,KKKKKKNGFXAWGXFGA,KKKKKKAAFAAWAAFAA,17,S-6K-F17-3GN,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",,Lack of significant structure,"Substitutions with polar, known 'helix-breaker' Gly residues led to losses in helical character until finally the peptide containing 3 Gly and 1 Asn (S-6K-F17-3GN) shows a severe loss in helical structure",Not found,Function: Antibacterial activity against Gram-negative bacteria. No experiments about antibacterial activity against Gram-positive bacteria are recorded.,[Ref.29275987] Gram-negative bacteria: E. coli (MIC= 4.2 μM),[Ref.29275987] MHC = 587 μM against human red blood cells. Note: Minimum hemolytic concentration (MHC) is the minimum peptide concentration at which red blood cells undergo > 2% hemolysis.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 10 and 14) in sequence indicates 2-(4'-pentenyl) alanine. ②Ⓧ (10) and Ⓧ (14) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,29275987,Bioorg Med Chem. 2018 Mar 15;26(6):1189-1196. doi: 10.1016/j.bmc.2017.10.020. Epub 2017 Oct 21.,"Tracy A Stone, Gregory B Cole, Huong Q Nguyen, Simon Sharpe, Charles M Deber",Influence of hydrocarbon-stapling on membrane interactions of synthetic antimicrobial peptides,Stapled AMP,,,,,
DRAMP21486,VNWKKⓍLGKⓍIKVVK,VNWKKXLGKXIKVVK,VNWKKILGKIIKVVK,15,LL-IIIs-1,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",,①20% α-helical content in water. ②55% α-helical content in 50% TFE. ③55% α-helical content in 8mM SDS.,It seems that the staple in the central part of the LL-IIIs-1 analog that crosslink the bend of the α-helix on its concave site around the Gly8 residue resulted in slight helix destabilization.,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria and Antifungal activity against Candida albicans.,"[Ref.22526241] Gram-positive bacteria: Micrococcus luteus (MIC = 0.7 μM), Bacillus subtilis (MIC = 0.8 μM), Staphylococcus aureus (MIC = 12.5 μM);##Gram-negative bacteria: E.coli (MIC = 4.4 μM), Pseudomonas aeruginosa (MIC = 78.7 μM);##Fungi: Candida albicans (MIC = 100 μM).",[Ref.22526241] LC50 = 31.3 μM. Note: LC50 is the concentration of a peptide able to lyse 50% of human erthrocytes in the assay.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 6 and 10) indicates 2-(4'-pentenyl) alanine in the S configuration. ②Ⓧ (6) and Ⓧ (10) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,22526241,Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 18.,"Hubert Chapuis, Jiřina Slaninová, Lucie Bednárová, Lenka Monincová, Miloš Buděšínský, Václav Čeřovský",Effect of hydrocarbon stapling on the properties of α-helical antimicrobial peptides isolated from the venom of hymenoptera,Stapled AMP,,,,,
DRAMP21487,VNWKKILGKⓍIKVⓍK,VNWKKILGKXIKVXK,VNWKKILGKIIKVVK,15,LL-IIIs-2,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",,①31% α-helical content in water. ②51% α-helical content in 50% TFE. ③58% α-helical content in 8mM SDS.,"For the LL-IIIs-2 analog, the helical content increment is slightly higher (8 %).",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria and Antifungal activity against Candida albicans.,"[Ref.22526241] Gram-positive bacteria: Micrococcus luteus (MIC = 0.9 μM), Bacillus subtilis (MIC = 1.2 μM), Staphylococcus aureus (MIC = 20.3 μM);##Gram-negative bacteria: E.coli (MIC = 8.8 μM), Pseudomonas aeruginosa (MIC = 86.7 μM);##Fungi: Candida albicans (MIC = 100 μM).",[Ref.22526241] LC50 = 69 μM. Note: LC50 is the concentration of a peptide able to lyse 50% of human erthrocytes in the assay.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 10 and 14) indicates 2-(4'-pentenyl) alanine in the S configuration. ②Ⓧ (10) and Ⓧ (14)are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,22526241,Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 19.,"Hubert Chapuis, Jiřina Slaninová, Lucie Bednárová, Lenka Monincová, Miloš Buděšínský, Václav Čeřovský",Effect of hydrocarbon stapling on the properties of α-helical antimicrobial peptides isolated from the venom of hymenoptera,Stapled AMP,,,,,
DRAMP21488,VⓍWKKⓍLGKIIKVVK,VXWKKXLGKIIKVVK,VNWKKILGKIIKVVK,15,LL-IIIs-3,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",,①27% α-helical content in water. ②52% α-helical content in 50% TFE. ③62% α-helical content in 8mM SDS.,"The CD spectra of the singly stapled peptides of the i, i + 4 type acquired in water show a slight increase (by 5 %) of helical content in the case of MEP-Ns-1, MEP-Ns-2 and LL-IIIs-3 compared to their unstapled precursors.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria and Antifungal activity against Candida albicans.,"[Ref.22526241] Gram-positive bacteria: Micrococcus luteus (MIC = 1.4 μM), Bacillus subtilis (MIC = 1.1 μM), Staphylococcus aureus (MIC = 21.7 μM);##Gram-negative bacteria: E.coli (MIC = 1.2 μM), Pseudomonas aeruginosa (MIC = 76.3 μM);##Fungi: Candida albicans (MIC = 93.3 μM).",[Ref.22526241] LC50 = 30 μM. Note: LC50 is the concentration of a peptide able to lyse 50% of human erthrocytes in the assay.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 2 and 6) indicates 2-(4'-pentenyl) alanine in the S configuration. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,22526241,Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 20.,"Hubert Chapuis, Jiřina Slaninová, Lucie Bednárová, Lenka Monincová, Miloš Buděšínský, Václav Čeřovský",Effect of hydrocarbon stapling on the properties of α-helical antimicrobial peptides isolated from the venom of hymenoptera,Stapled AMP,,,,,
DRAMP21489,VNⓍKKIⓍGKⓍIKVⓍK,VNXKKIXGKXIKVXK,VNWKKILGKIIKVVK,15,LL-IIIs-4,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,①45% α-helical content in water. ②48% α-helical content in 50% TFE. ③63% α-helical content in 8mM SDS.,"On the other hand, the difference in α-helical content between doubly stapled analogs (LL-IIIs-4, MEP-Ns-3, MEP-Ns-5, and MEP-Ns-6) and their unstapled precursors is apparently higher, on average by 15 %",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Antifungal activity against Candida albicans is not noteable under 100 μM.,"[Ref.22526241] Gram-positive bacteria: Micrococcus luteus (MIC = 2 μM), Bacillus subtilis (MIC = 1.1 μM), Staphylococcus aureus (MIC = 80 μM);##Gram-negative bacteria: E.coli (MIC = 20 μM), Pseudomonas aeruginosa (MIC > 100 μM);##Fungi: Candida albicans (MIC > 100 μM).",[Ref.22526241] LC50 > 100 μM. Note: LC50 is the concentration of a peptide able to lyse 50% of human erthrocytes in the assay.,Cyclic (Stapled),Free,Amidation,"①The Ⓧ (position: 3, 7, 10 and 14) indicates 2-(4'-pentenyl) alanine in the S configuration. ②Ⓧ (3) and Ⓧ (7), Ⓧ (10) and Ⓧ (14) are cross-linked by hydrocarbon stapling respectively.",L,No cytotoxicity information found in the reference,22526241,Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 21.,"Hubert Chapuis, Jiřina Slaninová, Lucie Bednárová, Lenka Monincová, Miloš Buděšínský, Václav Čeřovský",Effect of hydrocarbon stapling on the properties of α-helical antimicrobial peptides isolated from the venom of hymenoptera,Stapled AMP,,,,,
DRAMP21490,VNⓏKKILGKⓍIKVVK,VNZKKILGKXIKVVK,VNWKKILGKIIKVVK,15,LL-IIIs-5 cis,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,①22% α-helical content in water. ②54% α-helical content in 50% TFE. ③69% α-helical content in 8mM SDS.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Antifungal activity against Candida albicans is not noteable under 100 μM.,"[Ref.22526241] Gram-positive bacteria: Micrococcus luteus (MIC = 0.9 μM), Bacillus subtilis (MIC = 0.9 μM), Staphylococcus aureus (MIC = 45 μM);##Gram-negative bacteria: E.coli (MIC = 3.5 μM), Pseudomonas aeruginosa (MIC = 80 μM);##Fungi: Candida albicans (MIC > 100 μM).",[Ref.22526241] LC50 = 100 μM. Note: LC50 is the concentration of a peptide able to lyse 50% of human erthrocytes in the assay.,Cyclic (Stapled),Free,Amidation,①The Ⓩ (position: 3) indicates 2-(7'-octenyl) alanine in the R configuration. ②The Ⓧ (position: 10) is 2-(4'-pentenyl) alanine in the S configuration. ③Ⓩ (3) and Ⓧ (10) are cross-linked by hydrocarbon stapling.,"L, cis",No cytotoxicity information found in the reference,22526241,Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 22.,"Hubert Chapuis, Jiřina Slaninová, Lucie Bednárová, Lenka Monincová, Miloš Buděšínský, Václav Čeřovský",Effect of hydrocarbon stapling on the properties of α-helical antimicrobial peptides isolated from the venom of hymenoptera,Stapled AMP,,,,,
DRAMP21491,VNⓏKKILGKⓍIKVVK,VNZKKILGKXIKVVK,VNWKKILGKIIKVVK,15,LL-IIIs-5 trans,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,①26% α-helical content in water. ②54% α-helical content in 50% TFE. ③62% α-helical content in 8mM SDS.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Antifungal activity against Candida albicans is not noteable under 100 μM.,"[Ref.22526241] Gram-positive bacteria: Micrococcus luteus (MIC = 1.1 μM), Bacillus subtilis (MIC = 1.3 μM), Staphylococcus aureus (MIC = 65 μM);##Gram-negative bacteria: E.coli (MIC = 5.5 μM), Pseudomonas aeruginosa (MIC = 80 μM);##Fungi: Candida albicans (MIC > 100 μM).",[Ref.22526241] LC50 > 100 μM. Note: LC50 is the concentration of a peptide able to lyse 50% of human erthrocytes in the assay.,Cyclic (Stapled),Free,Amidation,①The Ⓩ (position: 3) indicates 2-(7'-octenyl) alanine in the R configuration. ②The Ⓧ (position: 10) is 2-(4'-pentenyl) alanine in the S configuration. ③Ⓩ (3) and Ⓧ (10) are cross-linked by hydrocarbon stapling.,"L, trans",No cytotoxicity information found in the reference,22526241,Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 23.,"Hubert Chapuis, Jiřina Slaninová, Lucie Bednárová, Lenka Monincová, Miloš Buděšínský, Václav Čeřovský",Effect of hydrocarbon stapling on the properties of α-helical antimicrobial peptides isolated from the venom of hymenoptera,Stapled AMP,,,,,
DRAMP21492,VNⓍKKIⓍPKⓍIKVⓍK,VNXKKIXPKXIKVXK,VNWKKILGKIIKVVK,15,LL-IIIs-6a,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,①36% α-helical content in water. ②42% α-helical content in 50% TFE. ③36% α-helical content in 8mM SDS.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Antifungal activity against Candida albicans is not noteable under 100 μM.,"[Ref.22526241] Gram-positive bacteria: Micrococcus luteus (MIC = 1 μM), Bacillus subtilis (MIC = 1.1 μM), Staphylococcus aureus (MIC = 93 μM);##Gram-negative bacteria: E.coli (MIC = 7.8 μM), Pseudomonas aeruginosa (MIC = 93 μM);##Fungi: Candida albicans (MIC > 100 μM).",[Ref.22526241] LC50 > 100 μM. Note: LC50 is the concentration of a peptide able to lyse 50% of human erthrocytes in the assay.,Cyclic (Stapled),Free,Amidation,"①The Ⓧ (position: 3, 7, 10 and 14) indicates 2-(4'-pentenyl) alanine in the S configuration. ②Ⓧ (3) and Ⓧ (7), Ⓧ (10) and Ⓧ (14) are cross-linked by hydrocarbon stapling respectively.","L, cis(around the S₅-Pro8 peptide bond)",No cytotoxicity information found in the reference,22526241,Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 24.,"Hubert Chapuis, Jiřina Slaninová, Lucie Bednárová, Lenka Monincová, Miloš Buděšínský, Václav Čeřovský",Effect of hydrocarbon stapling on the properties of α-helical antimicrobial peptides isolated from the venom of hymenoptera,Stapled AMP,,,,,
DRAMP21493,VNⓍKKIⓍPKⓍIKVⓍK,VNXKKIXPKXIKVXK,VNWKKILGKIIKVVK,15,LL-IIIs-6b,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,①33% α-helical content in water. ②38% α-helical content in 50% TFE. ③35% α-helical content in 8mM SDS.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Antifungal activity against Candida albicans is not noteable under 100 μM.,"[Ref.22526241] Gram-positive bacteria: Micrococcus luteus (MIC = 0.9 μM), Bacillus subtilis (MIC = 0.8 μM), Staphylococcus aureus (MIC = 50 μM);##Gram-negative bacteria: E.coli (MIC = 7.8 μM), Pseudomonas aeruginosa (MIC = 63 μM);##Fungi: Candida albicans (MIC > 100 μM).",[Ref.22526241] LC50 = 82μM. Note: LC50 is the concentration of a peptide able to lyse 50% of human erthrocytes in the assay.,Cyclic (Stapled),Free,Amidation,"①The Ⓧ (position: 3, 7, 10 and 14) indicates 2-(4'-pentenyl) alanine in the S configuration. ②Ⓧ (3) and Ⓧ (7), Ⓧ (10) and Ⓧ (14) are cross-linked by hydrocarbon stapling respectively.","L, trans(around the S₅-Pro8 peptide bond)",No cytotoxicity information found in the reference,22526241,Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 25.,"Hubert Chapuis, Jiřina Slaninová, Lucie Bednárová, Lenka Monincová, Miloš Buděšínský, Václav Čeřovský",Effect of hydrocarbon stapling on the properties of α-helical antimicrobial peptides isolated from the venom of hymenoptera,Stapled AMP,,,,,
DRAMP21495,GFLSILKKVLPKⓍJAHⓍK,GFLSILKKVLPKXJAHXK,GFLSILKKVLPKVMAHMK,18,MEP-Ns-1,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",,①19% α-helical content in water.②66% α-helical content in 50% TFE. ③75% α-helical content in 8mM SDS.,"The CD spectra of the singly stapled peptides of the i, i + 4 type acquired in water show a slight increase (by 5 %) of helical content in the case of MEP-Ns-1, MEP-Ns-2 and LL-IIIs-3 compared to their unstapled precursors.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria and Antifungal activity against Candida albicans.,"[Ref.22526241] Gram-positive bacteria: Micrococcus luteus (MIC = 0.8 μM), Bacillus subtilis (MIC = 1.1 μM), Staphylococcus aureus (MIC = 10.8 μM);##Gram-negative bacteria: E.coli (MIC = 2.5 μM), Pseudomonas aeruginosa (MIC = 77 μM);##Fungi: Candida albicans (MIC = 30 μM).",[Ref.22526241] LC50 = 18.1 μM. Note: LC50 is the concentration of a peptide able to lyse 50% of human erthrocytes in the assay.,Cyclic (Stapled),Free,Amidation,①The J (position: 14) in sequence indicates norleucine. ②The Ⓧ (position: 13 and 17) indicates 2-(4'-pentenyl) alanine in the S configuration. ③Ⓧ (13) and Ⓧ (17) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,22526241,Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 28.,"Hubert Chapuis, Jiřina Slaninová, Lucie Bednárová, Lenka Monincová, Miloš Buděšínský, Václav Čeřovský",Effect of hydrocarbon stapling on the properties of α-helical antimicrobial peptides isolated from the venom of hymenoptera,Stapled AMP,,,,,
DRAMP21496,GFLSⓍLKKⓍLPKVJAHJK,GFLSXLKKXLPKVJAHJK,GFLSILKKVLPKVMAHMK,18,MEP-Ns-2,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,①16% α-helical content in water.②61% α-helical content in 50% TFE. ③62% α-helical content in 8mM SDS.,"The CD spectra of the singly stapled peptides of the i, i + 4 type acquired in water show a slight increase (by 5 %) of helical content in the case of MEP-Ns-1, MEP-Ns-2 and LL-IIIs-3 compared to their unstapled precursors.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Antifungal activity against Candida albicans is not noteable under 100 μM.,"[Ref.22526241] Gram-positive bacteria: Micrococcus luteus (MIC = 1.5 μM), Bacillus subtilis (MIC = 1.2 μM), Staphylococcus aureus (MIC = 37 μM);##Gram-negative bacteria: E.coli (MIC = 7.8 μM), Pseudomonas aeruginosa (MIC ≥ 100 μM);##Fungi: Candida albicans (MIC ≥ 100 μM).",[Ref.22526241] LC50 = 14.7 μM. Note: LC50 is the concentration of a peptide able to lyse 50% of human erthrocytes in the assay.,Cyclic (Stapled),Free,Amidation,①The J (position: 14 and 17) in sequence indicates norleucine. ②The Ⓧ (position: 5 and 9) indicates 2-(4'-pentenyl) alanine in the S configuration. ③Ⓧ (5) and Ⓧ (9) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,22526241,Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 29.,"Hubert Chapuis, Jiřina Slaninová, Lucie Bednárová, Lenka Monincová, Miloš Buděšínský, Václav Čeřovský",Effect of hydrocarbon stapling on the properties of α-helical antimicrobial peptides isolated from the venom of hymenoptera,Stapled AMP,,,,,
DRAMP21497,GFLSⓍLKKⓍLPKⓍJAHⓍK,GFLSXLKKXLPKXJAHXK,GFLSILKKVLPKVMAHMK,18,MEP-Ns-3,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,①34% α-helical content in water.②56% α-helical content in 50% TFE. ③48% α-helical content in 8mM SDS.,"On the other hand, the difference in α-helical content between doubly stapled analogs (LL-IIIs-4, MEP-Ns-3, MEP-Ns-5, and MEP-Ns-6) and their unstapled precursors is apparently higher, on average by 15 %",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Antifungal activity against Candida albicans is not noteable under 100 μM.,"[Ref.22526241] Gram-positive bacteria: Micrococcus luteus (MIC =  1.3 μM), Bacillus subtilis (MIC = 1.2 μM), Staphylococcus aureus (MIC ≥ 100 μM);##Gram-negative bacteria: E.coli (MIC = 46.7 μM), Pseudomonas aeruginosa (MIC > 100 μM);##Fungi: Candida albicans (MIC > 100 μM).",[Ref.22526241] LC50 = 13.9 μM. Note: LC50 is the concentration of a peptide able to lyse 50% of human erthrocytes in the assay.,Cyclic (Stapled),Free,Amidation,"①The J (position: 14) in sequence indicates norleucine. ②Ⓧ (position: 5, 9, 13 and 17) are 2-(4'-pentenyl) alanine in the S configuration. ③Ⓧ (5) and Ⓧ (9), Ⓧ (13) and Ⓧ (17) are cross-linked by hydrocarbon stapling respectively.",L,No cytotoxicity information found in the reference,22526241,Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 30.,"Hubert Chapuis, Jiřina Slaninová, Lucie Bednárová, Lenka Monincová, Miloš Buděšínský, Václav Čeřovský",Effect of hydrocarbon stapling on the properties of α-helical antimicrobial peptides isolated from the venom of hymenoptera,Stapled AMP,,,,,
DRAMP21498,GFⓏSILKKVⓍPKVJAHJK,GFZSILKKVXPKVJAHJK,GFLSILKKVLPKVMAHMK,18,MEP-Ns-4 cis,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,Unknown,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Antifungal activity against Candida albicans is not noteable under 100 μM.,"[Ref.22526241] Gram-positive bacteria: Micrococcus luteus (MIC = 1.5 μM), Bacillus subtilis (MIC = 1.3 μM), Staphylococcus aureus (MIC = 37 μM);##Gram-negative bacteria: E.coli (MIC = 8.1 μM), Pseudomonas aeruginosa (MIC ≥ 100 μM);##Fungi: Candida albicans (MIC ≥ 100 μM).",[Ref.22526241] LC50 = 11 μM. Note: LC50 is the concentration of a peptide able to lyse 50% of human erthrocytes in the assay.,Cyclic (Stapled),Free,Amidation,①The J (position: 14 and 17) in sequence indicates norleucine. ②Ⓧ (position: 10) is 2-(4'-pentenyl) alanine in the S configuration. ③Ⓩ (position: 3) is 2-(7'-pctenyl) lalnine in the R configuration. ④Ⓧ (10) and Ⓩ (3) are cross-linked by hydrocarbon stapling.,"L, cis",No cytotoxicity information found in the reference,22526241,Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 31.,"Hubert Chapuis, Jiřina Slaninová, Lucie Bednárová, Lenka Monincová, Miloš Buděšínský, Václav Čeřovský",Effect of hydrocarbon stapling on the properties of α-helical antimicrobial peptides isolated from the venom of hymenoptera,Stapled AMP,,,,,
DRAMP21499,GFⓏSILKKVⓍPKVJAHJK,GFZSILKKVXPKVJAHJK,GFLSILKKVLPKVMAHMK,18,MEP-Ns-4 trans,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,Unknown,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Antifungal activity against Candida albicans is not noteable under 100 μM.,"[Ref.22526241] Gram-positive bacteria: Micrococcus luteus (MIC = 2 μM), Bacillus subtilis (MIC = 1.7 μM), Staphylococcus aureus (MIC = 63 μM);##Gram-negative bacteria: E.coli (MIC = 16.3 μM), Pseudomonas aeruginosa (MIC ≥ 100 μM);##Fungi: Candida albicans (MIC ≥ 100 μM).",[Ref.22526241] LC50 = 20 μM. Note: LC50 is the concentration of a peptide able to lyse 50% of human erthrocytes in the assay.,Cyclic (Stapled),Free,Amidation,①The J (position: 14 and 17) in sequence indicates norleucine. ②Ⓧ (position: 10) is 2-(4'-pentenyl) alanine in the S configuration. ③Ⓩ (position: 3) is 2-(7'-pctenyl) lalnine in the R configuration. ④Ⓧ (10) and Ⓩ (3) are cross-linked by hydrocarbon stapling.,"L, trans",No cytotoxicity information found in the reference,22526241,Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 32.,"Hubert Chapuis, Jiřina Slaninová, Lucie Bednárová, Lenka Monincová, Miloš Buděšínský, Václav Čeřovský",Effect of hydrocarbon stapling on the properties of α-helical antimicrobial peptides isolated from the venom of hymenoptera,Stapled AMP,,,,,
DRAMP21500,GFLSⓍLKKⓍLGKⓍJAHⓍK,GFLSXLKKXLGKXJAHXK,GFLSILKKVLPKVMAHMK,18,MEP-Ns-5,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,①52% α-helical content in water.②67% α-helical content in 50% TFE. ③59% α-helical content in 8mM SDS.,"On the other hand, the difference in α-helical content between doubly stapled analogs (LL-IIIs-4, MEP-Ns-3, MEP-Ns-5, and MEP-Ns-6) and their unstapled precursors is apparently higher, on average by 15 %",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Antifungal activity against Candida albicans is not noteable under 100 μM.,"[Ref.22526241] Gram-positive bacteria: Micrococcus luteus (MIC = 1.5 μM), Bacillus subtilis (MIC = 1.2 μM), Staphylococcus aureus (MIC = 57 μM);##Gram-negative bacteria: E.coli (MIC = 5.6 μM), Pseudomonas aeruginosa (MIC > 100 μM);##Fungi: Candida albicans (MIC > 100 μM).",[Ref.22526241] LC50 = 29 μM. Note: LC50 is the concentration of a peptide able to lyse 50% of human erthrocytes in the assay.,Cyclic (Stapled),Free,Amidation,"①The J (position: 14) in sequence indicates norleucine. ②Ⓧ (position: 5, 9, 13 and 17) indicates 2-(4'-pentenyl) alanine in the S configuration. ③Ⓧ (5) and Ⓧ (9), Ⓧ (13) and Ⓧ (17) are cross-linked by hydrocarbon stapling respectively.",L,No cytotoxicity information found in the reference,22526241,Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 33.,"Hubert Chapuis, Jiřina Slaninová, Lucie Bednárová, Lenka Monincová, Miloš Buděšínský, Václav Čeřovský",Effect of hydrocarbon stapling on the properties of α-helical antimicrobial peptides isolated from the venom of hymenoptera,Stapled AMP,,,,,
DRAMP21501,GFLSⓍLKKⓍLAKⓍJAHⓍK,GFLSXLKKXLAKXJAHXK,GFLSILKKVLPKVMAHMK,18,MEP-Ns-6,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,①56% α-helical content in water.②64% α-helical content in 50% TFE. ③56% α-helical content in 8mM SDS.,"On the other hand, the difference in α-helical content between doubly stapled analogs (LL-IIIs-4, MEP-Ns-3, MEP-Ns-5, and MEP-Ns-6) and their unstapled precursors is apparently higher, on average by 15 %",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Antifungal activity against Candida albicans is not noteable under 100 μM.,"[Ref.22526241] Gram-positive bacteria: Micrococcus luteus (MIC = 1.5 μM), Bacillus subtilis (MIC = 1.2 μM), Staphylococcus aureus (MIC = 43 μM);##Gram-negative bacteria: E.coli (MIC = 5.6 μM), Pseudomonas aeruginosa (MIC > 100 μM);##Fungi: Candida albicans (MIC > 100 μM).",[Ref.22526241] LC50 = 39.5 μM. Note: LC50 is the concentration of a peptide able to lyse 50% of human erthrocytes in the assay.,Cyclic (Stapled),Free,Amidation,"①The J (position: 14) in sequence indicates norleucine. ②Ⓧ (position: 5, 9, 13 and 17) indicates 2-(4'-pentenyl) alanine in the S configuration. ③Ⓧ (5) and Ⓧ (9), Ⓧ (13) and Ⓧ (17) are cross-linked by hydrocarbon stapling respectively.",L,No cytotoxicity information found in the reference,22526241,Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 34.,"Hubert Chapuis, Jiřina Slaninová, Lucie Bednárová, Lenka Monincová, Miloš Buděšínský, Václav Čeřovský",Effect of hydrocarbon stapling on the properties of α-helical antimicrobial peptides isolated from the venom of hymenoptera,Stapled AMP,,,,,
DRAMP21502,IDWKKLLⓀAAKⒼIL,IDWKKLLKAAKGIL,IDWKKLLDAAKQIL,14,C-MP1-1,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,①Slight α-helical structure in aqueous solution. ②Increased α-helical conformation in 30 mM SDS and 50% TFE compared with MPI,"①By CD, we observed that C-MPI-2 and MPI did not display any structural preferences in aqueous solution, whereas C-MPI-1 adopoted a slight α-helical structure. ②C-MPI-1 also had higher α-helicity than MPI in membrane mimicking environments, including 30 mM sodium dodecyl sulfate (SDS) and 50% trifluoroethyl alcohol (TFE).",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.28833783] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 64 μM), Bacillus subtilis ATCC 23857 (MIC = 8 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 64 μM), Pseudomonas aeruginosa ATCC 27853 (No antimicrobial activity)","[Ref.28833783] It has 0%, 0%, 2.1%, 9.5%, 22.7%, 25.4% and 34.7% against human red blood cells at peptide concentrations of 0, 5, 10, 25, 50, 75 and 150 μM.",Cyclic (Stapled),Acetylation,Amidation,"①The Ⓚ (position: 8) is lysine with the methyltrityl side chain. ②The Ⓖ (position: 12) is propargylglycine. ③Ⓚ (8) and Ⓖ (12) are cross-linked by hydrocarbon stapling by 1,3-diploar azide-alkyne cyclization.",L,No cytotoxicity information found in the reference,28833783,J Pept Sci. 2017 Nov;23(11):824-832. doi: 10.1002/psc.3031. Epub 2017 Aug 23.,"Beijun Liu, Wei Zhang, Sanhu Gou, Haifeng Huang, Jia Yao, Zhibin Yang, Hui Liu, Chao Zhong, Beiyin Liu, Jingman Ni, Rui Wang",Intramolecular cyclization of the antimicrobial peptide Polybia-MPI with triazole stapling: influence on stability and bioactivity,Stapled AMP,,,,,
DRAMP21503,IⓀWKKLLⒼAAKQIL,IKWKKLLGAAKQIL,IDWKKLLDAAKQIL,14,C-MP1-2,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,No structural preference in aqueous solution.,"By CD, we observed that C-MPI-2 and MPI did not display any structural preferences in aqueous solution, whereas C-MPI-1 adopoted a slight α-helical structure.",Not found,Function: Antibacterial activity against Gram-positive bacteria. Antibacterial activity against Gram-negative bacteria is not so evident.,"[Ref.28833783] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 256 μM), Bacillus subtilis ATCC 23857 (MIC = 128 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 128 μM), Pseudomonas aeruginosa ATCC 27853 (No antimicrobial activity)",[Ref.28833783] No hemolytic information found.,Cyclic (Stapled),Acetylation,Amidation,"①The Ⓚ (position: 2) is lysine with the methyltrityl side chain. ②The Ⓖ (position: 8) is propargylglycine. ③Ⓚ (2) and Ⓖ (8) are cross-linked by hydrocarbon stapling by 1,3-diploar azide-alkyne cyclization.",L,No cytotoxicity information found in the reference,28833783,J Pept Sci. 2017 Nov;23(11):824-832. doi: 10.1002/psc.3031. Epub 2017 Aug 23.,"Beijun Liu, Wei Zhang, Sanhu Gou, Haifeng Huang, Jia Yao, Zhibin Yang, Hui Liu, Chao Zhong, Beiyin Liu, Jingman Ni, Rui Wang",Intramolecular cyclization of the antimicrobial peptide Polybia-MPI with triazole stapling: influence on stability and bioactivity,Stapled AMP,,,,,
DRAMP21504,ⓍIGKⓍLHSAKKFGKAFVGEIJNS,XIGKXLHSAKKFGKAFVGEIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(I+4)0,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,15% α-helical content in 25-50 μM potassium phosphate solution.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 59.46 μg/mL), Bacillus cereus ATCC 14579 (MIC = 10.49 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 3.13 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 25.00 μg/mL)",[Ref.31427820] It has 5.6% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 1 and 5) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (1) and Ⓧ (5) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21505,GⓍGKFⓍHSAKKFGKAFVGEIJNS,GXGKFXHSAKKFGKAFVGEIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+4)1,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,12% α-helical content in 25-50 μM potassium phosphate solution.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 100.00 μg/mL), Bacillus cereus ATCC 14579 (MIC = 14.87 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 3.72 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 12.50 μg/mL)",[Ref.31427820] It has 4.6% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 2 and 6) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21506,GIⓍKFLⓍSAKKFGKAFVGEIJNS,GIXKFLXSAKKFGKAFVGEIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+4)2,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,21% α-helical content in 25-50 μM potassium phosphate solution.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 12.50 μg/mL), Bacillus cereus ATCC 14579 (MIC = 7.43 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 3.13 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 10.51 μg/mL)",[Ref.31427820] It has 18.3% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 3 and 7) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (3) and Ⓧ (7) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21507,GIGⓍFLHⓍAKKFGKAFVGEIJNS,GIGXFLHXAKKFGKAFVGEIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(I+4)3,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,18% α-helical content in 25-50 μM potassium phosphate solution.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 8.84 μg/mL), Bacillus cereus ATCC 14579 (MIC = 10.51 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 7.43 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 25.00 μg/mL)",[Ref.31427820] It has 42.1% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 4 and 8) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (4) and Ⓧ (8) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21508,GIGKⓍLHSⓍKKFGKAFVGEIJNS,GIGKXLHSXKKFGKAFVGEIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(I+4)4,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,24% α-helical content in 25-50 μM potassium phosphate solution.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 25.00 μg/mL), Bacillus cereus ATCC 14579 (MIC = 6.25 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 4.42 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 10.51 μg/mL)",[Ref.31427820] It has 18.3% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 5 and 9) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (5) and Ⓧ (9) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21509,GIGKFⓍHSAⓍKFGKAFVGEIJNS,GIGKFXHSAXKFGKAFVGEIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(I+4)5,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,14% α-helical content in 25-50 μM potassium phosphate solution.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 25.00 μg/mL), Bacillus cereus ATCC 14579 (MIC = 17.68 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 14.87 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 50.00 μg/mL)",[Ref.31427820] It has 13.2% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 6 and 10) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (6) and Ⓧ (10) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21510,GIGKFLⓍSAKⓍFGKAFVGEIJNS,GIGKFLXSAKXFGKAFVGEIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(I+4)6,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,18% α-helical content in 25-50 μM potassium phosphate solution.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 25.00 μg/mL), Bacillus cereus ATCC 14579 (MIC = 12.50 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 7.43 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 29.73 μg/mL)",[Ref.31427820] It has 7.6% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 7 and 11) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (7) and Ⓧ (11) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21511,GIGKFLHⓍAKKⓍGKAFVGEIJNS,GIGKFLHXAKKXGKAFVGEIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(I+4)7,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,26% α-helical content in 25-50 μM potassium phosphate solution.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 6.25 μg/mL), Bacillus cereus ATCC 14579 (MIC = 3.72 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 2.63 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 6.25 μg/mL)",[Ref.31427820] It has 62.4% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 8 and 12) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (8) and Ⓧ (12) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21512,GIGKFLHSⓍKKFⓍKAFVGEIJNS,GIGKFLHSXKKFXKAFVGEIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(I+4)8,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,49% α-helical content in 25-50 μM potassium phosphate solution.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 7.44 μg/mL), Bacillus cereus ATCC 14579 (MIC = 5.26 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 2.63 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 3.72 μg/mL)",[Ref.31427820] It has 74.6% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 9 and 13) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (9) and Ⓧ (13) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21513,GIGKFLHSAⓍKFGⓍAFVGEIJNS,GIGKFLHSAXKFGXAFVGEIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(I+4)9,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,28% α-helical content in 25-50 μM potassium phosphate solution.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 17.68 μg/mL), Bacillus cereus ATCC 14579 (MIC = 12.50 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 4.42 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 59.46 μg/mL)",[Ref.31427820] It has 60.0% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 10 and 14) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (10) and Ⓧ (14) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21514,GIGKFLHSAKⓍFGKⓍFVGEIJNS,GIGKFLHSAKXFGKXFVGEIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(I+4)10,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,15% α-helical content in 25-50 μM potassium phosphate solution.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 8.84 μg/mL), Bacillus cereus ATCC 14579 (MIC = 4.42 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 4.42 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 14.87 μg/mL)",[Ref.31427820] It has 23.9% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 11 and 15) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (11) and Ⓧ (15) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21515,GIGKFLHSAKKⓍGKAⓍVGEIJNS,GIGKFLHSAKKXGKAXVGEIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(I+4)11,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,16% α-helical content in 25-50 μM potassium phosphate solution.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 12.50 μg/mL), Bacillus cereus ATCC 14579 (MIC = 5.26 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 3.13 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 8.84 μg/mL)",[Ref.31427820] It has 17.8% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 12 and 16) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (12) and Ⓧ (16) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21516,GIGKFLHSAKKFⓍKAFⓍGEIJNS,GIGKFLHSAKKFXKAFXGEIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(I+4)12,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,51% α-helical content in 25-50 μM potassium phosphate solution.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 7.43 μg/mL), Bacillus cereus ATCC 14579 (MIC = 3.72 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 2.63 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 4.42 μg/mL)",[Ref.31427820] It has 76.6% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 13 and 17) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (13) and Ⓧ (17) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21517,GIGKFLHSAKKFGⓍAFVⓍEIJNS,GIGKFLHSAKKFGXAFVXEIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(I+4)13,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,23% α-helical content in 25-50 μM potassium phosphate solution.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 5.26 μg/mL), Bacillus cereus ATCC 14579 (MIC = 3.72 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 3.13 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 7.43 μg/mL)",[Ref.31427820] It has 60.0% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 14 and 18) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (14) and Ⓧ (18) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21518,GIGKFLHSAKKFGKⓍFVGⓍIJNS,GIGKFLHSAKKFGKXFVGXIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(I+4)14,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,19% α-helical content in 25-50 μM potassium phosphate solution.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 2.63 μg/mL), Bacillus cereus ATCC 14579 (MIC = 2.63 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 1.86 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 3.13 μg/mL)",[Ref.31427820] It has 92.4% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 15 and 19) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (15) and Ⓧ (19) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21519,GIGKFLHSAKKFGKAⓍVGEⓍJNS,GIGKFLHSAKKFGKAXVGEXJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(I+4)15,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,15% α-helical content in 25-50 μM potassium phosphate solution.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 10.51 μg/mL), Bacillus cereus ATCC 14579 (MIC = 5.26 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 2.63 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 7.43 μg/mL)",[Ref.31427820] It has 11.7% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 16 and 20) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (16) and Ⓧ (20) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21520,GIGKFLHSAKKFGKAFⓍGEIⓍNS,GIGKFLHSAKKFGKAFXGEIXNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(I+4)16,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,11% α-helical content in 25-50 μM potassium phosphate solution.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 42.04 μg/mL), Bacillus cereus ATCC 14579 (MIC = 7.44 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 3.72 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 8.84 μg/mL)",[Ref.31427820] It has 8.1% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 17 and 21) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②Ⓧ (17) and Ⓧ (21) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21521,GIGKFLHSAKKFGKAFVⓍEIJⓍS,GIGKFLHSAKKFGKAFVXEIJXS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(I+4)17,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,30% α-helical content in 25-50 μM potassium phosphate solution.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 2.63 μg/mL), Bacillus cereus ATCC 14579 (MIC = 1.86 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 1.56 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 5.26 μg/mL)",[Ref.31427820] It has 56.3% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 18 and 22) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (18) and Ⓧ (22) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21522,GIGKFLHSAKKFGKAFVGⓍIJNⓍ,GIGKFLHSAKKFGKAFVGXIJNX,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(I+4)18,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,19% α-helical content in 25-50 μM potassium phosphate solution.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 1.56 μg/mL), Bacillus cereus ATCC 14579 (MIC = 2.21 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 1.56 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 2.21 μg/mL)",[Ref.31427820] It has 101.0% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 19 and 23) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (19) and Ⓧ (23) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21523,KIGKFLHSAKKFGKAⓍVGEⓍJNS,KIGKFLHSAKKFGKAXVGEXJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+4)15(G1K),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 21.02 μg/mL), Bacillus cereus ATCC 14579 (MIC = 10.49 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 1.60 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 5.41 μg/mL)",[Ref.31427820] It has 4.4% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 16 and 20) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (16) and Ⓧ (20) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21524,GKGKFLHSAKKFGKAⓍVGEⓍJNS,GKGKFLHSAKKFGKAXVGEXJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+4)15(I2K),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 35.36 μg/mL), Bacillus cereus ATCC 14579 (MIC = 25.00 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 1.60 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 4.75 μg/mL)",[Ref.31427820] It has 2.2% hemolysis against human red blood cells at 25 μg/mL..,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 16 and 20) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (16) and Ⓧ (20) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21525,GIKKFLHSAKKFGKAⓍVGEⓍJNS,GIKKFLHSAKKFGKAXVGEXJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+4)15(G3K),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 10.49 μg/mL), Bacillus cereus ATCC 14579 (MIC = 5.21 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 1.60 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 3.34 μg/mL)",[Ref.31427820] It has 3.7% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 16 and 20) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (16) and Ⓧ (20) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21526,GIGKKLHSAKKFGKAⓍVGEⓍJNS,GIGKKLHSAKKFGKAXVGEXJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+4)15(F5K),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-negative bacteria. Antibacterial activity against Gram-positive bacteria is not noteable under 50 μg/mL.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC > 50 μg/mL), Bacillus cereus ATCC 14579 (MIC > 50 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 3.69 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 17.68 μg/mL)",[Ref.31427820] It has 1.5% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 16 and 20) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (16) and Ⓧ (20) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21527,GIGKFKHSAKKFGKAⓍVGEⓍJNS,GIGKFKHSAKKFGKAXVGEXJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+4)15(L6K),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-negative bacteria. Antibacterial activity against Gram-positive bacteria is not noteable under 50 μg/mL.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC > 50 μg/mL), Bacillus cereus ATCC 14579 (MIC > 50 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 2.63 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 17.68 μg/mL)",[Ref.31427820] It has 1.7% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 16 and 20) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (16) and Ⓧ (20) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21528,GIGKFLKSAKKFGKAⓍVGEⓍJNS,GIGKFLKSAKKFGKAXVGEXJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+4)15(H7K),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 6.20 μg/mL), Bacillus cereus ATCC 14579 (MIC = 5.21 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 1.60 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 2.69 μg/mL)",[Ref.31427820] It has 3.1% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 16 and 20) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (16) and Ⓧ (20) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21529,GIGKFLHKAKKFGKAⓍVGEⓍJNS,GIGKFLHKAKKFGKAXVGEXJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+4)15(S8K),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 6.20 μg/mL), Bacillus cereus ATCC 14579 (MIC = 4.38 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 1.60 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 2.65 μg/mL)",[Ref.31427820] It has 3.3% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 16 and 20) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (16) and Ⓧ (20) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21530,GIGKFLHSKKKFGKAⓍVGEⓍJNS,GIGKFLHSKKKFGKAXVGEXJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+4)15(A9K),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-negative bacteria. Antibacterial activity against Gram-positive bacteria is not noteable under 50 μg/mL.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC > 50 μg/mL), Bacillus cereus ATCC 14579 (MIC > 50 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 4.38 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 15.81 μg/mL)",[Ref.31427820] It has 1.7% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 16 and 20) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (16) and Ⓧ (20) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21531,GIGKFLHSAKKKGKAⓍVGEⓍJNS,GIGKFLHSAKKKGKAXVGEXJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+4)15(F12K),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-negative bacteria. Antibacterial activity against Gram-positive bacteria is not noteable under 50 μg/mL.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC > 50 μg/mL), Bacillus cereus ATCC 14579 (MIC > 50 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 2.63 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 14.03 μg/mL)",[Ref.31427820] It has 1.9% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 16 and 20) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (16) and Ⓧ (20) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21532,GIGKFLHSAKKFKKAⓍVGEⓍJNS,GIGKFLHSAKKFKKAXVGEXJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+4)15(G13K),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-negative bacteria. Antibacterial activity against Gram-positive bacteria is not noteable under 50 μg/mL.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC > 50 μg/mL), Bacillus cereus ATCC 14579 (MIC > 50 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 3.10 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 12.82 μg/mL)",[Ref.31427820] It has 1.8% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 16 and 20) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (16) and Ⓧ (20) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21533,GIGKFLHSAKKFGKKⓍVGEⓍJNS,GIGKFLHSAKKFGKKXVGEXJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+4)15(A15K),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 31.50 μg/mL), Bacillus cereus ATCC 14579 (MIC = 9.89 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 3.10 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 4.97 μg/mL)",[Ref.31427820] It has 6.5% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 16 and 20) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (16) and Ⓧ (20) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21534,GIGKFLHSAKKFGKAⓍKGEⓍJNS,GIGKFLHSAKKFGKAXKGEXJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+4)15(V17K),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC > 50 μg/mL), Bacillus cereus ATCC 14579 (MIC > 50 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 3.91 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 19.84 μg/mL)",[Ref.31427820] It has 2.1% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 16 and 20) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (16) and Ⓧ (20) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21535,GIGKFLHSAKKFGKAⓍVKEⓍJNS,GIGKFLHSAKKFGKAXVKEXJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+4)15(G18K),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 8.80 μg/mL), Bacillus cereus ATCC 14579 (MIC = 4.38 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 2.23 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 3.57 μg/mL)",[Ref.31427820] It has 8.3% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 16 and 20) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (16) and Ⓧ (20) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21536,GIGKFLHSAKKFGKAⓍVGKⓍJNS,GIGKFLHSAKKFGKAXVGKXJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+4)15(E19K),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 25.00 μg/mL), Bacillus cereus ATCC 14579 (MIC = 5.21 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 1.60 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 2.23 μg/mL)",[Ref.31427820] It has 6.0% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 16 and 20) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (16) and Ⓧ (20) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21537,GIGKFLHSAKKFGKAⓍVGEⓍKNS,GIGKFLHSAKKFGKAXVGEXKNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+4)15(B21K),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC > 50 μg/mL), Bacillus cereus ATCC 14579 (MIC = 29.73 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 2.23 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 8.97 μg/mL)",[Ref.31427820] It has 3.2% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 16 and 20) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②Ⓧ (16) and Ⓧ (20) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21538,GIGKFLHSAKKFGKAⓍVGEⓍJKS,GIGKFLHSAKKFGKAXVGEXJKS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+4)15(N22K),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 21.02 μg/mL), Bacillus cereus ATCC 14579 (MIC = 4.38 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 1.60 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 3.57 μg/mL)",[Ref.31427820] It has 11.9% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 16 and 20) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (16) and Ⓧ (20) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21539,GIGKFLHSAKKFGKAⓍVGEⓍJNK,GIGKFLHSAKKFGKAXVGEXJNK,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+4)15(S23K),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 42.04 μg/mL), Bacillus cereus ATCC 14579 (MIC = 7.39 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 2.23 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 3.57 μg/mL)",[Ref.31427820] It has 4.9% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 16 and 20) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (16) and Ⓧ (20) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21540,GⓍGSFⓍKKKAHVGKHⓍGKAⓍLTHYL,GXGSFXKKKAHVGKHXGKAXLTHYL,GWGSFFKKAAHVGKHVGKAALTHYL,25,"Pleu(i+4)1,15(A9K)",No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 3.13 μg/mL), Bacillus cereus ATCC 14579 (MIC = 3.13 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 1.56 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 1.56 μg/mL)",[Ref.31427820] It has 17.1% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,"①The Ⓧ (position: 2, 6, 16 and 20) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②Ⓧ (2) and Ⓧ (6), Ⓧ (16) and Ⓧ (20) are cross-linked by hydrocarbon stapling respectively.",L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21541,GⓍRKRⓍRKFRNKIKEKKKKIGQKⓍQGLⓍPKLA,GXRKRXRKFRNKIKEKKKKIGQKXQGLXPKLA,GLRKRLRKFRNKIKEKLKKIGQKIQGFVPKLAPRTDY,32,"CAP(i+4)1,23(L17K)",No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 12.5 μg/mL), Bacillus cereus ATCC 14579 (MIC = 3.13 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 1.56 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 1.56 μg/mL)",[Ref.31427820] It has 4.0% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,"①The Ⓧ (position: 2, 6, 24 and 28) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②Ⓧ (2) and Ⓧ (6), Ⓧ (24) and X (28) are cross-linked by hydrocarbon stapling respectively.",L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21542,GⓍGKFⓍHSKKKFGKAⓍVGEⓍBNS,GXGKFXHSKKKFGKAXVGEXBNS,GIGKFLHSAKKFGKAFVGEIMNS,23,"Mag(i+4)1,15(A9K)",No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 50 μg/mL), Bacillus cereus ATCC 14579 (MIC = 6.25 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 1.56 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 3.12 μg/mL)",[Ref.31427820] It has 1.9% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,"①The Ⓧ (position: 2, 6, 16 and 20) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The B (position: 21) in sequence is norlercine. ③Ⓧ (2) and Ⓧ (6), Ⓧ (16) and Ⓧ (20) are cross-linked by hydrocarbon stapling respectively.",L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21543,GⓍFSKⓍKGKKIKNLⓍISGⓍKG,GXFSKXKGKKIKNLXISGXKG,GIFSKLAGKKIKNLLISGLK,21,"Esc(i+4)1,14(A7K)",No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 50 μg/mL), Bacillus cereus ATCC 14579 (MIC = 12.5 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 1.56 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 1.56 μg/mL)",[Ref.31427820] It has 2.5% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,"①The Ⓧ (position: 2, 6, 15 and 19) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②Ⓧ (2) and Ⓧ (6), Ⓧ (15) and Ⓧ (19) are cross-linked by hydrocarbon stapling respectively.",L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21544,GⓏGKFLHSⓍKKFGKAFVGEIJNS,GZGKFLHSXKKFGKAFVGEIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+7)1,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 10.51 μg/mL), Bacillus cereus ATCC 14579 (MIC = 4.42 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 2.63 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 3.72 μg/mL)",[Ref.31427820] It has 49.7% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 9) in sequence is S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The Ⓩ (position: 2) in sequence is R8 stapling amino acid. Note: R8 is (R)-octenyl alanine. ③The J (position: 21) in sequence is norlercine. ④Ⓧ (9) and Ⓩ (2) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21545,GIⓏKFLHSAⓍKFGKAFVGEIJNS,GIZKFLHSAXKFGKAFVGEIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+7)2,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 12.50 μg/mL), Bacillus cereus ATCC 14579 (MIC = 8.84 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 4.42 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 21.02 μg/mL)",[Ref.31427820] It has 66.1% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 10) in sequence is S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The Ⓩ (position: 3) in sequence is R8 stapling amino acid. Note: R8 is (R)-octenyl alanine. ③The J (position: 21) in sequence is norlercine. ④Ⓧ (10) and Ⓩ (3) are cross-linked by hydrocarbon stapling. ,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21546,GIGⓏFLHSAKⓍFGKAFVGEIJNS,GIGZFLHSAKXFGKAFVGEIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+7)3,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 14.87 μg/mL), Bacillus cereus ATCC 14579 (MIC = 12.50 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 10.51 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 21.02 μg/mL)",[Ref.31427820] It has 52.6% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 11) in sequence is S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The Ⓩ (position: 4) in sequence is R8 stapling amino acid. Note: R8 is (R)-octenyl alanine. ③The J (position: 21) in sequence is norlercine. ④Ⓧ (11) and Ⓩ (4) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21547,GIGKⓏLHSAKKⓍGKAFVGEIJNS,GIGKZLHSAKKXGKAFVGEIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+7)4,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 21.02 μg/mL), Bacillus cereus ATCC 14579 (MIC = 5.26 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 2.21 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 6.25 μg/mL)",[Ref.31427820] It has 42.5% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 12) in sequence is S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The Ⓩ (position: 5) in sequence is R8 stapling amino acid. Note: R8 is (R)-octenyl alanine. ③The J (position: 21) in sequence is norlercine. ④Ⓧ (12) and Ⓩ (5) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21548,GIGKFⓏHSAKKFⓍKAFVGEIJNS,GIGKFZHSAKKFXKAFVGEIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+7)5,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 8.84 μg/mL), Bacillus cereus ATCC 14579 (MIC = 3.13 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 3.13 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 3.13 μg/mL)",[Ref.31427820] It has 82.9% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 13) in sequence is S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The Ⓩ (position: 6) in sequence is R8 stapling amino acid. Note: R8 is (R)-octenyl alanine. ③The J (position: 21) in sequence is norlercine. ④Ⓧ (13) and Ⓩ (6) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21549,GIGKFLⓏSAKKFGⓍAFVGEIJNS,GIGKFLZSAKKFGXAFVGEIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+7)6,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 6.25 μg/mL), Bacillus cereus ATCC 14579 (MIC = 4.42 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 3.13 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 14.87 μg/mL)",[Ref.31427820] It has 45.3% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 14) in sequence is S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The Ⓩ (position: 7) in sequence is R8 stapling amino acid. Note: R8 is (R)-octenyl alanine. ③The J (position: 21) in sequence is norlercine. ④Ⓧ (14) and Ⓩ (7) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21550,GIGKFLHⓏAKKFGKⓍFVGEIJNS,GIGKFLHZAKKFGKXFVGEIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+7)7,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 3.72 μg/mL), Bacillus cereus ATCC 14579 (MIC = 3.72 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 3.13 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 5.26 μg/mL)",[Ref.31427820] It has 95.3% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 15) in sequence is S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The Ⓩ (position: 8) in sequence is R8 stapling amino acid. Note: R8 is (R)-octenyl alanine. ③The J (position: 21) in sequence is norlercine. ④Ⓧ (15) and Ⓩ (8) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21551,GIGKFLHSⓏKKFGKAⓍVGEIJNS,GIGKFLHSZKKFGKAXVGEIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+7)8,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 6.25 μg/mL), Bacillus cereus ATCC 14579 (MIC = 3.72 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 2.21 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 3.72 μg/mL)",[Ref.31427820] It has 85.2% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 16) in sequence is S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The Ⓩ (position: 9) in sequence is R8 stapling amino acid. Note: R8 is (R)-octenyl alanine. ③The J (position: 21) in sequence is norlercine. ④Ⓧ (16) and Ⓩ (9) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21552,GIGKFLHSAⓏKFGKAFⓍGEIJNS,GIGKFLHSAZKFGKAFXGEIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+7)9,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 3.72 μg/mL), Bacillus cereus ATCC 14579 (MIC = 4.42 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 3.72 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 5.26 μg/mL)",[Ref.31427820] It has 94.6% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 17) in sequence is S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The Ⓩ (position: 10) in sequence is R8 stapling amino acid. Note: R8 is (R)-octenyl alanine. ③The J (position: 21) in sequence is norlercine. ④Ⓧ (17) and Ⓩ (10) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21553,GIGKFLHSAKⓏFGKAFVⓍEIJNS,GIGKFLHSAKZFGKAFVXEIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+7)10,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 4.42 μg/mL), Bacillus cereus ATCC 14579 (MIC = 3.72 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 3.13 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 7.43 μg/mL)",[Ref.31427820] It has 43.8% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 18) in sequence is S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The Ⓩ (position: 11) in sequence is R8 stapling amino acid. Note: R8 is (R)-octenyl alanine. ③The J (position: 21) in sequence is norlercine. ④Ⓧ (18) and Ⓩ (11) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21554,GIGKFLHSAKKⓏGKAFVGⓍIJNS,GIGKFLHSAKKZGKAFVGXIJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+7)11,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 2.63 μg/mL), Bacillus cereus ATCC 14579 (MIC = 2.63 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 2.21 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 2.21 μg/mL)",[Ref.31427820] It has 84.7% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 19) in sequence is S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The Ⓩ (position: 12) in sequence is R8 stapling amino acid. Note: R8 is (R)-octenyl alanine. ③The J (position: 21) in sequence is norlercine. ④Ⓧ (19) and Ⓩ (12) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21555,GIGKFLHSAKKFⓏKAFVGEⓍJNS,GIGKFLHSAKKFZKAFVGEXJNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+7)12,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 7.44 μg/mL), Bacillus cereus ATCC 14579 (MIC = 3.72 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 2.21 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 3.13 μg/mL)",[Ref.31427820] It has 75.4% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 20) in sequence is S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The Ⓩ (position: 13) in sequence is R8 stapling amino acid. Note: R8 is (R)-octenyl alanine. ③The J (position: 21) in sequence is norlercine. ④Ⓧ (20) and Ⓩ (13) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21556,GIGKFLHSAKKFGⓏAFVGEIⓍNS,GIGKFLHSAKKFGZAFVGEIXNS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+7)13,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 7.44 μg/mL), Bacillus cereus ATCC 14579 (MIC = 4.42 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 2.21 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 6.25 μg/mL)",[Ref.31427820] It has 63.5% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 21) in sequence is S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The Ⓩ (position: 14) in sequence is R8 stapling amino acid. Note: R8 is (R)-octenyl alanine. ③Ⓧ (21) and Ⓩ (14) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21557,GIGKFLHSAKKFGKⓏFVGEIJⓍS,GIGKFLHSAKKFGKZFVGEIJXS,GIGKFLHSAKKFGKAFVGEIMNS,23,Mag(i+7)14,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in potassium phosphate buffer.,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 2.63 μg/mL), Bacillus cereus ATCC 14579 (MIC = 1.56 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 1.86 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 5.26 μg/mL)",[Ref.31427820] It has 68.1% hemolysis against human red blood cells at 25 μg/mL.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 22) in sequence is S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The Ⓩ (position: 15) in sequence is R8 stapling amino acid. Note: R8 is (R)-octenyl alanine. ③The J (position: 21) in sequence is norlercine. ④Ⓧ (22) and Ⓩ (15) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information found in the reference,31427820,Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.,"Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky","Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice",Stapled AMP,,,,,
DRAMP21558,KⓍWKJⓍK,KXWKJXK,/,7,KKK,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in a 25 mM potassium phosphate solution (pH 6.5).,"①[Ref.30361948] All analogs displayed similar CD spectra to that of KKK, having two minima near 208 and 222 nm and a maximum near 190nm, which are characteristic of α-helices. ②[Ref.28547390] Peptide NLE and LYS maintained a compatible helicity to LEU.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.30361948] Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 12.5 μM), Staphyolococcus aureus ATCC 6538p (MIC = 6.3 μM),  Staphylococcus epidermidis ATCC 12228 (MIC= 25 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 12.5 μM), Shigella dysenteriae ATCC 9752 (MIC = 25 μM), Salmonella typhimurium ATCC 14028 (MIC = 50 μM), Klebsiella pneumoniae ATCC 10031 (MIC = 18.8 μM), Pseudomonas aeruginosa ATCC 27853 (MIC = 25 μM).##[Ref.28547390] Gram-positive bacteria: Bacillus subtilis (MIC = 6.3 μg/mL), Staphylococcus aureus (MIC = 6.3 μg/mL), Staphylococcus epidermidis (MIC = 12.5 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC = 12.5 μg/mL), Shigella dysenteriae (MIC = 12.5 μg/mL), Salmonella typhimurium (MIC = 50 μg/mL), Klebsiella pneumoniae (MIC = 18.8 μg/mL), Pseudomonas aeruginosa (MIC = 12.5 μg/mL).",[Ref.30361948] It has 1.5% hemolysis against human red blood cells at 25 μM and 3.0% hemolysis at 50 μM.##[Ref.28547390] 3.3% hemolysis against human red blood cells at 25 μM and 7.9% hemolysis t 50 μM.,Cyclic (Stapled),Free,Amidation,"①The J (position: 5) in sequence is norleucine. ②The Ⓧ (position: 2 and 6) indicates (S)-α-methyl, α-pentenylglycine. ③Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,30361948##28547390,Arch Pharm Res. 2018 Nov;41(11):1092-1097. doi: 10.1007/s12272-018-1084-5. Epub 2018 Oct 25.##Arch Pharm Res. 2017 Jun;40(6):713-719. doi: 10.1007/s12272-017-0922-1. Epub 2017 May 25.,"Huy X Luong, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim. ##Huy X Luong, Do-Hee Kim, Ngoan T Mai, Bong-Jin Lee, Young-Woo Kim",Effects of lysine-to-arginine substitution on antimicrobial activity of cationic stapled heptapeptides.##Mono-substitution effects on antimicrobial activity of stapled heptapeptides.,Stapled AMP,,,,,
DRAMP21559,RⓍWKJⓍK,RXWKJXK,/,7,RKK,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in a 25 mM potassium phosphate solution (pH 6.5).,"All analogs displayed similar CD spectra to that of KKK, having two minima near 208 and 222 nm and a maximum near 190nm, which are characteristic of α-helices.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.30361948] Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 6.3 μM), Staphyolococcus aureus ATCC 6538p (MIC = 6.3 μM),  Staphylococcus epidermidis ATCC 12228 (MIC= 12.5 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 12.5 μM), Shigella dysenteriae ATCC 9752 (MIC = 25 μM), Salmonella typhimurium ATCC 14028 (MIC = 25 μM), Klebsiella pneumoniae ATCC 10031 (MIC = 12.5 μM), Pseudomonas aeruginosa ATCC 27853 (MIC = 25 μM)",[Ref.30361948] It has 1.5% hemolysis against human red blood cells at 25 μM and 4.3% hemolysis at 50 μM.,Cyclic (Stapled),Free,Amidation,"①The J (position: 5) in sequence is norleucine. ②The Ⓧ (position: 2 and 6) indicates (S)-α-methyl, α-pentenylglycine. ③Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,30361948,Arch Pharm Res. 2018 Nov;41(11):1092-1097. doi: 10.1007/s12272-018-1084-5. Epub 2018 Oct 25.,"Huy X Luong, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim",Effects of lysine-to-arginine substitution on antimicrobial activity of cationic stapled heptapeptides,Stapled AMP,,,,,
DRAMP21560,KⓍWRJⓍK,KXWRJXK,/,7,KRK,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in a 25 mM potassium phosphate solution (pH 6.5).,"All analogs displayed similar CD spectra to that of KKK, having two minima near 208 and 222 nm and a maximum near 190nm, which are characteristic of α-helices.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.30361948] Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 12.5 μM), Staphyolococcus aureus ATCC 6538p (MIC = 6.3 μM),  Staphylococcus epidermidis ATCC 12228 (MIC= 25 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 25 μM), Shigella dysenteriae ATCC 9752 (MIC = 50 μM), Salmonella typhimurium ATCC 14028 (MIC = 75 μM), Klebsiella pneumoniae ATCC 10031 (MIC = 37.5 μM), Pseudomonas aeruginosa ATCC 27853 (MIC = 25 μM)",[Ref.30361948] It has <1% hemolysis against human red blood cells at 25 μM and 2.0% hemolysis at 50 μM.,Cyclic (Stapled),Free,Amidation,"①The J (position: 5) in sequence is norleucine. ②The Ⓧ (position: 2 and 6) indicates (S)-α-methyl, α-pentenylglycine. ③Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,30361948,Arch Pharm Res. 2018 Nov;41(11):1092-1097. doi: 10.1007/s12272-018-1084-5. Epub 2018 Oct 25.,"Huy X Luong, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim",Effects of lysine-to-arginine substitution on antimicrobial activity of cationic stapled heptapeptides,Stapled AMP,,,,,
DRAMP21561,KⓍWKJⓍR,KXWKJXR,/,7,KKR,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in a 25 mM potassium phosphate solution (pH 6.5).,"All analogs displayed similar CD spectra to that of KKK, having two minima near 208 and 222 nm and a maximum near 190nm, which are characteristic of α-helices.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.30361948] Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 9.4 μM), Staphyolococcus aureus ATCC 6538p (MIC = 6.3 μM),  Staphylococcus epidermidis ATCC 12228 (MIC = 25 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 12.5 μM), Shigella dysenteriae ATCC 9752 (MIC = 25 μM), Salmonella typhimurium ATCC 14028 (MIC = 50 μM), Klebsiella pneumoniae ATCC 10031 (MIC = 12.5 μM), Pseudomonas aeruginosa ATCC 27853 (MIC = 25 μM)",[Ref.30361948] It has 1.4% hemolysis against human red blood cells at 25 μM and % hemolysis at 50 μM.,Cyclic (Stapled),Free,Amidation,"①The J (position: 5) in sequence is norleucine. ②The Ⓧ (position: 2 and 6) indicates (S)-α-methyl, α-pentenylglycine. ③Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,30361948,Arch Pharm Res. 2018 Nov;41(11):1092-1097. doi: 10.1007/s12272-018-1084-5. Epub 2018 Oct 25.,"Huy X Luong, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim",Effects of lysine-to-arginine substitution on antimicrobial activity of cationic stapled heptapeptides,Stapled AMP,,,,,
DRAMP21562,RⓍWRJⓍK,RXWRJXK,/,7,RRK,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in a 25 mM potassium phosphate solution (pH 6.5).,"All analogs displayed similar CD spectra to that of KKK, having two minima near 208 and 222 nm and a maximum near 190nm, which are characteristic of α-helices.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.30361948] Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 12.5 μM), Staphyolococcus aureus ATCC 6538p (MIC = 6.3 μM),  Staphylococcus epidermidis ATCC 12228 (MIC = 25 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 25 μM), Shigella dysenteriae ATCC 9752 (MIC = 37.5 μM), Salmonella typhimurium ATCC 14028 (MIC = 100 μM), Klebsiella pneumoniae ATCC 10031 (MIC = 50 μM), Pseudomonas aeruginosa ATCC 27853 (MIC = 37.5 μM)",[Ref.30361948] It has <1% hemolysis against human red blood cells at 25 μM and <1% hemolysis at 50 μM.,Cyclic (Stapled),Free,Amidation,"①The J (position: 5) in sequence is norleucine. ②The Ⓧ (position: 2 and 6) indicates (S)-α-methyl, α-pentenylglycine. ③Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,30361948,Arch Pharm Res. 2018 Nov;41(11):1092-1097. doi: 10.1007/s12272-018-1084-5. Epub 2018 Oct 25.,"Huy X Luong, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim",Effects of lysine-to-arginine substitution on antimicrobial activity of cationic stapled heptapeptides,Stapled AMP,,,,,
DRAMP21563,RⓍWKJⓍR,RXWKJXR,/,7,RKR,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in a 25 mM potassium phosphate solution (pH 6.5).,"All analogs displayed similar CD spectra to that of KKK, having two minima near 208 and 222 nm and a maximum near 190nm, which are characteristic of α-helices.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.30361948] Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 6.3 μM), Staphyolococcus aureus ATCC 6538p (MIC = 3.2 μM),  Staphylococcus epidermidis ATCC 12228 (MIC = 12.5 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 6.3 μM), Shigella dysenteriae ATCC 9752 (MIC = 25 μM), Salmonella typhimurium ATCC 14028 (MIC = 25 μM), Klebsiella pneumoniae ATCC 10031 (MIC = 18.8 μM), Pseudomonas aeruginosa ATCC 27853 (MIC = 25 μM)",[Ref.30361948] It has 8.2% hemolysis against human red blood cells at 25 μM and 17.0% hemolysis at 50 μM.,Cyclic (Stapled),Free,Amidation,"①The J (position: 5) in sequence is norleucine. ②The Ⓧ (position: 2 and 6) indicates (S)-α-methyl, α-pentenylglycine. ③Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,30361948,Arch Pharm Res. 2018 Nov;41(11):1092-1097. doi: 10.1007/s12272-018-1084-5. Epub 2018 Oct 25.,"Huy X Luong, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim",Effects of lysine-to-arginine substitution on antimicrobial activity of cationic stapled heptapeptides,Stapled AMP,,,,,
DRAMP21564,KⓍWRJⓍR,KXWRJXR,/,7,KRR,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in a 25 mM potassium phosphate solution (pH 6.5).,"All analogs displayed similar CD spectra to that of KKK, having two minima near 208 and 222 nm and a maximum near 190nm, which are characteristic of α-helices.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.30361948] Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 6.3 μM), Staphyolococcus aureus ATCC 6538p (MIC = 3.2 μM),  Staphylococcus epidermidis ATCC 12228 (MIC = 12.5 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 12.5 μM), Shigella dysenteriae ATCC 9752 (MIC = 25 μM), Salmonella typhimurium ATCC 14028 (MIC = 50 μM), Klebsiella pneumoniae ATCC 10031 (MIC = 18.8 μM), Pseudomonas aeruginosa ATCC 27853 (MIC = 37.5 μM)",[Ref.30361948] It has 1.8% hemolysis against human red blood cells at 25 μM and 5.6% hemolysis at 50 μM.,Cyclic (Stapled),Free,Amidation,"①The J (position: 5) in sequence is norleucine. ②The Ⓧ (position: 2 and 6) indicates (S)-α-methyl, α-pentenylglycine. ③Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,30361948,Arch Pharm Res. 2018 Nov;41(11):1092-1097. doi: 10.1007/s12272-018-1084-5. Epub 2018 Oct 25.,"Huy X Luong, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim",Effects of lysine-to-arginine substitution on antimicrobial activity of cationic stapled heptapeptides,Stapled AMP,,,,,
DRAMP21565,RⓍWRJⓍR,RXWRJXR,/,7,RRR,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in a 25 mM potassium phosphate solution (pH 6.5).,"All analogs displayed similar CD spectra to that of KKK, having two minima near 208 and 222 nm and a maximum near 190nm, which are characteristic of α-helices.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.30361948] Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 12.5 μM), Staphyolococcus aureus ATCC 6538p (MIC = 6.3 μM),  Staphylococcus epidermidis ATCC 12228 (MIC = 25 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 25 μM), Shigella dysenteriae ATCC 9752 (MIC = 50 μM), Salmonella typhimurium ATCC 14028 (MIC = 100 μM), Klebsiella pneumoniae ATCC 10031 (MIC = 50 μM), Pseudomonas aeruginosa ATCC 27853 (MIC = 100 μM)",[Ref.30361948] It has <1% hemolysis against human red blood cells at 25 μM and 3.2% hemolysis at 50 μM.,Cyclic (Stapled),Free,Amidation,"①The J (position: 5) in sequence is norleucine. ②The Ⓧ (position: 2 and 6) indicates (S)-α-methyl, α-pentenylglycine. ③Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,30361948,Arch Pharm Res. 2018 Nov;41(11):1092-1097. doi: 10.1007/s12272-018-1084-5. Epub 2018 Oct 25.,"Huy X Luong, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim",Effects of lysine-to-arginine substitution on antimicrobial activity of cationic stapled heptapeptides,Stapled AMP,,,,,
DRAMP21566,IDWKKⓍLDAⓍKQIL,IDWKKXLDAXKQIL,IDWKKLLDAAKQIL,14,MP1S,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+",,96.1% α-helical content in a 25 mM potassium phosphate buffer solution at 20℃,"①Helical contents of all stapled analogues were increased by more than a three-fold compared to their unmodified counterpart, MP1. ②MP1S appears to be the most helical among this panel of peptides, showing 96% helicity, which is 3.7-fold higher than that of MP1.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.29075946] Gram-positive bacteria: Bacillus subtilis (MIC = 1.6 μg/mL), Staphylococcus aureus (MIC = 2.4 μg/mL), Staphylococcus epidermidis (MIC > 100 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC > 100 μg/mL), Shigella dysenteriae (MIC > 100 μg/mL), Salmonella typhimurium (MIC > 100 μg/mL), Klebsiella pneumoniae (MIC > 100 μg/mL), Pseudomonas aeruginosa (MIC > 100 μg/mL)",[Ref.29075946] It has 6.7% hemolysis against human red blood cells at 12.5 μM and 12.3% hemolysis at 25 μM.,Cyclic (Stapled),Free,Amidation,"①The Ⓧ (position: 6 and 10) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (6) and Ⓧ (10) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,29075946,Arch Pharm Res. 2017 Dec;40(12):1414-1419. doi: 10.1007/s12272-017-0963-5. Epub 2017 Oct 26.,"Huy X Luong, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim ",Antimicrobial activity and stability of stapled helices of polybia-MP1,Stapled AMP,,,,,
DRAMP21567,IDWKKⓍLNAⓍKQIL,IDWKKXLNAXKQIL,IDWKKLLDAAKQIL,14,MP1S-D8N,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,89.4% α-helical content in a 25 mM potassium phosphate buffer solution at 20℃,"①Helical contents of all stapled analogues were increased by more than a three-fold compared to their unmodified counterpart, MP1. ②MP1S-D8N and MP1S-Q12K showed slightly lower helical contents (89.4% and 81.8, respectively).",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.29075946] Gram-positive bacteria: Bacillus subtilis (MIC = 0.8 μg/mL), Staphylococcus aureus (MIC = 0.8 μg/mL), Staphylococcus epidermidis (MIC = 37.5 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC = 50 μg/mL), Shigella dysenteriae (MIC = 100 μg/mL), Salmonella typhimurium (MIC > 100 μg/mL), Klebsiella pneumoniae (MIC = 37.5 μg/mL), Pseudomonas aeruginosa (MIC ≥ 100 μg/mL)",[Ref.29075946] It has 16.3% hemolysis against human red blood cells at 12.5 μM and 37.8% hemolysis at 25 μM.,Cyclic (Stapled),Free,Amidation,"①The Ⓧ (position: 6 and 10) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (6) and Ⓧ (10) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,29075946,Arch Pharm Res. 2017 Dec;40(12):1414-1419. doi: 10.1007/s12272-017-0963-5. Epub 2017 Oct 26.,"Huy X Luong, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim ",Antimicrobial activity and stability of stapled helices of polybia-MP1,Stapled AMP,,,,,
DRAMP21568,IDWKKⓍLDAⓍKKIL,IDWKKXLDAXKKIL,IDWKKLLDAAKQIL,14,MP1S-Q12K,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+",,81.8% α-helical content in a 25 mM potassium phosphate buffer solution at 20℃,"①Helical contents of all stapled analogues were increased by more than a three-fold compared to their unmodified counterpart, MP1. ②MP1S-D8N and MP1S-Q12K showed slightly lower helical contents (89.4% and 81.8, respectively).",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.29075946] Gram-positive bacteria: Bacillus subtilis (MIC = 0.8 μg/mL), Staphylococcus aureus (MIC = 1.2 μg/mL), Staphylococcus epidermidis (MIC = 50 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC >100  μg/mL), Shigella dysenteriae (MIC > 100 μg/mL), Salmonella typhimurium (MIC > 100 μg/mL), Klebsiella pneumoniae (MIC > 100 μg/mL), Pseudomonas aeruginosa (MIC > 100 μg/mL)",[Ref.29075946] It has 9.6% hemolysis against human red blood cells at 12.5 μM and 13.9% hemolysis at 25 μM.,Cyclic (Stapled),Free,Amidation,"①The Ⓧ (position: 6 and 10) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (6) and Ⓧ (10) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,29075946,Arch Pharm Res. 2017 Dec;40(12):1414-1419. doi: 10.1007/s12272-017-0963-5. Epub 2017 Oct 26.,"Huy X Luong, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim ",Antimicrobial activity and stability of stapled helices of polybia-MP1,Stapled AMP,,,,,
DRAMP21569,KⓍWKAⓍK,KXWKAXK,/,7,ALA,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in a 25 mM potassium phosphate buffer solution at 20 ℃,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.28547390] Gram-positive bacteria: Bacillus subtilis (MIC = 25 μg/mL), Staphylococcus aureus (MIC = 25 μg/mL), Staphylococcus epidermidis (MIC = 100 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC = 25 μg/mL), Shigella dysenteriae (MIC = 50 μg/mL), Salmonella typhimurium (MIC = 100 μg/mL), Klebsiella pneumoniae (MIC = 25 μg/mL), Pseudomonas aeruginosa (MIC = 25 μg/mL)",[Ref.28547390] It has <1% hemolysis against human red blood cells at 25 μM and <1% hemolysis at 50 μM.,Cyclic (Stapled),Free,Amidation,"①The Ⓧ (position: 2 and 6) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,28547390,Arch Pharm Res. 2017 Jun;40(6):713-719. doi: 10.1007/s12272-017-0922-1. Epub 2017 May 25.,"Huy X Luong, Do-Hee Kim, Ngoan T Mai, Bong-Jin Lee, Young-Woo Kim",Mono-substitution effects on antimicrobial activity of stapled heptapeptides,Stapled AMP,,,,,
DRAMP21570,KⓍWKLⓍK,KXWKLXK,/,7,LEU,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in a 25 mM potassium phosphate buffer solution at 20 ℃,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.28547390] Gram-positive bacteria: Bacillus subtilis (MIC = 25 μg/mL), Staphylococcus aureus (MIC = 12.5 μg/mL), Staphylococcus epidermidis (MIC = 50 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC = 12.5 μg/mL), Shigella dysenteriae (MIC = 25 μg/mL), Salmonella typhimurium (MIC = 50 μg/mL), Klebsiella pneumoniae (MIC = 18.8 μg/mL), Pseudomonas aeruginosa (MIC = 18.8 μg/mL)",[Ref.28547390] It has <1% hemolysis against human red blood cells at 25 μM and <1% hemolysis at 50 μM.,Cyclic (Stapled),Free,Amidation,"①The Ⓧ (position: 2 and 6) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,28547390,Arch Pharm Res. 2017 Jun;40(6):713-719. doi: 10.1007/s12272-017-0922-1. Epub 2017 May 25.,"Huy X Luong, Do-Hee Kim, Ngoan T Mai, Bong-Jin Lee, Young-Woo Kim",Mono-substitution effects on antimicrobial activity of stapled heptapeptides,Stapled AMP,,,,,
DRAMP21571,KⓍWKVⓍK,KXWKVXK,/,7,VAL,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in a 25 mM potassium phosphate buffer solution at 20 ℃,"Compared to LEU, the previously reported stapled heptapeptide containing leucine in position 5, peptides VAL and ILE, carrying valine and isoleucine, respectively, appeared slightly more helical as determined by the CD signal intensity at 222 nm.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.28547390] Gram-positive bacteria: Bacillus subtilis (MIC = 18.8 μg/mL), Staphylococcus aureus (MIC = 12.5 μg/mL), Staphylococcus epidermidis (MIC = 50 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC = 18.8 μg/mL), Shigella dysenteriae (MIC = 25 μg/mL), Salmonella typhimurium (MIC = 100 μg/mL), Klebsiella pneumoniae (MIC = 18.8 μg/mL), Pseudomonas aeruginosa (MIC = 12.5 μg/mL)",[Ref.28547390] It has 1.3% hemolysis against human red blood cells at 25 μM and 2.5% hemolysis at 50 μM.,Cyclic (Stapled),Free,Amidation,"①The Ⓧ (position: 2 and 6) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,28547390,Arch Pharm Res. 2017 Jun;40(6):713-719. doi: 10.1007/s12272-017-0922-1. Epub 2017 May 25.,"Huy X Luong, Do-Hee Kim, Ngoan T Mai, Bong-Jin Lee, Young-Woo Kim",Mono-substitution effects on antimicrobial activity of stapled heptapeptides,Stapled AMP,,,,,
DRAMP21572,KⓍWKIⓍK,KXWKIXK,/,7,ILE,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in a 25 mM potassium phosphate buffer solution at 20 ℃,"Compared to LEU, the previously reported stapled heptapeptide containing leucine in position 5, peptides VAL and ILE, carrying valine and isoleucine, respectively, appeared slightly more helical as determined by the CD signal intensity at 222 nm.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.28547390] Gram-positive bacteria: Bacillus subtilis (MIC = 25 μg/mL), Staphylococcus aureus (MIC = 25 μg/mL), Staphylococcus epidermidis (MIC = 50 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC = 25 μg/mL), Shigella dysenteriae (MIC = 25 μg/mL), Salmonella typhimurium (MIC = 100 μg/mL), Klebsiella pneumoniae (MIC = 37.5 μg/mL), Pseudomonas aeruginosa (MIC = 12.5 μg/mL)",[Ref.28547390] It has 1.5% hemolysis against human red blood cells at 25 μM and 3.0% hemolysis at 50 μM.,Cyclic (Stapled),Free,Amidation,"①The Ⓧ (position: 2 and 6) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,28547390,Arch Pharm Res. 2017 Jun;40(6):713-719. doi: 10.1007/s12272-017-0922-1. Epub 2017 May 25.,"Huy X Luong, Do-Hee Kim, Ngoan T Mai, Bong-Jin Lee, Young-Woo Kim",Mono-substitution effects on antimicrobial activity of stapled heptapeptides,Stapled AMP,,,,,
DRAMP21573,KⓍWKFⓍK,KXWKFXK,/,7,PHE,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in a 25 mM potassium phosphate buffer solution at 20 ℃,"On the other hand, peptide PHE, TRP, and GLU, bearing phenylalanine, tryptophan, and glutamate, respectively, showed a slightly decreased helicity.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.28547390] Gram-positive bacteria: Bacillus subtilis (MIC = 25 μg/mL), Staphylococcus aureus (MIC = 25 μg/mL), Staphylococcus epidermidis (MIC = 50 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC = 25 μg/mL), Shigella dysenteriae (MIC = 50 μg/mL), Salmonella typhimurium (MIC = 100 μg/mL), Klebsiella pneumoniae (MIC = 25 μg/mL), Pseudomonas aeruginosa (MIC = 12.5 μg/mL)",[Ref.28547390] It has 1.9% hemolysis against human red blood cells at 25 μM and 4.4% hemolysis at 50 μM.,Cyclic (Stapled),Free,Amidation,"①The Ⓧ (position: 2 and 6) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,28547390,Arch Pharm Res. 2017 Jun;40(6):713-719. doi: 10.1007/s12272-017-0922-1. Epub 2017 May 25.,"Huy X Luong, Do-Hee Kim, Ngoan T Mai, Bong-Jin Lee, Young-Woo Kim",Mono-substitution effects on antimicrobial activity of stapled heptapeptides,Stapled AMP,,,,,
DRAMP21574,KⓍWKWⓍK,KXWKWXK,/,7,TRP,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in a 25 mM potassium phosphate buffer solution at 20 ℃,"On the other hand, peptide PHE, TRP, and GLU, bearing phenylalanine, tryptophan, and glutamate, respectively, showed a slightly decreased helicity.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.28547390] Gram-positive bacteria: Bacillus subtilis (MIC = 12.5 μg/mL), Staphylococcus aureus (MIC = 12.5 μg/mL), Staphylococcus epidermidis (MIC = 25 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC = 12.5 μg/mL), Shigella dysenteriae (MIC = 25 μg/mL), Salmonella typhimurium (MIC = 50 μg/mL), Klebsiella pneumoniae (MIC = 12.5 μg/mL), Pseudomonas aeruginosa (MIC = 12.5 μg/mL)",[Ref.28547390] It has 3.2% hemolysis against human red blood cells at 25 μM and 5.9% hemolysis at 50 μM.,Cyclic (Stapled),Free,Amidation,"①The Ⓧ (position: 2 and 6) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,28547390,Arch Pharm Res. 2017 Jun;40(6):713-719. doi: 10.1007/s12272-017-0922-1. Epub 2017 May 25.,"Huy X Luong, Do-Hee Kim, Ngoan T Mai, Bong-Jin Lee, Young-Woo Kim",Mono-substitution effects on antimicrobial activity of stapled heptapeptides,Stapled AMP,,,,,
DRAMP21575,KⓍWKEⓍK,KXWKEXK,/,7,GLU,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",,α-helix in a 25 mM potassium phosphate buffer solution at 20 ℃,"On the other hand, peptide PHE, TRP, and GLU, bearing phenylalanine, tryptophan, and glutamate, respectively, showed a slightly decreased helicity.",Not found,Function: Antibacterial activity against Gram-negative bacteria. Antibacterial activity against Gram-positive bacteria is not noteable under 100 μg/mL.,"[Ref.28547390] Gram-positive bacteria: Bacillus subtilis (MIC > 100 μg/mL), Staphylococcus aureus (MIC > 100 μg/mL), Staphylococcus epidermidis (MIC > 100 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC = 37.5 μg/mL), Shigella dysenteriae (MIC > 100 μg/mL), Salmonella typhimurium (MIC > 100 μg/mL), Klebsiella pneumoniae (MIC = 50 μg/mL), Pseudomonas aeruginosa (MIC = 25 μg/mL)",[Ref.28547390] It has <1% hemolysis against human red blood cells at 25 μM and <1% hemolysis at 50 μM.,Cyclic (Stapled),Free,Amidation,"①The Ⓧ (position: 2 and 6) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,28547390,Arch Pharm Res. 2017 Jun;40(6):713-719. doi: 10.1007/s12272-017-0922-1. Epub 2017 May 25.,"Huy X Luong, Do-Hee Kim, Ngoan T Mai, Bong-Jin Lee, Young-Woo Kim",Mono-substitution effects on antimicrobial activity of stapled heptapeptides,Stapled AMP,,,,,
DRAMP21576,KⓍWKKⓍK,KXWKKXK,/,7,LYS,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in a 25 mM potassium phosphate buffer solution at 20 ℃,Peptide NLE and LYS maintained a compatible helicity to LEU.,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.28547390] Gram-positive bacteria: Bacillus subtilis (MIC = 100 μg/mL), Staphylococcus aureus (MIC = 50 μg/mL), Staphylococcus epidermidis (MIC > 100 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC = 50 μg/mL), Shigella dysenteriae (MIC = 100 μg/mL), Salmonella typhimurium (MIC > 100 μg/mL), Klebsiella pneumoniae (MIC = 75 μg/mL), Pseudomonas aeruginosa (MIC = 6.3 μg/mL)",[Ref.28547390] It has <1% hemolysis against human red blood cells at 25 μM and <1% hemolysis at 50 μM.,Cyclic (Stapled),Free,Amidation,"①The Ⓧ (position: 2 and 6) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,28547390,Arch Pharm Res. 2017 Jun;40(6):713-719. doi: 10.1007/s12272-017-0922-1. Epub 2017 May 25.,"Huy X Luong, Do-Hee Kim, Ngoan T Mai, Bong-Jin Lee, Young-Woo Kim",Mono-substitution effects on antimicrobial activity of stapled heptapeptides,Stapled AMP,,,,,
DRAMP21578,WWVⓍARAⓍRR,WWVXARAXRR,WWVXARAXRR,10,Val-HSLP,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,0.0% α-helix and 34.3% β-strand in 20 mM potassium phosphate buffer; 0.8% α-helix and 36.9% β-strand in 20 mM potassium phosphate buffer made 30% in TFE.,"Only slghtly higher β-strand characteristics were observed for the hydrocarbon-stapled peptides in 30% TFE. Overall, the peptides showed some β-strand secondary structural characteristics and little α-helical content.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Antifungal activity against Candida albicans is not noteable under 20 μM.,"[Ref.28073163] Gram-positive bacteria: Bacillus megaterium ATCC 14581 (IC50 = 0.69 μM, MIC = 5.00 μM), Staphylococcus aureus ATCC 6538 (IC50 = 0.63 μM, MIC = 5.00 μM), Enterococcus faecalis ATCC 29212 (IC50 = 0.65 μM, MIC = 5.00 μM);##Gram-negative bacteria: Escherichia coli ATCC 700926 (IC50 = 14.8 μM, MIC > 20 μM);## Fungi: Candida albicans 002 ATCC 64385 (IC50 > 20 μM, MIC > 20 μM), C. albicans 004 ATCC MYA-2876 (IC50 > 20 μM, MIC > 20 μM).",[Ref.28073163] HC50 = 14.5 μM against human red blood cells. Note:  HC50 is the half-maximal hemolytic concentration.,Cyclic (Stapled),Acylation (Valerylamide),Amidation,①The Ⓧ (position: 4 and 8) in sequence indicates (S)-2-(4'-pentenyl)-alanine. ②Ⓧ (4) and Ⓧ (8) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,28073163,Biopolymers. 2017 May;108(3). doi: 10.1002/bip.23006.,"Zachary B Jenner, Christopher M Crittenden, Martín Gonzalez, Jennifer S Brodbelt, Kerry A Bruns",Hydrocarbon-stapled lipopeptides exhibit selective antimicrobial activity,Stapled AMP,,,,,
DRAMP21580,WWVⓍAFAⓍRRR,WWVXAFAXRRR,WWVXAFAXRRR,11,Cap-HSLP,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+",,0.3% α-helix and 31.9% β-strand in 20 mM potassium phosphate buffer; 0.7% α-helix and 40.0% β-strand in 20 mM potassium phosphate buffer made 30% in TFE.,"Only slghtly higher β-strand characteristics were observed for the hydrocarbon-stapled peptides in 30% TFE. Overall, the peptides showed some β-strand secondary structural characteristics and little α-helical content.",Not found,Function: Antibacterial activity against Gram-positive bacteria. Antibacterial activity against Gram-negative bacteria and antifungal activity against Candida albicans are not noteable under 20 μM.,"[Ref.28073163] Gram-positive bacteria: Bacillus megaterium ATCC 14581 (IC50 = 1.63 μM, MIC = 5.00 μM), Staphylococcus aureus ATCC 6538 (IC50 = 0.64 μM, MIC = 5.00 μM), Enterococcus faecalis ATCC 29212 (IC50 = 0.63 μM, MIC = 1.25 μM);##Gram-negative bacteria: Escherichia coli ATCC 700926 (IC50 = 169 μM, MIC > 20 μM);## Fungi: Candida albicans 002 ATCC 64385 (IC50 > 20 μM, MIC > 20 μM), C. albicans 004 ATCC MYA-2876 (IC50 > 20 μM, MIC > 20 μM).",[Ref.28073163] HC50 = 4.49 μM against human red blood cells. Note:  HC50 is the half-maximal hemolytic concentration.,Cyclic (Stapled),Acylation (Caproylamide),Amidation,①The Ⓧ (position: 4 and 8) in sequence indicates (S)-2-(4'-pentenyl)-alanine. ②Ⓧ (4) and Ⓧ (8) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,28073163,Biopolymers. 2017 May;108(3). doi: 10.1002/bip.23006.,"Zachary B Jenner, Christopher M Crittenden, Martín Gonzalez, Jennifer S Brodbelt, Kerry A Bruns",Hydrocarbon-stapled lipopeptides exhibit selective antimicrobial activity,Stapled AMP,,,,,
DRAMP21582,KⓍWKLⓍK,KXWKLXK,/,7,S3,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,Stable α-helix in a 25 mM potassium phosphate buffer solution at 20 ℃,No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. ,"Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 25 μg/mL), Staphylcocccus aureus ATCC 6538p (MIC = 25 μg/mL), Staphylcococcus epidermis ATCC 12228 (MIC = 100 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 25 μg/mL), Shigella dysentariae ATCC 9752 (MIC = 50 μg/mL), Salmonella typhimurium ATCC 14028 (MIC = 100 μg/mL), Klebsiella pneumonia ATCC 10031 (MIC = 50 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 75 μg/mL)",It has <1% hemolysis against human red blood cells at 6.3 μM and <1% hemolysis at 12.5 μM.,Cyclic (Stapled),Acetylation,Amidation,"①The Ⓧ (position: 2 and 6) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found.,PubMed ID is not available,B KOREAN CHEM SOC. 2016 Aug;37(8)1199-1203. doi: 10.1002/bkcs.10839.,"Huy X Luong, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim",Antimicrobial and Hemolytic Activity of Stapled Heptapeptide Dimers,Stapled AMP,,,,,
DRAMP21583,KⓍWKLⓍKGKⓍWKLⓍK,KXWKLXKGKXWKLXK,/,15,3GL3,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in a 25 mM potassium phosphate buffer solution at 20 ℃,3GL3 apperaed to be the most helical in this series as indicated by the distinct double minima near at 208 and 222 nm with similar intensities.,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. ,"Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 2.3 μg/mL), Staphylcocccus aureus ATCC 6538p (MIC = 1.6 μg/mL), Staphylcococcus epidermis ATCC 12228 (MIC = 3.1 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 3.1 μg/mL), Shigella dysentariae ATCC 9752 (MIC = 37.5 μg/mL), Salmonella typhimurium ATCC 14028 (MIC = 50 μg/mL), Klebsiella pneumonia ATCC 10031 (MIC = 6.3 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 9.4 μg/mL)",It has 19.1% hemolysis against human red blood cells at 6.3 μM and 31.8% hemolysis at 12.5 μM.,Cyclic (Stapled),Acetylation,Amidation,"①The Ⓧ (position: 2, 6, 10 and 14) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (2) and Ⓧ (6), Ⓧ (10) and Ⓧ (14) are cross-linked respectively by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found.,PubMed ID is not available,B KOREAN CHEM SOC. 2016 Aug;37(8)1199-1203. doi: 10.1002/bkcs.10839.,"Huy X Luong, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim",Antimicrobial and Hemolytic Activity of Stapled Heptapeptide Dimers,Stapled AMP,,,,,
DRAMP21584,KⓍWKLⓍKAKⓍWKLⓍK,KXWKLXKAKXWKLXK,/,15,3BA3,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,"No specific results about the strcture presented in the forms of tables, graphs or words",No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. ,"Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 2.3 μg/mL), Staphylcocccus aureus ATCC 6538p (MIC = 1.6 μg/mL), Staphylcococcus epidermis ATCC 12228 (MIC = 3.1 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 3.1 μg/mL), Shigella dysentariae ATCC 9752 (MIC = 6.3 μg/mL), Salmonella typhimurium ATCC 14028 (MIC = 12.5 μg/mL), Klebsiella pneumonia ATCC 10031 (MIC = 3.1 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 3.1 μg/mL)",It has 14.2% hemolysis against human red blood cells at 6.3 μM and 24.9% hemolysis at 12.5 μM.,Cyclic (Stapled),Acetylation,Amidation,"①The A (position: 8) in sequence is β-Ala. ②The Ⓧ (position: 2, 6, 10 and 14) in sequence indicates (S)-α-methyl, α-pentenylglycine. ③Ⓧ (2) and Ⓧ (6), Ⓧ (10) and Ⓧ (14) are cross-linked respectively by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found.,PubMed ID is not available,B KOREAN CHEM SOC. 2016 Aug;37(8)1199-1203. doi: 10.1002/bkcs.10839.,"Huy X Luong, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim",Antimicrobial and Hemolytic Activity of Stapled Heptapeptide Dimers,Stapled AMP,,,,,
DRAMP21585,KⓍWKLⓍKBKⓍWKLⓍK,KXWKLXKBKXWKLXK,/,15,3GA3,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,"No specific results about the strcture presented in the forms of tables, graphs or words",No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. ,"Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 4.0 μg/mL), Staphylcocccus aureus ATCC 6538p (MIC = 3.1 μg/mL), Staphylcococcus epidermis ATCC 12228 (MIC = 12.5 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 4.7 μg/mL), Shigella dysentariae ATCC 9752 (MIC = 18.8 μg/mL), Salmonella typhimurium ATCC 14028 (MIC = 37.5 μg/mL), Klebsiella pneumonia ATCC 10031 (MIC = 9.4 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 9.4 μg/mL)",It has 12.9% hemolysis against human red blood cells at 6.3 μM and 24.4% hemolysis at 12.5 μM.,Cyclic (Stapled),Acetylation,Amidation,"①The B (position: 8) in sequence is γ-aminobutyric acid (GABA). ②The Ⓧ (position: 2, 6, 10 and 14) in sequence indicates (S)-α-methyl, α-pentenylglycine. ③Ⓧ (2) and Ⓧ (6), Ⓧ (10) and Ⓧ (14) are cross-linked respectively by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found.,PubMed ID is not available,B KOREAN CHEM SOC. 2016 Aug;37(8)1199-1203. doi: 10.1002/bkcs.10839.,"Huy X Luong, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim",Antimicrobial and Hemolytic Activity of Stapled Heptapeptide Dimers,Stapled AMP,,,,,
DRAMP21586,KⓍWKLⓍKPKⓍWKLⓍK,KXWKLXKPKXWKLXK,/,15,3PR3-X,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in a 25 mM potassium phosphate buffer solution at 20 ℃,"Whereas all other
dimeric analogs were obtained as a single exclusive product,
the proline-containing sequence yielded two products
(3PR3-X and 3PR3-Y) in similar amounts. These might be
conformational isomers induced by the cis–trans configuration
of the proline linker. 3PR3-X, which showed the weakest hemolytic activity, displayed a CD spectrum similar to that of the monomeric S3 and the lowest helical content in this series.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. ,"Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 3.1 μg/mL), Staphylcocccus aureus ATCC 6538p (MIC = 4.7 μg/mL), Staphylcococcus epidermis ATCC 12228 (MIC = 12.5 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 3.1 μg/mL), Shigella dysentariae ATCC 9752 (MIC = 6.3 μg/mL), Salmonella typhimurium ATCC 14028 (MIC = 12.5 μg/mL), Klebsiella pneumonia ATCC 10031 (MIC = 4.7 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 9.4 μg/mL)",It has 5.7% hemolysis against human red blood cells at 6.3 μM and 9.7% hemolysis at 12.5 μM.,Cyclic (Stapled),Acetylation,Amidation,"①The Ⓧ (position: 2, 6, 10 and 14) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (2) and Ⓧ (6), Ⓧ (10) and Ⓧ (14) are cross-linked respectively by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple. ",L,No cytotoxicity information found.,PubMed ID is not available,B KOREAN CHEM SOC. 2016 Aug;37(8)1199-1203. doi: 10.1002/bkcs.10839.,"Huy X Luong, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim",Antimicrobial and Hemolytic Activity of Stapled Heptapeptide Dimers,Stapled AMP,,,,,
DRAMP21587,KⓍWKLⓍKPKⓍWKLⓍK,KXWKLXKPKXWKLXK,/,15,3PR3-Y,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in a 25 mM potassium phosphate buffer solution at 20 ℃,"Whereas all other
dimeric analogs were obtained as a single exclusive product,
the proline-containing sequence yielded two products
(3PR3-X and 3PR3-Y) in similar amounts. These might be
conformational isomers induced by the cis–trans configuration
of the proline linker.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 1.2 μg/mL), Staphylcocccus aureus ATCC 6538p (MIC = 1.2 μg/mL), Staphylcococcus epidermis ATCC 12228 (MIC = 4.7 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 2.3 μg/mL), Shigella dysentariae ATCC 9752 (MIC = 4.7 μg/mL), Salmonella typhimurium ATCC 14028 (MIC = 12.5 μg/mL), Klebsiella pneumonia ATCC 10031 (MIC = 3.1 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 6.3 μg/mL)",It has 16.2% hemolysis against human red blood cells at 6.3 μM and 31.9% hemolysis at 12.5 μM.,Cyclic (Stapled),Acetylation,Amidation,"①The Ⓧ (position: 2, 6, 10 and 14) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (2) and Ⓧ (6), Ⓧ (10) and Ⓧ (14) are cross-linked respectively by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple. ③The P (position: 8) in sequence is D-proline.",Mixed (D-Pro8),No cytotoxicity information found.,PubMed ID is not available,B KOREAN CHEM SOC. 2016 Aug;37(8)1199-1203. doi: 10.1002/bkcs.10839.,"Huy X Luong, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim",Antimicrobial and Hemolytic Activity of Stapled Heptapeptide Dimers,Stapled AMP,,,,,
DRAMP21588,KⓍWKAⓍK,KXWKAXK,/,7,Ac-S1,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in a 25 mM potassium phosphate buffer solution (pH 6.5),"On the contraty, conformations of sequences S1 and S3 appear to be not greatly affected by the presence of the N-acetyl cap.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 25 μM), Staphylococcus aureus ATCC 6538p (MIC = 25 μM), Staphylcocccus epidermis ATCC 12228 (MIC > 100 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 37.5 μM), Shigella dysentariae ATCC 9752 (MIC = 100 μM), Salmonella typhimurium ATCC 14028 (MIC > 100 μM), Klebsiella pneumonia ATCC 10031 (MIC = 50 μM), Pseudomonas aeruginose ATCC 27853 (MIC = 50 μM)","It has <1.0%, <1.0%, <1.0%, <1.0%, <1.0%, <1.0%, <1.0% and <1.0% hemolysis against human red blood cells at 0.8,1.6, 3.1, 6.3, 12.5, 25.0, 50.0 and 100.0 μM.",Cyclic (Stapled),Acetylation,Amidation,"①The Ⓧ (position: 2 and 6) in sequence indicates (S)-α-methyl, α-pententylglycine. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found.,PubMed ID is not available,B KOREAN CHEM SOC. 2015 Oct;36(10)2511-2515. doi: 10.1002/bkcs.10483.,"Thuy T.T. Dinh, Do-Hee Kim, Thang Q. Nguyen, Bong-Jin Lee, Young-Woo Kim",N-Capping Effects of Stapled Heptapeptides on Antimicrobial and Hemolytic Activities,Stapled AMP,,,,,
DRAMP21589,KⓍWKAⓍK,KXWKAXK,/,7,H-S1,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in a 25 mM potassium phosphate buffer solution (pH 6.5),"On the contraty, conformations of sequences S1 and S3 appear to be not greatly affected by the presence of the N-acetyl cap.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 25 μM), Staphylococcus aureus ATCC 6538p (MIC = 37.5 μM), Staphylcocccus epidermis ATCC 12228 (MIC > 100 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 25 μM), Shigella dysentariae ATCC 9752 (MIC = 100 μM), Salmonella typhimurium ATCC 14028 (MIC = 100 μM), Klebsiella pneumonia ATCC 10031 (MIC = 25 μM), Pseudomonas aeruginose ATCC 27853 (MIC = 25 μM)","It has <1.0%, <1.0%, <1.0%, <1.0%, <1.0%, <1.0%, <1.0% and <1.0% hemolysis against human red blood cells at 0.8,1.6, 3.1, 6.3, 12.5, 25.0, 50.0 and 100.0 μM.",Cyclic (Stapled),Free,Amidation,"①The Ⓧ (position: 2 and 6) in sequence indicates (S)-α-methyl, α-pententylglycine. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found.,PubMed ID is not available,B KOREAN CHEM SOC. 2015 Oct;36(10)2511-2515. doi: 10.1002/bkcs.10483.,"Thuy T.T. Dinh, Do-Hee Kim, Thang Q. Nguyen, Bong-Jin Lee, Young-Woo Kim",N-Capping Effects of Stapled Heptapeptides on Antimicrobial and Hemolytic Activities,Stapled AMP,,,,,
DRAMP21590,KⓍAKWⓍK,KXAKWXK,/,7,Ac-S2,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in a 25 mM potassium phosphate buffer solution (pH 6.5),Conformational analysis using far ultraviolet CD spectrometry indicates that the removal of the N-acetyl cap from Ac-S2 and Ac-S4 causes a significant loss of their helical contents.,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 25 μM), Staphylococcus aureus ATCC 6538p (MIC = 37.5 μM), Staphylcocccus epidermis ATCC 12228 (MIC > 100 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 25 μM), Shigella dysentariae ATCC 9752 (MIC = 100 μM), Salmonella typhimurium ATCC 14028 (MIC > 100 μM), Klebsiella pneumonia ATCC 10031 (MIC = 37.5 μM), Pseudomonas aeruginose ATCC 27853 (MIC = 50 μM)","It has <1.0%, <1.0%, <1.0%, <1.0%, <1.0%, <1.0%, <1.0% and <1.0% hemolysis against human red blood cells at 0.8,1.6, 3.1, 6.3, 12.5, 25.0, 50.0 and 100.0 μM.",Cyclic (Stapled),Acetylation,Amidation,"①The Ⓧ (position: 2 and 6) in sequence indicates (S)-α-methyl, α-pententylglycine. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found.,PubMed ID is not available,B KOREAN CHEM SOC. 2015 Oct;36(10)2511-2515. doi: 10.1002/bkcs.10483.,"Thuy T.T. Dinh, Do-Hee Kim, Thang Q. Nguyen, Bong-Jin Lee, Young-Woo Kim",N-Capping Effects of Stapled Heptapeptides on Antimicrobial and Hemolytic Activities,Stapled AMP,,,,,
DRAMP21591,KⓍAKWⓍK,KXAKWXK,/,7,H-S2,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix (but less helical than Ac-S2) in a 25 mM potassium phosphate buffer solution (pH 6.5),Conformational analysis using far ultraviolet CD spectrometry indicates that the removal of the N-acetyl cap from Ac-S2 and Ac-S4 causes a significant loss of their helical contents.,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 37.5 μM), Staphylococcus aureus ATCC 6538p (MIC = 37.5 μM), Staphylcocccus epidermis ATCC 12228 (MIC > 100 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 50 μM), Shigella dysentariae ATCC 9752 (MIC > 100 μM), Salmonella typhimurium ATCC 14028 (MIC > 100 μM), Klebsiella pneumonia ATCC 10031 (MIC = 50 μM), Pseudomonas aeruginose ATCC 27853 (MIC = 37.5 μM)","It has <1.0%, <1.0%, <1.0%, <1.0%, <1.0%, <1.0%, <1.0% and <1.0% hemolysis against human red blood cells at 0.8,1.6, 3.1, 6.3, 12.5, 25.0, 50.0 and 100.0 μM.",Cyclic (Stapled),Free,Amidation,"①The Ⓧ (position: 2 and 6) in sequence indicates (S)-α-methyl, α-pententylglycine. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found.,PubMed ID is not available,B KOREAN CHEM SOC. 2015 Oct;36(10)2511-2515. doi: 10.1002/bkcs.10483.,"Thuy T.T. Dinh, Do-Hee Kim, Thang Q. Nguyen, Bong-Jin Lee, Young-Woo Kim",N-Capping Effects of Stapled Heptapeptides on Antimicrobial and Hemolytic Activities,Stapled AMP,,,,,
DRAMP21592,KⓍWKLⓍK,KXWKLXK,/,7,Ac-S3,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in a 25 mM potassium phosphate buffer solution (pH 6.5),"On the contraty, conformations of sequences S1 and S3 appear to be not greatly affected by the presence of the N-acetyl cap.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 18.8 μM), Staphylococcus aureus ATCC 6538p (MIC = 25 μM), Staphylcocccus epidermis ATCC 12228 (MIC = 100 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 25 μM), Shigella dysentariae ATCC 9752 (MIC = 50 μM), Salmonella typhimurium ATCC 14028 (MIC = 75 μM), Klebsiella pneumonia ATCC 10031 (MIC = 37.5 μM), Pseudomonas aeruginose ATCC 27853 (MIC = 50 μM)","It has <1.0%, <1.0%, <1.0%, <1.0%, <1.0%, <1.0%, 1.59% and 5.53% hemolysis against human red blood cells at 0.8,1.6, 3.1, 6.3, 12.5, 25.0, 50.0 and 100.0 μM.",Cyclic (Stapled),Acetylation,Amidation,"①The Ⓧ (position: 2 and 6) in sequence indicates (S)-α-methyl, α-pententylglycine. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found.,PubMed ID is not available,B KOREAN CHEM SOC. 2015 Oct;36(10)2511-2515. doi: 10.1002/bkcs.10483.,"Thuy T.T. Dinh, Do-Hee Kim, Thang Q. Nguyen, Bong-Jin Lee, Young-Woo Kim",N-Capping Effects of Stapled Heptapeptides on Antimicrobial and Hemolytic Activities,Stapled AMP,,,,,
DRAMP21593,KⓍWKLⓍK,KXWKLXK,/,7,H-S3,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in a 25 mM potassium phosphate buffer solution (pH 6.5),"①On the contraty, conformations of sequences S1 and S3 appear to be not greatly affected by the presence of the N-acetyl cap. ②It should be also noted that H-S3 displays a CD spectrum that is typically observed from α-helical peptides even without the N-acetyl cal.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 12.5 μM), Staphylococcus aureus ATCC 6538p (MIC = 12.5 μM), Staphylcocccus epidermis ATCC 12228 (MIC = 25 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 12.5 μM), Shigella dysentariae ATCC 9752 (MIC = 50 μM), Salmonella typhimurium ATCC 14028 (MIC = 50 μM), Klebsiella pneumonia ATCC 10031 (MIC = 25 μM), Pseudomonas aeruginose ATCC 27853 (MIC = 25 μM)","It has <1.0%, <1.0%, <1.0%, <1.0%, <1.0%, <1.0%, <1.0% and 2.05% hemolysis against human red blood cells at 0.8,1.6, 3.1, 6.3, 12.5, 25.0, 50.0 and 100.0 μM.",Cyclic (Stapled),Free,Amidation,"①The Ⓧ (position: 2 and 6) in sequence indicates (S)-α-methyl, α-pententylglycine. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found.,PubMed ID is not available,B KOREAN CHEM SOC. 2015 Oct;36(10)2511-2515. doi: 10.1002/bkcs.10483.,"Thuy T.T. Dinh, Do-Hee Kim, Thang Q. Nguyen, Bong-Jin Lee, Young-Woo Kim",N-Capping Effects of Stapled Heptapeptides on Antimicrobial and Hemolytic Activities,Stapled AMP,,,,,
DRAMP21594,KⓍLKWⓍK,KXLKWXK,/,7,Ac-S4,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in a 25 mM potassium phosphate buffer solution (pH 6.5),Conformational analysis using far ultraviolet CD spectrometry indicates that the removal of the N-acetyl cap from Ac-S2 and Ac-S4 causes a significant loss of their helical contents.,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 12.5 μM), Staphylococcus aureus ATCC 6538p (MIC = 25 μM), Staphylcocccus epidermis ATCC 12228 (MIC = 100 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 25 μM), Shigella dysentariae ATCC 9752 (MIC = 50 μM), Salmonella typhimurium ATCC 14028 (MIC = 100 μM), Klebsiella pneumonia ATCC 10031 (MIC = 37.5 μM), Pseudomonas aeruginose ATCC 27853 (MIC = 50 μM)","It has <1.0%, <1.0%, <1.0%, <1.0%, <1.0%, 1.29%, 2.84% and 5.74% hemolysis against human red blood cells at 0.8,1.6, 3.1, 6.3, 12.5, 25.0, 50.0 and 100.0 μM.",Cyclic (Stapled),Acetylation,Amidation,"①The Ⓧ (position: 2 and 6) in sequence indicates (S)-α-methyl, α-pententylglycine. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found.,PubMed ID is not available,B KOREAN CHEM SOC. 2015 Oct;36(10)2511-2515. doi: 10.1002/bkcs.10483.,"Thuy T.T. Dinh, Do-Hee Kim, Thang Q. Nguyen, Bong-Jin Lee, Young-Woo Kim",N-Capping Effects of Stapled Heptapeptides on Antimicrobial and Hemolytic Activities,Stapled AMP,,,,,
DRAMP21595,KⓍLKWⓍK,KXLKWXK,/,7,H-S4,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix (but less helix content Ac-S4) in a 25 mM potassium phosphate buffer solution (pH 6.5),Conformational analysis using far ultraviolet CD spectrometry indicates that the removal of the N-acetyl cap from Ac-S2 and Ac-S4 causes a significant loss of their helical contents.,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 25 μM), Staphylococcus aureus ATCC 6538p (MIC = 50 μM), Staphylcocccus epidermis ATCC 12228 (MIC = 100 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 25 μM), Shigella dysentariae ATCC 9752 (MIC = 75 μM), Salmonella typhimurium ATCC 14028 (MIC = 100 μM), Klebsiella pneumonia ATCC 10031 (MIC = 37.5 μM), Pseudomonas aeruginose ATCC 27853 (MIC = 25 μM)","It has <1.0%, <1.0%, <1.0%, <1.0%, <1.0%, <1.0%, <1.0% and <1.0% hemolysis against human red blood cells at 0.8,1.6, 3.1, 6.3, 12.5, 25.0, 50.0 and 100.0 μM.",Cyclic (Stapled),Free,Amidation,"①The Ⓧ (position: 2 and 6) in sequence indicates (S)-α-methyl, α-pententylglycine. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found.,PubMed ID is not available,B KOREAN CHEM SOC. 2015 Oct;36(10)2511-2515. doi: 10.1002/bkcs.10483.,"Thuy T.T. Dinh, Do-Hee Kim, Thang Q. Nguyen, Bong-Jin Lee, Young-Woo Kim",N-Capping Effects of Stapled Heptapeptides on Antimicrobial and Hemolytic Activities,Stapled AMP,,,,,
DRAMP21597,KⓍAKAⓍKKAAKAAWK,KXAKAXKKAAKAAWK,KAAKAAKKAAKAAWK,15,Ac-SS-14W,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in 25 mM potassium phosphate buffer solution (pH6.5),"On the other hand, singly-stapled analog Ac-SS-14W exhibited a typical CD spectrum for α-helix, characterized by two minima near 208 and 222 nm and a maximum near 190 nm. ",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.26235946] Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 25 μM), Staphylococcus aureus ATCC 6538p (MIC = 9.4 μM), Staphylococcus epidermis ATCC 12228 (MIC = 75 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 3.1 μM), Shigella dysentariae ATCC 9752 (MIC = 18.8 μM), Salmonella typhimurium ATCC 14028 (MIC > 200 μM), Klebsiella pneumonia ATCC 10031 (MIC = 18.8 μM), Pseudomonas aeruginosa ATCC 27853 (MIC = 100 μM).",[Ref.26235946] It has <1% hemolysis against human red blood cells at 12.5 μM and <1% hemolysis at 25 μM.,Cyclic (Stapled),Acetylation,Amidation,"①The Ⓧ (position: 2 and 6) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,26235946,Bioorg Med Chem Lett. 2015 Sep 15;25(18):4016-9. doi: 10.1016/j.bmcl.2015.06.053. Epub 2015 Jun 19.,"Thuy T T Dinh, Do-Hee Kim, Huy X Luong, Bong-Jin Lee, Young-Woo Kim",Antimicrobial activity of doubly-stapled alanine/lysine-based peptides,Stapled AMP,,,,,
DRAMP21598,KⓍAKAⓍKKⓍAKAⓍWK,KXAKAXKKXAKAXWK,KAAKAAKKAAKAAWK,15,Ac-DS-14W,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in 25 mM potassium phosphate buffer solution (pH6.5),Doubly-stapled Ac-Ds-14W showed the most enhaced helical contents among this series of peptides. ,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.26235946] Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 1.6 μM), Staphylococcus aureus ATCC 6538p (MIC = 4.8 μM), Staphylococcus epidermis ATCC 12228 (MIC = 3.1 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 25 μM), Shigella dysentariae ATCC 9752 (MIC = 25 μM), Salmonella typhimurium ATCC 14028 (MIC = 100 μM), Klebsiella pneumonia ATCC 10031 (MIC = 200 μM), Pseudomonas aeruginosa ATCC 27853 (MIC = 100 μM).",[Ref.26235946] It has 22.1% hemolysis against human red blood cells at 12.5 μM and 38.8% hemolysis at 25 μM. ,Cyclic (Stapled),Acetylation,Amidation,"①The Ⓧ (position: 2 ,6, 9 and 13) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (2) and Ⓧ (6), Ⓧ (9) and Ⓧ (13) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,26235946,Bioorg Med Chem Lett. 2015 Sep 15;25(18):4016-9. doi: 10.1016/j.bmcl.2015.06.053. Epub 2015 Jun 19.,"Thuy T T Dinh, Do-Hee Kim, Huy X Luong, Bong-Jin Lee, Young-Woo Kim",Antimicrobial activity of doubly-stapled alanine/lysine-based peptides,Stapled AMP,,,,,
DRAMP21599,KⓍAKAⓍKKⓍAKWⓍAK,KXAKAXKKXAKWXAK,KAAKAAKKAAKAAWK,15,Ac-DS-12W,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in 25 mM potassium phosphate buffer solution (pH 6.5),"In addition, the positional modification of tryptophan caused significant changes in the conformation: in the CD analysis, the most active Ac-DS-5W exhibited markedly enhanced helical content whereas the equipotent Ac-DS-12W showed decreased helicity compared to Ac-DS-14W",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.26235946] Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 1.6 μM), Staphylococcus aureus ATCC 6538p (MIC = 3.1 μM), Staphylococcus epidermis ATCC 12228 (MIC = 4.8 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 50 μM), Shigella dysentariae ATCC 9752 (MIC = 50 μM), Salmonella typhimurium ATCC 14028 (MIC = 200 μM), Klebsiella pneumonia ATCC 10031 (MIC = 100 μM), Pseudomonas aeruginosa ATCC 27853 (MIC = 100 μM).",[Ref.26235946] It has 25.3% hemolysis against human red blood cells at 12.5 μM and 42.5% hemolysis at 25 μM.,Cyclic (Stapled),Acetylation,Amidation,"①The Ⓧ (position: 2 ,6, 9 and 13) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (2) and Ⓧ (6), Ⓧ (9) and Ⓧ (13) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,26235946,Bioorg Med Chem Lett. 2015 Sep 15;25(18):4016-9. doi: 10.1016/j.bmcl.2015.06.053. Epub 2015 Jun 19.,"Thuy T T Dinh, Do-Hee Kim, Huy X Luong, Bong-Jin Lee, Young-Woo Kim",Antimicrobial activity of doubly-stapled alanine/lysine-based peptides,Stapled AMP,,,,,
DRAMP21600,KⓍAKWⓍKKⓍAKAⓍAK,KXAKWXKKXAKAXAK,KAAKAAKKAAKAAWK,15,Ac-DS-3W,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in 25 mM potassium phosphate buffer solution (pH 6.5),No other descriptive information about the structure found in the literature,Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.26235946] Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 3.1 μM), Staphylococcus aureus ATCC 6538p (MIC = 4.8 μM), Staphylococcus epidermis ATCC 12228 (MIC = 4.8 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 25 μM), Shigella dysentariae ATCC 9752 (MIC = 50 μM), Salmonella typhimurium ATCC 14028 (MIC = 100 μM), Klebsiella pneumonia ATCC 10031 (MIC = 100 μM), Pseudomonas aeruginosa ATCC 27853 (MIC = 200 μM).",[Ref.26235946] It has 28.9% hemolysis against human red blood cells at 12.5 μM and 42.5% hemolysis at 25 μM.,Cyclic (Stapled),Acetylation,Amidation,"①The Ⓧ (position: 2 ,6, 9 and 13) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (2) and Ⓧ (6), Ⓧ (9) and Ⓧ (13) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,26235946,Bioorg Med Chem Lett. 2015 Sep 15;25(18):4016-9. doi: 10.1016/j.bmcl.2015.06.053. Epub 2015 Jun 19.,"Thuy T T Dinh, Do-Hee Kim, Huy X Luong, Bong-Jin Lee, Young-Woo Kim",Antimicrobial activity of doubly-stapled alanine/lysine-based peptides,Stapled AMP,,,,,
DRAMP21601,KⓍWKAⓍKKⓍAKAⓍAK,KXWKAXKKXAKAXAK,KAAKAAKKAAKAAWK,15,Ac-DS-5W,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in 25 mM potassium phosphate buffer solution (pH 6.5),"In addition, the positional modification of tryptophan caused significant changes in the conformation: in the CD analysis, the most active Ac-DS-5W exhibited markedly enhanced helical content whereas the equipotent Ac-DS-12W showed decreased helicity compared to Ac-DS-14W",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.26235946] Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 1.6 μM), Staphylococcus aureus ATCC 6538p (MIC = 1.6 μM), Staphylococcus epidermis ATCC 12228 (MIC = 1.6 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 18.8 μM), Shigella dysentariae ATCC 9752 (MIC = 25 μM), Salmonella typhimurium ATCC 14028 (MIC = 37.5 μM), Klebsiella pneumonia ATCC 10031 (MIC = 37.5 μM), Pseudomonas aeruginosa ATCC 27853 (MIC = 25 μM).",[Ref.26235946] It has 22.0% hemolysis against human red blood cells at 12.5 μM and 38.5% hemolysis at 25 μM.,Cyclic (Stapled),Acetylation,Amidation,"①The Ⓧ (position: 2 ,6, 9 and 13) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (2) and Ⓧ (6), Ⓧ (9) and Ⓧ (13) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,26235946,Bioorg Med Chem Lett. 2015 Sep 15;25(18):4016-9. doi: 10.1016/j.bmcl.2015.06.053. Epub 2015 Jun 19.,"Thuy T T Dinh, Do-Hee Kim, Huy X Luong, Bong-Jin Lee, Young-Woo Kim",Antimicrobial activity of doubly-stapled alanine/lysine-based peptides,Stapled AMP,,,,,
DRAMP21602,KⓍAKWⓍKKⓍAKAⓍAK,KXAKWXKKXAKAXAK,KAAKAAKKAAKAAWK,15,Su-DS-5W,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in 25 mM potassium phosphate buffer solution (pH 6.5),"In the CD experiments, these new analogs showed similar helicity to Ac-DS-5W although Su-DS-5W displayed a slight increase in helicity whereas H-DS-5W exhibited a slight decrease.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.26235946] Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 1.6 μM), Staphylococcus aureus ATCC 6538p (MIC = 1.6 μM), Staphylococcus epidermis ATCC 12228 (MIC = 1.6 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 12.5 μM), Shigella dysentariae ATCC 9752 (MIC = 50 μM), Salmonella typhimurium ATCC 14028 (MIC > 200 μM), Klebsiella pneumonia ATCC 10031 (MIC = 25 μM), Pseudomonas aeruginosa ATCC 27853 (MIC = 50 μM).",[Ref.26235946] It has 19.5% hemolysis against human red blood cells at 12.5 μM and 32.6% hemolysis at 25 μM.,Cyclic (Stapled),Succinylation,Amidation,"①The Ⓧ (position: 2 ,6, 9 and 13) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (2) and Ⓧ (6), Ⓧ (9) and Ⓧ (13) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,26235946,Bioorg Med Chem Lett. 2015 Sep 15;25(18):4016-9. doi: 10.1016/j.bmcl.2015.06.053. Epub 2015 Jun 19.,"Thuy T T Dinh, Do-Hee Kim, Huy X Luong, Bong-Jin Lee, Young-Woo Kim",Antimicrobial activity of doubly-stapled alanine/lysine-based peptides,Stapled AMP,,,,,
DRAMP21603,KⓍAKWⓍKKⓍAKAⓍAK,KXAKWXKKXAKAXAK,KAAKAAKKAAKAAWK,15,H-DS-5W,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in 25 mM potassium phosphate buffer solution (pH 6.5),"In the CD experiments, these new analogs showed similar helicity to Ac-DS-5W although Su-DS-5W displayed a slight increase in helicity whereas H-DS-5W exhibited a slight decrease.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.26235946] Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 1.6 μM), Staphylococcus aureus ATCC 6538p (MIC = 1.6 μM), Staphylococcus epidermis ATCC 12228 (MIC = 1.6 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 3.1 μM), Shigella dysentariae ATCC 9752 (MIC = 12.5 μM), Salmonella typhimurium ATCC 14028 (MIC = 6.3 μM), Klebsiella pneumonia ATCC 10031 (MIC = 12.5 μM), Pseudomonas aeruginosa ATCC 27853 (MIC = 6.3 μM).",[Ref.26235946] It has 13.5% hemolysis against human red blood cells at 12.5 μM and 25.5% hemolysis at 25 μM.,Cyclic (Stapled),Free,Amidation,"①The Ⓧ (position: 2 ,6, 9 and 13) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (2) and Ⓧ (6), Ⓧ (9) and Ⓧ (13) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found in the reference,26235946,Bioorg Med Chem Lett. 2015 Sep 15;25(18):4016-9. doi: 10.1016/j.bmcl.2015.06.053. Epub 2015 Jun 19.,"Thuy T T Dinh, Do-Hee Kim, Huy X Luong, Bong-Jin Lee, Young-Woo Kim",Antimicrobial activity of doubly-stapled alanine/lysine-based peptides,Stapled AMP,,,,,
DRAMP21605,KⓍWKAⓍK,KXWKAXK,KXWKAXK,7,S1,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in 25 mM potassium phosphate buffer solution (pH 6.5),"As expected, in the far ultraviolet circular dichroism (CD) experiment, the stapled heptapeptides displayed enhanced helical contents compared to their corresponding unstapled counterparts.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 25 μM), Staphylococcus aureus ATCC 6538p (MIC = 25 μM), Staphylococcus epidermis ATCC 12228 (MIC > 100 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 25 μM), Shigella dysentariae ATCC 9752 (MIC = 100 μM), Salmonella typhimurium ATCC 14028 (MIC > 100 μM), Klebsiella pneumonia ATCC 10031 (MIC = 50 μM), Pseudomonas aeruginosa ATCC 27853 (MIC = 50 μM).","It has 0.53%, 0.53%, 0.67%, 0.66%, 0.83%, 1.36%, 1.17% and 1.21% hemolysis against human red blood cells at 0.8, 1.6, 3.1, 6.3, 12.5, 25.0, 50.0 and 100.0 μM.",Cyclic (Stapled),Acetylation,Amidation,"①The Ⓧ (position: 2 and 6) in sequence indicates (S)-α-methyl, α-pentenylglycine. Note: the Experimental section presenst that X is (S)-α-methyl, α-pentenylglycine, while the Results section presents that X is pentenylalanine. We incline to the former representation according to previous papers published by the research group which the author belonged. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found.,PubMed ID is not available,B KOREAN CHEM SOC,"Thuy T.T. Dinh, Do-Hee Kim, Song-Jin Lee, Young-Woo Kim",De Novo Design and Their Antimicrobial Activity of Stapled Amphipathic Helices of Heptapeptides,Stapled AMP,,,,,
DRAMP21607,KⓍAKWⓍK,KXAKWXK,KXAKWXK,7,S2,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in 25 mM potassium phosphate buffer solution (pH 6.5),"As expected, in the far ultraviolet circular dichroism (CD) experiment, the stapled heptapeptides displayed enhanced helical contents compared to their corresponding unstapled counterparts.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 50 μM), Staphylococcus aureus ATCC 6538p (MIC = 100 μM), Staphylococcus epidermis ATCC 12228 (MIC > 100 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 50 μM), Shigella dysentariae ATCC 9752 (MIC > 100 μM), Salmonella typhimurium ATCC 14028 (MIC > 100 μM), Klebsiella pneumonia ATCC 10031 (MIC = 100 μM), Pseudomonas aeruginosa ATCC 27853 (MIC > 100 μM).","It has 0.91%, 1.01%, 0.66%, 0.99%, 0.63%, 0.82%, 1.75% and 1.24% hemolysis against human red blood cells at 0.8, 1.6, 3.1, 6.3, 12.5, 25.0, 50.0 and 100.0 μM.",Cyclic (Stapled),Acetylation,Amidation,"①The Ⓧ (position: 2 and 6) in sequence indicates (S)-α-methyl, α-pentenylglycine. Note: the Experimental section presenst that X is (S)-α-methyl, α-pentenylglycine, while the Results section presents that X is pentenylalanine. We incline to the former representation according to previous papers published by the research group which the author belonged. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found.,PubMed ID is not available,B KOREAN CHEM SOC,"Thuy T.T. Dinh, Do-Hee Kim, Song-Jin Lee, Young-Woo Kim",De Novo Design and Their Antimicrobial Activity of Stapled Amphipathic Helices of Heptapeptides,Stapled AMP,,,,,
DRAMP21609,KⓍWKLⓍK,KXWKLXK,KXWKLXK,7,S3,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in 25 mM potassium phosphate buffer solution (pH 6.5),"As expected, in the far ultraviolet circular dichroism (CD) experiment, the stapled heptapeptides displayed enhanced helical contents compared to their corresponding unstapled counterparts.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 12.5 μM), Staphylococcus aureus ATCC 6538p (MIC = 25 μM), Staphylococcus epidermis ATCC 12228 (MIC = 100 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 12.5 μM), Shigella dysentariae ATCC 9752 (MIC = 25 μM), Salmonella typhimurium ATCC 14028 (MIC = 50 μM), Klebsiella pneumonia ATCC 10031 (MIC = 25 μM), Pseudomonas aeruginosa ATCC 27853 (MIC = 25 μM).","It has 0.87%, 0.65%, 1.02%, 0.94%, 2.13%, 2.52%, 3.81% and 7.75% hemolysis against human red blood cells at 0.8, 1.6, 3.1, 6.3, 12.5, 25.0, 50.0 and 100.0 μM.",Cyclic (Stapled),Acetylation,Amidation,"①The Ⓧ (position: 2 and 6) in sequence indicates (S)-α-methyl, α-pentenylglycine. Note: the Experimental section presenst that X is (S)-α-methyl, α-pentenylglycine, while the Results section presents that X is pentenylalanine. We incline to the former representation according to previous papers published by the research group which the author belonged. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found.,PubMed ID is not available,B KOREAN CHEM SOC,"Thuy T.T. Dinh, Do-Hee Kim, Song-Jin Lee, Young-Woo Kim",De Novo Design and Their Antimicrobial Activity of Stapled Amphipathic Helices of Heptapeptides,Stapled AMP,,,,,
DRAMP21611,KⓍLKWⓍK,KXLKWXK,KXLKWXK,7,S4,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in 25 mM potassium phosphate buffer solution (pH 6.5),"As expected, in the far ultraviolet circular dichroism (CD) experiment, the stapled heptapeptides displayed enhanced helical contents compared to their corresponding unstapled counterparts.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 12.5 μM), Staphylococcus aureus ATCC 6538p (MIC = 12.5 μM), Staphylococcus epidermis ATCC 12228 (MIC = 100 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 25 μM), Shigella dysentariae ATCC 9752 (MIC = 25 μM), Salmonella typhimurium ATCC 14028 (MIC = 50 μM), Klebsiella pneumonia ATCC 10031 (MIC = 25 μM), Pseudomonas aeruginosa ATCC 27853 (MIC = 25 μM).","It has 0.71%, 0.90%, 0.71%, 0.68%, 1.08%, 1.87%, 2.46% and 4.50% hemolysis against human red blood cells at 0.8, 1.6, 3.1, 6.3, 12.5, 25.0, 50.0 and 100.0 μM.",Cyclic (Stapled),Acetylation,Amidation,"①The Ⓧ (position: 2 and 6) in sequence indicates (S)-α-methyl, α-pentenylglycine. Note: the Experimental section presenst that X is (S)-α-methyl, α-pentenylglycine, while the Results section presents that X is pentenylalanine. We incline to the former representation according to previous papers published by the research group which the author belonged. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found.,PubMed ID is not available,B KOREAN CHEM SOC,"Thuy T.T. Dinh, Do-Hee Kim, Song-Jin Lee, Young-Woo Kim",De Novo Design and Their Antimicrobial Activity of Stapled Amphipathic Helices of Heptapeptides,Stapled AMP,,,,,
DRAMP21613,KⓍWAKⓍA,KXWAKXA,KXWAKXA,7,S5,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in 25 mM potassium phosphate buffer solution (pH 6.5),"As expected, in the far ultraviolet circular dichroism (CD) experiment, the stapled heptapeptides displayed enhanced helical contents compared to their corresponding unstapled counterparts.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 50 μM), Staphylococcus aureus ATCC 6538p (MIC = 50 μM), Staphylococcus epidermis ATCC 12228 (MIC > 100 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 50 μM), Shigella dysentariae ATCC 9752 (MIC > 100 μM), Salmonella typhimurium ATCC 14028 (MIC > 100 μM), Klebsiella pneumonia ATCC 10031 (MIC = 100 μM), Pseudomonas aeruginosa ATCC 27853 (MIC > 100 μM).","It has 0.65%, 0.60%, 0.59%, 0.76%, 0.83%, 0.76%, 0.88% and 1.04% hemolysis against human red blood cells at 0.8, 1.6, 3.1, 6.3, 12.5, 25.0, 50.0 and 100.0 μM.",Cyclic (Stapled),Acetylation,Amidation,"①The Ⓧ (position: 2 and 6) in sequence indicates (S)-α-methyl, α-pentenylglycine. Note: the Experimental section presenst that X is (S)-α-methyl, α-pentenylglycine, while the Results section presents that X is pentenylalanine. We incline to the former representation according to previous papers published by the research group which the author belonged. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found.,PubMed ID is not available,B KOREAN CHEM SOC,"Thuy T.T. Dinh, Do-Hee Kim, Song-Jin Lee, Young-Woo Kim",De Novo Design and Their Antimicrobial Activity of Stapled Amphipathic Helices of Heptapeptides,Stapled AMP,,,,,
DRAMP21615,KⓍAWKⓍA,KXAWKXA,KXAWKXA,7,S6,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",,α-helix in 25 mM potassium phosphate buffer solution (pH 6.5),"As expected, in the far ultraviolet circular dichroism (CD) experiment, the stapled heptapeptides displayed enhanced helical contents compared to their corresponding unstapled counterparts.",Not found,Function: Antibacterial activity against Gram-negative bacteria. Antibacterial activity against Gram-positive bacteria is not noteable under 100 μM.,"Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC > 100 μM), Staphylococcus aureus ATCC 6538p (MIC > 100 μM), Staphylococcus epidermis ATCC 12228 (MIC > 100 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 100 μM), Shigella dysentariae ATCC 9752 (MIC > 100 μM), Salmonella typhimurium ATCC 14028 (MIC > 100 μM), Klebsiella pneumonia ATCC 10031 (MIC > 100 μM), Pseudomonas aeruginosa ATCC 27853 (MIC > 100 μM).","It has 0.65%, 0.66%, 0.75%, 0.87%, 0.64%, 0.70%, 0.61% and 0.84% hemolysis against human red blood cells at 0.8, 1.6, 3.1, 6.3, 12.5, 25.0, 50.0 and 100.0 μM.",Cyclic (Stapled),Acetylation,Amidation,"①The Ⓧ (position: 2 and 6) in sequence indicates (S)-α-methyl, α-pentenylglycine. Note: the Experimental section presenst that X is (S)-α-methyl, α-pentenylglycine, while the Results section presents that X is pentenylalanine. We incline to the former representation according to previous papers published by the research group which the author belonged. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.",L,No cytotoxicity information found.,PubMed ID is not available,B KOREAN CHEM SOC,"Thuy T.T. Dinh, Do-Hee Kim, Song-Jin Lee, Young-Woo Kim",De Novo Design and Their Antimicrobial Activity of Stapled Amphipathic Helices of Heptapeptides,Stapled AMP,,,,,
DRAMP21617,qqrkrkiwsⓚlapⓓgttlvklvagig,qqrkrkiwsklapdgttlvklvagig,qqrkrkiwsilaplgttlvklvagig,26,sDRIM,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,"①Disordered (or unstructured) conformation in aqueous solutions [pure water (H₂O), phosphate buffer (PB, 10 mM), and phosphate buffer with high salt (NaF, 100 mM)]. ②50% average α-helix content in various membranes environments [57% in POPC; 67% in POPC/P","In the cases of sDRIM and sKFGF, stapling did not induce any conformational change, as these analogues remained just as unstructured.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.28921993] Gram-positive bacteria: Staphylococcus aureus (MIC = 128 μg/mL), Enterococcus faecalis (MIC = 64 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC = 32 μg/mL), Pseudomonas aeruginosa (MIC = 64 μg/mL)","[Ref.28921993] It has 13.4%, 18.6%, 25.4%, 33.4%, 42.0%, 46.9%, 42.2% and 47.1% hemolysis against human red blood cells at 5, 7.5, 10, 15, 20, 25, 30 and 40 μg/ml.",Cyclic (Stapled),Free,Amidation,ⓚ (10) and ⓓ (14) are corss-linked by lactam stapling through the polar amide bond of a lactam bridge.,D,[Ref.28921993] The toxicity of sDRIM toward HEK293 and HeLa cells is much less than nonaarginine (R9) by use of flow cytometry and the peptide doesn't show any cytotoxicity at 2 μM.,28921993,J Med Chem. 2017 Oct 12;60(19):8071-8082. doi: 10.1021/acs.jmedchem.7b00813. Epub 2017 Sep 26.,"Marco J Klein, Samuel Schmidt, Parvesh Wadhwani, Jochen Bürck, Johannes Reichert, Sergii Afonin, Marina Berditsch, Tim Schober, Roland Brock, Manfred Kansy, Anne S Ulrich",Lactam-Stapled Cell-Penetrating Peptides: Cell Uptake and Membrane Binding Properties.,Stapled AMP,,,,,
DRAMP21619,PLIⓀLRLⒹRGQF,PLIKLRLDRGQF,PLILLRLLRGQF,12,sWWSP,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,"①α-helix in aqueous solutions [pure water (H₂O), phosphate buffer (PB, 10 mM), and phosphate buffer with high salt (NaF, 100 mM)]. ②43% average α-helix content in various membranes environments [38% in POPC; 58% in POPC/POPG(3:1); 47% in POPC:lysoPC(9:1);","On the other hand, sWWSP and sMAP-1 assumed an α-helical conformation in aqueous solution, in contrast to their unstructured linear countparts.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.28921993] Gram-positive bacteria: Staphylococcus aureus (MIC > 256 μg/mL), Enterococcus faecalis (MIC > 256 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC > 256 μg/mL), Pseudomonas aeruginosa (MIC > 256 μg/mL)","[Ref.28921993] It has 4.0%, 4.8%, 4.6%, 4.2% and 7.0% hemolysis against human red blood cells at 15, 20, 25, 30 and 40 μg/ml.",Cyclic (Stapled),Free,Amidation,Ⓚ (4) and Ⓓ (8) are cross-linked by lactam stapling through the polar amide bond of a lactam bridge.,L,[Ref.28921993] The toxicity of sWWSP toward HEK293 and HeLa cells is much less than nonaarginine (R9) by use of flow cytometry and the peptide doesn't show any cytotoxicity at 2 μM.,28921993,J Med Chem. 2017 Oct 12;60(19):8071-8082. doi: 10.1021/acs.jmedchem.7b00813. Epub 2017 Sep 26.,"Marco J Klein, Samuel Schmidt, Parvesh Wadhwani, Jochen Bürck, Johannes Reichert, Sergii Afonin, Marina Berditsch, Tim Schober, Roland Brock, Manfred Kansy, Anne S Ulrich",Lactam-Stapled Cell-Penetrating Peptides: Cell Uptake and Membrane Binding Properties.,Stapled AMP,,,,,
DRAMP21621,AAⓀLLPⒹLLAAP,AAKLLPDLLAAP,AAVLLPVLLAAP,12,sKFGF,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,"①Disordered (or unstructured) conformation in aqueous solutions [pure water (H₂O), phosphate buffer (PB, 10 mM), and phosphate buffer with high salt (NaF, 100 mM)]. ②Around 22% average α-helix content in various membranes environments [13% in POPC; 32% in","In the cases of sDRIM and sKFGF, stapling did not induce any conformational change, as these analogues remained just as unstructured.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.28921993] Gram-positive bacteria: Staphylococcus aureus (MIC > 256 μg/mL), Enterococcus faecalis (MIC > 256 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC > 256 μg/mL), Pseudomonas aeruginosa (MIC > 256 μg/mL)","[Ref.28921993] It has 0.4%, 0%, 0.1%, 0.2%, 0.1%, 0.7%, 1.8% and 5.6% hemolysis against human red blood cells at 5, 7.5, 10, 15, 20, 25, 30 and 40 μg/ml.",Cyclic (Stapled),Free,Amidation,Ⓚ (3) and Ⓓ (7) are cross-linked by lactam stapling through the polar amide bond of a lactam bridge.,L,[Ref.28921993] The toxicity of sKFGF toward HEK293 and HeLa cells is much less than nonaarginine (R9) by use of flow cytometry and the peptide doesn't show any cytotoxicity at 2 μM.,28921993,J Med Chem. 2017 Oct 12;60(19):8071-8082. doi: 10.1021/acs.jmedchem.7b00813. Epub 2017 Sep 26.,"Marco J Klein, Samuel Schmidt, Parvesh Wadhwani, Jochen Bürck, Johannes Reichert, Sergii Afonin, Marina Berditsch, Tim Schober, Roland Brock, Manfred Kansy, Anne S Ulrich",Lactam-Stapled Cell-Penetrating Peptides: Cell Uptake and Membrane Binding Properties.,Stapled AMP,,,,,
DRAMP21623,KLALKALKⓀLKAⒹLKLA,KLALKALKKLKADLKLA,KLALKALKALKAALKLA,17,sMAP-1,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,"①α-helix in aqueous solutions [pure water (H₂O), phosphate buffer (PB, 10 mM), and phosphate buffer with high salt (NaF, 100 mM)]. ②46% average α-helix content in various membranes environments [37% in POPC; 59% in POPC/POPG(3:1); 45% in POPC:lysoPC(9:1);","On the other hand, sWWSP and sMAP-1 assumed an α-helical conformation in aqueous solution, in contrast to their unstructured linear countparts.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.28921993] Gram-positive bacteria: Staphylococcus aureus (MIC = 64 μg/mL), Enterococcus faecalis (MIC > 256 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC = 256 μg/mL), Pseudomonas aeruginosa (MIC > 256 μg/mL)","[Ref.28921993] It has 2.5%, 2.9%, 2.4%, 4.1%, 2.9%, 6.3%, 4.9% and 8.2% hemolysis against human red blood cells at 5, 7.5, 10, 15, 20, 25, 30 and 40 μg/ml.",Cyclic (Stapled),Free,Amidation,Ⓚ (9) and Ⓓ (13) are cross-linked by lactam stapling through the polar amide bond of a lactam bridge.,L,[Ref.28921993] The toxicity of sMAP-1 toward HEK293 and HeLa cells is much less than nonaarginine (R9) by use of flow cytometry and the peptide doesn't show any cytotoxicity at 2 μM.,28921993,J Med Chem. 2017 Oct 12;60(19):8071-8082. doi: 10.1021/acs.jmedchem.7b00813. Epub 2017 Sep 26.,"Marco J Klein, Samuel Schmidt, Parvesh Wadhwani, Jochen Bürck, Johannes Reichert, Sergii Afonin, Marina Berditsch, Tim Schober, Roland Brock, Manfred Kansy, Anne S Ulrich",Lactam-Stapled Cell-Penetrating Peptides: Cell Uptake and Membrane Binding Properties.,Stapled AMP,,,,,
DRAMP21624,ⓍLAAⒿRHⓍ,XLAAJRHX,ELAAIRHR,8,V30-SP-8,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+",,"26.1% α-helix content in 50 μM aqueous solution [a mixture of water and acetonitrile (9:1, v/v)].","①The helical propensities of two stapled peptides, V30-SP-8 and V30-SP-9, and their linear counterparts were analyzed via circular dichroism (CD) spectrometry. ②Surprisingly, in contrast to our expectation that the stitched peptide, V30-SP-8, would be more helical than the monostapled peptide, V30-SP-9, the monostapling strategy was more effective in inducing helicity (helicity: 26.1% for V30-SP-8 and 33.8% for V30-SP-9)",Not found,Function: Antibacterial activity against Gram-positive bacteria. The peptide shows a similar potency to vancomycin (MIC50 = 20 μM against M.smegmatis),"[Ref.32840352] Gram-positive bacteria: Mycobacterium smegmatis (The antibacterial effects of V30-SP-8 are 36.9%, 42.7%, 50.9% and 55.4% at 6.25, 12.5, 25 and 50 μM, and MIC50 is between 12.5 μM and 25.0 μM)",[Ref.32840352] No hemolytic activity information found.,Cyclic (Stapled),Free,Free,"①The Ⓧ (position: 1 and 8) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The Ⓙ (position: 5) in sequence is B5 stapling amino acid. Note: B5 is α-dipentenyl alanine. ③Ⓧ (1) and Ⓙ (5), Ⓙ (5) and Ⓧ (8) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple respectively.",L,No cytotoxicity information found in the reference,32840352,ACS Chem Biol. 2020 Sep 18;15(9):2493-2498. doi: 10.1021/acschembio.0c00492. Epub 2020 Sep 9.,"Sung-Min Kang, Heejo Moon, Sang-Woo Han, Do-Hee Kim, Byeong Moon Kim, Bong-Jin Lee",Structure-Based De Novo Design of Mycobacterium Tuberculosis VapC-Activating Stapled Peptides,Stapled AMP,,,,,
DRAMP21625,ⓏLAAIRHⓍ,ZLAAIRHX,ELAAIRHR,8,V30-SP-9,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+",,"33.8% α-helix content in 50 μM aqueous solution [a mixture of water and acetonitrile (9:1, v/v)].","①The helical propensities of two stapled peptides, V30-SP-8 and V30-SP-9, and their linear counterparts were analyzed via circular dichroism (CD) spectrometry. ②Surprisingly, in contrast to our expectation that the stitched peptide, V30-SP-8, would be more helical than the monostapled peptide, V30-SP-9, the monostapling strategy was more effective in inducing helicity (helicity: 26.1% for V30-SP-8 and 33.8% for V30-SP-9)",Not found,Function: Antibacterial activity against Gram-positive bacteria. ,"[Ref.32840352] Gram-positive bacteria: Mycobacterium smegmatis (The antibacterial effects of V30-SP-8 are 23.3%, 23.3%, 34.2% and 38.7% at 6.25, 12.5, 25 and 50 μM, and MIC50 is above 25 μM)",[Ref.32840352] No hemolytic activity information found.,Cyclic (Stapled),Free,Free,①The Ⓩ (position: 1) in sequence is R8 stapling amino acid. Note: R8 is (R)-octenyl alanine. ②The Ⓧ (position: 8) in sequence is (S)-pentenyl alanine. ③Ⓩ (1) and Ⓧ (8) are cross-linked by hydrocarbon stapling through a undec-4-enyl staple.,L,No cytotoxicity information found in the reference,32840352,ACS Chem Biol. 2020 Sep 18;15(9):2493-2498. doi: 10.1021/acschembio.0c00492. Epub 2020 Sep 9.,"Sung-Min Kang, Heejo Moon, Sang-Woo Han, Do-Hee Kim, Byeong Moon Kim, Bong-Jin Lee",Structure-Based De Novo Design of Mycobacterium Tuberculosis VapC-Activating Stapled Peptides,Stapled AMP,,,,,
DRAMP21628,TLKQFⓍKGVⓍKWLVK,TLKQFXKGVXKWLVK,TLKQFAKGVGKWLVK,15,E2EM15W-S1,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+",,47% α-helical content in a 25 mM potassium phosphate buffer solution at 20 ℃.,"①On the other hand, all three stapled analogs of E2EM15W showed substantial increases in helical contents, which again demonstrated the highly effective helix-stabilization through the all-hydrocarbon stapling technology. ②E2EM15W-S1, the most potent analog in the antimicrobial assay, showed the highest degree of helicity (47%) in the aqueous solution, supporting a close correlation between the helicity and the antimicrobial activity of the peptides in this series.",Not found,Function: Antibcaterial activity against Gram-positive bacteria. Antibacterial activity against Gram-negative bacteria is not noteable under 200 μg/mL.,"[Ref.24211019] Gram-positive bacteria: Bacillus subtilis (MIC = 3.13 μg/mL), Staphylococcus aureus (MIC = 3.13 μg/mL), Staphylococcus epidermis (MIC > 200 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC > 200 μg/mL), Shigella dysentariae (MIC > 200 μg/mL), Salmonella typhimurium (MIC > 200 μg/mL), Klebsiella pneumonia (MIC > 200 μg/mL), Proteus mirabilis (MIC > 200 μg/mL), Pseudomonas aeuginose (MIC > 200 μg/mL).",[Ref.24211019] No hemolytic activity information found.,Cyclic (Stapled),Acetylation,Amidation,"①The Ⓧ (position: 6 and 10) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (6) and Ⓧ (10) are cross-linked by hydrocarbon stapling through an oct-4-enyl staple.",L,No cytotoxicity information found in the reference,24211019,Bioorg Med Chem Lett. 2013 Dec 15;23(24):6717-20. doi: 10.1016/j.bmcl.2013.10.031. Epub 2013 Oct 26.,"Thanh Kim Pham, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim",Truncated and constrained helical analogs of antimicrobial esculentin-2EM,Stapled AMP,,,,,
DRAMP21629,TLKQFⓍKGWⓍKDLVK,TLKQFXKGWXKDLVK,TLKQFAKGVGKWLVK,15,E2EM15W-S2,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,27% α-helical content in a 25 mM potassium phosphate buffer solution at 20 ℃.,"①On the other hand, all three stapled analogs of E2EM15W showed substantial increases in helical contents, which again demonstrated the highly effective helix-stabilization through the all-hydrocarbon stapling technology. ②Although they bear the oce-4-enyl staple at the same positions as in E2EM15W-S1, the other stapled derivatives E2EM15W-S2 and E2EM15W-S3 exhibited markedly smaller helical contents: 27% and 37%, repectively.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.24211019] Gram-positive bacteria: Bacillus subtilis (MIC = 6.25 μg/mL), Staphylococcus aureus (MIC = 6.25 μg/mL), Staphylococcus epidermis (MIC > 200 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC = 100 μg/mL), Shigella dysentariae (MIC = 50 μg/mL), Salmonella typhimurium (MIC > 200 μg/mL), Klebsiella pneumonia (MIC = 50 μg/mL), Proteus mirabilis (MIC > 200 μg/mL), Pseudomonas aeuginose (MIC = 200 μg/mL).",[Ref.24211019] No hemolytic activity information found.,Cyclic (Stapled),Acetylation,Amidation,"①The Ⓧ (position: 6 and 10) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (6) and Ⓧ (10) are cross-linked by hydrocarbon stapling through an oct-4-enyl staple.",L,No cytotoxicity information found in the reference,24211019,Bioorg Med Chem Lett. 2013 Dec 15;23(24):6717-20. doi: 10.1016/j.bmcl.2013.10.031. Epub 2013 Oct 26.,"Thanh Kim Pham, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim",Truncated and constrained helical analogs of antimicrobial esculentin-2EM,Stapled AMP,,,,,
DRAMP21630,TLKQWⓍKGVⓍKDLVK,TLKQWXKGVXKDLVK,TLKQFAKGVGKWLVK,15,E2EM15W-S3,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,37% α-helical content in a 25 mM potassium phosphate buffer solution at 20 ℃.,"①On the other hand, all three stapled analogs of E2EM15W showed substantial increases in helical contents, which again demonstrated the highly effective helix-stabilization through the all-hydrocarbon stapling technology. ②Although they bear the oce-4-enyl staple at the same positions as in E2EM15W-S1, the other stapled derivatives E2EM15W-S2 and E2EM15W-S3 exhibited markedly smaller helical contents: 27% and 37%, repectively.",Not found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.24211019] Gram-positive bacteria: Bacillus subtilis (MIC = 6.25 μg/mL), Staphylococcus aureus (MIC = 6.25 μg/mL), Staphylococcus epidermis (MIC = 100 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC = 100 μg/mL), Shigella dysentariae (MIC = 50 μg/mL), Salmonella typhimurium (MIC > 200 μg/mL), Klebsiella pneumonia (MIC = 50 μg/mL), Proteus mirabilis (MIC > 200 μg/mL), Pseudomonas aeuginose (MIC > 200 μg/mL).",[Ref.24211019] No hemolytic activity information found.,Cyclic (Stapled),Acetylation,Amidation,"①The Ⓧ (position: 6 and 10) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (6) and Ⓧ (10) are cross-linked by hydrocarbon stapling through an oct-4-enyl staple.",L,No cytotoxicity information found in the reference,24211019,Bioorg Med Chem Lett. 2013 Dec 15;23(24):6717-20. doi: 10.1016/j.bmcl.2013.10.031. Epub 2013 Oct 26.,"Thanh Kim Pham, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim",Truncated and constrained helical analogs of antimicrobial esculentin-2EM,Stapled AMP,,,,,
DRAMP28986,ⓍIKKⓍLKSAKKFVKAFK,XIKKXLKSAKKFVKAFK,GIGKFLHSAKKFGKAFVGEIMNS,17,peptide 2 (Derived from Mag2),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in 20 mM PBS solution (pH = 7.4) with 1% SDS at peptide concentrations of 100 μM,"[Ref.33466998] All peptides with side-chain stapling showed negative maxima at around 208 and 222 nm, indicating that the peptides formed a stablized helical structure.",Nor found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria,"[Ref.33466998] Gram-positive bacteria: Staphylococcus aureus (MIC = 3.125 μM). 
##Gram-negative bacteria: Escherichia coli (MIC = 1.56 μM), Pseudomonas aeruginosa (MIC = 1.56 μM), 
multiple-drug resistant P.aeruginosa (MIC = 1.56 μM)",[Ref.33466998] It has hemolysis against human red blood cells at 50 μM,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 1 and 5) in sequence indicate (S)-4-pentenyl alanine. ②Ⓧ (1) and Ⓧ (5) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,33466998,Molecules. 2021 Jan 16;26(2):444. doi: 10.3390/molecules26020444.,"Motoharu Hirano, Chihiro Saito, Hidetomo Yokoo, Chihiro Goto, Ryuji Kawano, Takashi Misawa, Yosuke Demizu",Development of Antimicrobial Stapled Peptides Based on Magainin 2 Sequence,Stapled AMP,,,,,
DRAMP28987,GIKKⓍLKSⓍKKFVKAFK,GIKKXLKSXKKFVKAFK,GIGKFLHSAKKFGKAFVGEIMNS,17,peptide 3 (Derived from Mag2),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in 20 mM PBS solution (pH = 7.4) with 1% SDS at peptide concentrations of 100 μM,"[Ref.33466998] All peptides with side-chain stapling showed negative maxima at around 208 and 222 nm, indicating that the peptides formed a stablized helical structure.",Nor found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria,"[Ref.33466998] Gram-positive bacteria: Staphylococcus aureus (MIC = 3.125 μM). 
##Gram-negative bacteria: Escherichia coli (MIC = 1.56 μM), Pseudomonas aeruginosa (MIC = 3.125 μM), 
multiple-drug resistant P.aeruginosa (MIC = 0.78 μM)",[Ref.33466998] It has hemolysis against human red blood cells at 6.25 μM,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 5 and 9) in sequence indicate (S)-4-pentenyl alanine. ②Ⓧ (5) and Ⓧ (9) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,33466998,Molecules. 2021 Jan 16;26(2):444. doi: 10.3390/molecules26020444.,"Motoharu Hirano, Chihiro Saito, Hidetomo Yokoo, Chihiro Goto, Ryuji Kawano, Takashi Misawa, Yosuke Demizu",Development of Antimicrobial Stapled Peptides Based on Magainin 2 Sequence,Stapled AMP,,,,,
DRAMP28988,GIKKFLKⓍAKKⓍVKAFK,GIKKFLKXAKKXVKAFK,GIGKFLHSAKKFGKAFVGEIMNS,17,peptide 4 (Derived from Mag2),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in 20 mM PBS solution (pH = 7.4) with 1% SDS at peptide concentrations of 100 μM,"[Ref.33466998] All peptides with side-chain stapling showed negative maxima at around 208 and 222 nm, indicating that the peptides formed a stablized helical structure.",Nor found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria,"[Ref.33466998] Gram-positive bacteria: Staphylococcus aureus (MIC = 6.25 μM). 
##Gram-negative bacteria: Escherichia coli (MIC = 1.56 μM), Pseudomonas aeruginosa (MIC = 1.56 μM), 
multiple-drug resistant P.aeruginosa (MIC = 0.78 μM)",[Ref.33466998] It has hemolysis against human red blood cells at 3.125 μM,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 8 and 12) in sequence indicates (S)-4-pentenyl alanine. ②Ⓧ (8) and Ⓧ (12) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,33466998,Molecules. 2021 Jan 16;26(2):444. doi: 10.3390/molecules26020444.,"Motoharu Hirano, Chihiro Saito, Hidetomo Yokoo, Chihiro Goto, Ryuji Kawano, Takashi Misawa, Yosuke Demizu",Development of Antimicrobial Stapled Peptides Based on Magainin 2 Sequence,Stapled AMP,,,,,
DRAMP28989,GIKKFLKSⓍKKFⓍKAFK,GIKKFLKSXKKFXKAFK,GIGKFLHSAKKFGKAFVGEIMNS,17,peptide 5 (Derived from Mag2),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in 20 mM PBS solution (pH = 7.4) with 1% SDS at peptide concentrations of 100 μM,"[Ref.33466998] All peptides with side-chain stapling showed negative maxima at around 208 and 222 nm, indicating that the peptides formed a stablized helical structure.",Nor found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria,"[Ref.33466998] Gram-positive bacteria: Staphylococcus aureus (MIC = 12.5 μM). 
##Gram-negative bacteria: Escherichia coli (MIC = 1.56 μM), Pseudomonas aeruginosa (MIC = 6.25 μM), 
multiple-drug resistant P.aeruginosa (MIC = 3.125 μM)",[Ref.33466998] It has hemolysis against human red blood cells at 1.56 μM,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 9 and 13) in sequence indicate (S)-4-pentenyl alanine. ②Ⓧ (9) and Ⓧ (13) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,33466998,Molecules. 2021 Jan 16;26(2):444. doi: 10.3390/molecules26020444.,"Motoharu Hirano, Chihiro Saito, Hidetomo Yokoo, Chihiro Goto, Ryuji Kawano, Takashi Misawa, Yosuke Demizu",Development of Antimicrobial Stapled Peptides Based on Magainin 2 Sequence,Stapled AMP,,,,,
DRAMP28990,GIKKFLKSAKKⓍVKAⓍK,GIKKFLKSAKKXVKAXK,GIGKFLHSAKKFGKAFVGEIMNS,17,peptide 6 (Derived from Mag2),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in 20 mM PBS solution (pH = 7.4) with 1% SDS at peptide concentrations of 100 μM,"[Ref.33466998] All peptides with side-chain stapling showed negative maxima at around 208 and 222 nm, indicating that the peptides formed a stablized helical structure.",Nor found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria,"[Ref.33466998] Gram-positive bacteria: Staphylococcus aureus (MIC = 3.125 μM). 
##Gram-negative bacteria: Escherichia coli (MIC = 1.56 μM), Pseudomonas aeruginosa (MIC = 1.56 μM), 
multiple-drug resistant P.aeruginosa (MIC = 0.78 μM)",[Ref.33466998] It has hemolysis against human red blood cells at 3.125 μM,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 12 and 16) in sequence indicate (S)-4-pentenyl alanine. ②Ⓧ (12) and Ⓧ (16) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,33466998,Molecules. 2021 Jan 16;26(2):444. doi: 10.3390/molecules26020444.,"Motoharu Hirano, Chihiro Saito, Hidetomo Yokoo, Chihiro Goto, Ryuji Kawano, Takashi Misawa, Yosuke Demizu",Development of Antimicrobial Stapled Peptides Based on Magainin 2 Sequence,Stapled AMP,,,,,
DRAMP28991,GIKKⓏLKSAKKⓍVKAFK,GIKKZLKSAKKXVKAFK,GIGKFLHSAKKFGKAFVGEIMNS,17,peptide 7 (Derived from Mag2),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in 20 mM PBS solution (pH = 7.4) with 1% SDS at peptide concentrations of 100 μM,"[Ref.33466998] All peptides with side-chain stapling showed negative maxima at around 208 and 222 nm, indicating that the peptides formed a stablized helical structure.",Nor found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria,"[Ref.33466998] Gram-positive bacteria: Staphylococcus aureus (MIC = 25 μM). 
##Gram-negative bacteria: Escherichia coli (MIC = 3.125 μM), Pseudomonas aeruginosa (MIC = 3.125 μM), 
multiple-drug resistant P.aeruginosa (MIC = 1.56 μM)",[Ref.33466998] It has hemolysis against human red blood cells at 6.25 μM,Cyclic (Stapled),Free,Amidation,①The Ⓩ (position: 5) in sequence indicates (R)-7-octenyl alanine. ②The Ⓧ (position: 12) in sequence indicates (S)-4-pentenyl alanine. ③ Ⓩ (5) and Ⓧ (12) are cross-linked by hydrocarbon stapling through a undec-4-enyl staple.,L,No cytotoxicity information found in the reference,33466998,Molecules. 2021 Jan 16;26(2):444. doi: 10.3390/molecules26020444.,"Motoharu Hirano, Chihiro Saito, Hidetomo Yokoo, Chihiro Goto, Ryuji Kawano, Takashi Misawa, Yosuke Demizu",Development of Antimicrobial Stapled Peptides Based on Magainin 2 Sequence,Stapled AMP,,,,,
DRAMP28992,GIKKFLKⓏAKKFVKⓍFK,GIKKFLKZAKKFVKXFK,GIGKFLHSAKKFGKAFVGEIMNS,17,peptide 8 (Derived from Mag2),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",,α-helix in 20 mM PBS solution (pH = 7.4) with 1% SDS at peptide concentrations of 100 μM,"[Ref.33466998] All peptides with side-chain stapling showed negative maxima at around 208 and 222 nm, indicating that the peptides formed a stablized helical structure.",Nor found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria,"[Ref.33466998] Gram-positive bacteria: Staphylococcus aureus (MIC > 50 μM). 
##Gram-negative bacteria: Escherichia coli (MIC = 6.25 μM), Pseudomonas aeruginosa (MIC > 50 μM), 
multiple-drug resistant P.aeruginosa (MIC = 3.125 μM)",[Ref.33466998] It has hemolysis against human red blood cells at 0.19 μM,Cyclic (Stapled),Free,Amidation,①The Ⓩ (position: 8) in sequence indicates (R)-7-octenyl alanine. ②The Ⓧ (position: 15) in sequence indicates (S)-4-pentenyl alanine. ③ Ⓩ (8) and Ⓧ (15) are cross-linked by hydrocarbon stapling through a undec-4-enyl staple.,L,No cytotoxicity information found in the reference,33466998,Molecules. 2021 Jan 16;26(2):444. doi: 10.3390/molecules26020444.,"Motoharu Hirano, Chihiro Saito, Hidetomo Yokoo, Chihiro Goto, Ryuji Kawano, Takashi Misawa, Yosuke Demizu",Development of Antimicrobial Stapled Peptides Based on Magainin 2 Sequence,Stapled AMP,,,,,
DRAMP28993,GIKKFLKSⓏKKFVKAⓍK,GIKKFLKSZKKFVKAXK,GIGKFLHSAKKFGKAFVGEIMNS,17,peptide 9 (Derived from Mag2),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in 20 mM PBS solution (pH = 7.4) with 1% SDS at peptide concentrations of 100 μM,"[Ref.33466998] All peptides with side-chain stapling showed negative maxima at around 208 and 222 nm, indicating that the peptides formed a stablized helical structure.",Nor found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria,"[Ref.33466998] Gram-positive bacteria: Staphylococcus aureus (MIC = 6.25 μM). 
##Gram-negative bacteria: Escherichia coli (MIC = 3.125 μM), Pseudomonas aeruginosa (MIC = 6.25 μM), 
multiple-drug resistant P.aeruginosa (MIC = 3.125 μM)",[Ref.33466998] It has hemolysis against human red blood cells at 3.125 μM,Cyclic (Stapled),Free,Amidation,①The Ⓩ (position: 9) in sequence indicates (R)-7-octenyl alanine. ②The Ⓧ (position: 16) in sequence indicates (S)-4-pentenyl alanine. ③ Ⓩ (9) and Ⓧ (16) are cross-linked by hydrocarbon stapling through a undec-4-enyl staple.,L,No cytotoxicity information found in the reference,33466998,Molecules. 2021 Jan 16;26(2):444. doi: 10.3390/molecules26020444.,"Motoharu Hirano, Chihiro Saito, Hidetomo Yokoo, Chihiro Goto, Ryuji Kawano, Takashi Misawa, Yosuke Demizu",Development of Antimicrobial Stapled Peptides Based on Magainin 2 Sequence,Stapled AMP,,,,,
DRAMP28994,ⓍIKKⓍLKSAKKFVKAFK,XIKKXLKSAKKFVKAFK,GIGKFLHSAKKFGKAFVGEIMNS,17,peptide C6-2 (Derived from Mag2),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in 20 mM PBS solution (pH = 7.4) with 1% SDS at peptide concentrations of 100 μM,[Ref.33466998] Peptide C6-2 and C12-2 showed a curve similar to that of peptide 2,Nor found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria,"[Ref.33466998] Gram-positive bacteria: Staphylococcus aureus (MIC = 1.56 μM). 
##Gram-negative bacteria: Escherichia coli (MIC = 1.56 μM), Pseudomonas aeruginosa (MIC = 3.125 μM), 
multiple-drug resistant P.aeruginosa (MIC = 3.125 μM)",[Ref.33466998] It has hemolysis against human red blood cells at 12.5 μM,Cyclic (Stapled),Hexanoylation,Amidation,①The Ⓧ (position: 1 and 5) in sequence indicate (S)-4-pentenyl alanine. ②Ⓧ (1) and Ⓧ (5) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,33466998,Molecules. 2021 Jan 16;26(2):444. doi: 10.3390/molecules26020444.,"Motoharu Hirano, Chihiro Saito, Hidetomo Yokoo, Chihiro Goto, Ryuji Kawano, Takashi Misawa, Yosuke Demizu",Development of Antimicrobial Stapled Peptides Based on Magainin 2 Sequence,Stapled AMP,,,,,
DRAMP28995,ⓍIKKⓍLKSAKKFVKAFK,XIKKXLKSAKKFVKAFK,GIGKFLHSAKKFGKAFVGEIMNS,17,peptide C12-2 (Derived from Mag2),No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,α-helix in 20 mM PBS solution (pH = 7.4) with 1% SDS at peptide concentrations of 100 μM,[Ref.33466998] Peptide C6-2 and C12-2 showed a curve similar to that of peptide 2,Nor found,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria,"[Ref.33466998] Gram-positive bacteria: Staphylococcus aureus (MIC = 6.25 μM). 
##Gram-negative bacteria: Escherichia coli (MIC = 6.25 μM), Pseudomonas aeruginosa (MIC = 12.5 μM), 
multiple-drug resistant P.aeruginosa (MIC = 25 μM)",[Ref.33466998] It has hemolysis against human red blood cells at 0.78 μM,Cyclic (Stapled),Laurylation,Amidation,①The Ⓧ (position: 1 and 5) in sequence indicate (S)-4-pentenyl alanine. ②Ⓧ (1) and Ⓧ (5) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,33466998,Molecules. 2021 Jan 16;26(2):444. doi: 10.3390/molecules26020444.,"Motoharu Hirano, Chihiro Saito, Hidetomo Yokoo, Chihiro Goto, Ryuji Kawano, Takashi Misawa, Yosuke Demizu",Development of Antimicrobial Stapled Peptides Based on Magainin 2 Sequence,Stapled AMP,,,,,
DRAMP28996,ⓍIKKⓍLKSAKKFVKAFK,XIKKXLKSAKKFVKAFK,GIGKFLHSAKKFGKAFVGEIMNS,17,peptide C18-2 (Derived from Mag2),No entry found,,Synthetic construct,Non-Antimicrobial,,Unknown,[Ref.33466998] The circular dichroism (CD) spectral analysis of C18-2 could not be performed because of its poor solubility in the aqueous buffer solution.,Nor found,Function: Antibacterial activity against bacteria is not significant under the concentration of 50 μM.,"[Ref.33466998] Gram-positive bacteria: Staphylococcus aureus (MIC > 50 μM). 
##Gram-negative bacteria: Escherichia coli (MIC > 50 μM), Pseudomonas aeruginosa (MIC > 50 μM), 
multiple-drug resistant P.aeruginosa (MIC > 50 μM)",[Ref.33466998] It has hemolysis against human red blood cells at 0.78 μM,Cyclic (Stapled),Stearylation,Amidation,①The Ⓧ (position: 1 and 5) in sequence indicate (S)-4-pentenyl alanine. ②Ⓧ (1) and Ⓧ (5) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,33466998,Molecules. 2021 Jan 16;26(2):444. doi: 10.3390/molecules26020444.,"Motoharu Hirano, Chihiro Saito, Hidetomo Yokoo, Chihiro Goto, Ryuji Kawano, Takashi Misawa, Yosuke Demizu",Development of Antimicrobial Stapled Peptides Based on Magainin 2 Sequence,Stapled AMP,,,,,
DRAMP28998,RⓍWWRⓍW,RXWWRXW,RWWWRWW,7,Stapled heptapeptide 2,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+",,Helicity = 61.3% in 10 mM sodium phosphate buffer (pH 7.4) at peptide concentrations of 100 μM,"CD spectroscopy was used to characterize the secondary structure of five unstapled heptapeptides and their stapled counterparts in phosphate buffer, indicating a significant increase in peptide helical content upon the stapling, with helicity change from h = 14.1% - 33.7% (for unstapled peptides) to h = 58.9%-75.1% (for stapled peptides).",Not found,"Function: Antibacterial activity against Gram-positive bacteria.
The stapled peptide was much more active against bacteria than the unstapled one.",Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC = 19 ± 4 μg/mL). Methicillin-resistant Staphylococcus aureus (MRSA) (MIC > 25 ± 6 μg/mL),No hemolytic activity information found.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 2 and 6) in sequence indicate (S)-4-pentenyl alanine. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,PubMed ID is not available,Int J Pept Res Ther. 2019 Nov 14; 26(4):1711–1719. doi: 10.1007/s10989-019-09964-7.,"Zhixia Chen, Xiuli Yu, Aiying Zhang, Fangfang Wang, Yankun Xing",De Novo Hydrocarbon-Stapling Design of Single-Turn α-Helical Antimicrobial Peptides,Stapled AMP,,,,,
DRAMP29000,WⓍKWWⓍK,WXKWWXK,WWKWWWK,7,Stapled heptapeptide 4,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+",,Helicity = 69.8% in 10 mM sodium phosphate buffer (pH 7.4) at peptide concentrations of 100 μM,"CD spectroscopy was used to characterize the secondary structure of five unstapled heptapeptides and their stapled counterparts in phosphate buffer, indicating a significant increase in peptide helical content upon the stapling, with helicity change from h = 14.1% - 33.7% (for unstapled peptides) to h = 58.9%-75.1% (for stapled peptides).",Not found,"Function: Antibacterial activity against Gram-positive bacteria.
The stapled peptide was much more active against bacteria than the unstapled one.",Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC = 8.3 ± 1.8 μg/mL). Methicillin-resistant Staphylococcus aureus (MRSA) (MIC = 14 ± 3 μg/mL),No hemolytic activity information found.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 2 and 6) in sequence indicate (S)-4-pentenyl alanine. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,PubMed ID is not available,Int J Pept Res Ther. 2019 Nov 14; 26(4):1711–1719. doi: 10.1007/s10989-019-09964-7.,"Zhixia Chen, Xiuli Yu, Aiying Zhang, Fangfang Wang, Yankun Xing",De Novo Hydrocarbon-Stapling Design of Single-Turn α-Helical Antimicrobial Peptides,Stapled AMP,,,,,
DRAMP29002,LⓍLRLⓍR,LXLRLXR,LLLRLLR,7,Stapled heptapeptide 6,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+",,Helicity = 75.1% in 10 mM sodium phosphate buffer (pH 7.4) at peptide concentrations of 100 μM,"CD spectroscopy was used to characterize the secondary structure of five unstapled heptapeptides and their stapled counterparts in phosphate buffer, indicating a significant increase in peptide helical content upon the stapling, with helicity change from h = 14.1% - 33.7% (for unstapled peptides) to h = 58.9%-75.1% (for stapled peptides).",Not found,"Function: Antibacterial activity against Gram-positive bacteria.
The stapled peptide was much more active against bacteria than the unstapled one.",Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC = 24 ± 4 μg/mL). Methicillin-resistant Staphylococcus aureus (MRSA) (MIC = 15 ± 3 μg/mL),No hemolytic activity information found.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 2 and 6) in sequence indicate (S)-4-pentenyl alanine. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,PubMed ID is not available,Int J Pept Res Ther. 2019 Nov 14; 26(4):1711–1719. doi: 10.1007/s10989-019-09964-7.,"Zhixia Chen, Xiuli Yu, Aiying Zhang, Fangfang Wang, Yankun Xing",De Novo Hydrocarbon-Stapling Design of Single-Turn α-Helical Antimicrobial Peptides,Stapled AMP,,,,,
DRAMP29004,WⓍRRWⓍR,WXRRWXR,WWRRWWR,7,Stapled heptapeptide 8,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+",,Helicity = 58.9% in 10 mM sodium phosphate buffer (pH 7.4) at peptide concentrations of 100 μM,"CD spectroscopy was used to characterize the secondary structure of five unstapled heptapeptides and their stapled counterparts in phosphate buffer, indicating a significant increase in peptide helical content upon the stapling, with helicity change from h = 14.1% - 33.7% (for unstapled peptides) to h = 58.9%-75.1% (for stapled peptides).",Not found,"Function: Antibacterial activity against Gram-positive bacteria.
The stapled peptide was much more active against bacteria than the unstapled one.",Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC = 56 ± 12 μg/mL). Methicillin-resistant Staphylococcus aureus (MRSA) (MIC = 72 ± 18 μg/mL),No hemolytic activity information found.,Cyclic (Stapled),Free,Amidation,①The Ⓧ (position: 2 and 6) in sequence indicate (S)-4-pentenyl alanine. ②Ⓧ (2) and Ⓧ (6) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,PubMed ID is not available,Int J Pept Res Ther. 2019 Nov 14; 26(4):1711–1719. doi: 10.1007/s10989-019-09964-7.,"Zhixia Chen, Xiuli Yu, Aiying Zhang, Fangfang Wang, Yankun Xing",De Novo Hydrocarbon-Stapling Design of Single-Turn α-Helical Antimicrobial Peptides,Stapled AMP,,,,,
DRAMP29007,GⓍFAVⓍKKVASVIKGL,GXFAVXKKVASVIKGL,GLFAVIKKVASVIKGL,16,A4K14-citropin1.1-Sp1,No entry found,,Synthetic construct,"Antimicrobial, Anticancer",,"Helicity = 89.8% in 50% 2,2,2-trifluoroethanol (TFE) aqueous solution (0.1mg/mL)","[Ref.33363118] ①CD analysis indicates that the helicity of intial A4K14-citropin 1.1 was 61.5% and that of the stapled peptides ranged from 13.6 to 89.8%. ②Among them, A4K14-citropin 1.1-Sp1 and A4K14-citropin 1.1-Sp4 displayed the top 2 degrees of helicity (89.8 and 85.3%, respectively) in the aqueous solution and acquired 1.46- and 1.38-fold improvements compared to A4K14-citropin 1.1, respectively.",Not found,"Function: Antitumor activity against A549, HCT116 and HepG2 cancer cells.
The hydrolysis enzyme (α-chymotrypsin-mediated) degradation half-life of A4K14-citropin1.1-Sp1  is over 10 hours. A4K14-citropin1.1-Sp1 and A4K14-citropin1.1-Sp4 are much more stable than other A4K14-citropin1.1 stapling derivatives in Ref.33363118.","[Ref.33363118] Cancer cell lines: C4-2B (IC50 = 8.94 μM), A549 (IC50 = 12.48 μM), U87 (IC50 = 11.88 μM), MCF-7 (11.26 μM)",No hemolytic activity information found.,Cyclic (Stapled),Acetylation,Amidation,① The Ⓧ (position: 2 and 6) in sequence indicate (S)-2-(4-pentenyl)alanine. ② Ⓧ (2) and Ⓧ (6) are cross-linked by ring-closing metathesis through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,33363118,Front Chem. 2020 Dec 10;8:616147. doi: 10.3389/fchem.2020.616147. eCollection 2020.,"Nan Wang, Gang Xie, Chao Liu, Wei Cong, Shipeng He, Yinghua Li, Li Fan, Hong-Gang Hu ","Design, Synthesis, and Antitumor Activities Study of Stapled A4K14-Citropin 1.1 Peptides",Stapled AMP,,,,,
DRAMP29008,GLFAⓍIKKⓍASVIKGL,GLFAXIKKXASVIKGL,GLFAVIKKVASVIKGL,16,A4K14-citropin1.1-Sp2,No entry found,,Synthetic construct,"Antimicrobial, Anticancer",,"Helicity = 66.1% in 50% 2,2,2-trifluoroethanol (TFE) aqueous solution (0.1mg/mL)",[Ref.33363118] CD analysis indicates that the helicity of intial A4K14-citropin 1.1 was 61.5% and that of the stapled peptides ranged from 13.6 to 89.8%.,Not found,"Function: Antitumor activity against A549, HCT116 and HepG2 cancer cells.","[Ref.33363118] Cancer cell lines: C4-2B (IC50 = 10.14 μM), A549 (IC50 = 12.55 μM), U87 (IC50 = 14.76 μM), MCF-7 (12.65 μM)",No hemolytic activity information found.,Cyclic (Stapled),Acetylation,Amidation,① The Ⓧ (position: 5 and 9) in sequence indicate (S)-2-(4-pentenyl)alanine. ② Ⓧ (5) and Ⓧ (9) are cross-linked by ring-closing metathesis through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,33363118,Front Chem. 2020 Dec 10;8:616147. doi: 10.3389/fchem.2020.616147. eCollection 2020.,"Nan Wang, Gang Xie, Chao Liu, Wei Cong, Shipeng He, Yinghua Li, Li Fan, Hong-Gang Hu ","Design, Synthesis, and Antitumor Activities Study of Stapled A4K14-Citropin 1.1 Peptides",Stapled AMP,,,,,
DRAMP29009,GLFAVⓍKKVⓍSVIKGL,GLFAVXKKVXSVIKGL,GLFAVIKKVASVIKGL,16,A4K14-citropin1.1-Sp3,No entry found,,Synthetic construct,"Antimicrobial, Anticancer",,"Helicity = 49.2% in 50% 2,2,2-trifluoroethanol (TFE) aqueous solution (0.1mg/mL)",[Ref.33363118] CD analysis indicates that the helicity of intial A4K14-citropin 1.1 was 61.5% and that of the stapled peptides ranged from 13.6 to 89.8%.,Not found,"Function: Antitumor activity against A549, HCT116 and HepG2 cancer cells.","[Ref.33363118] Cancer cell lines: C4-2B (IC50 = 17.89 μM), A549 (IC50 = 12.11 μM), U87 (IC50 = 11.93 μM), MCF-7 (11.92 μM)",No hemolytic activity information found.,Cyclic (Stapled),Acetylation,Amidation,① The Ⓧ (position: 6 and 10) in sequence indicate (S)-2-(4-pentenyl)alanine. ② Ⓧ (6) and Ⓧ (10) are cross-linked by ring-closing metathesis through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,33363118,Front Chem. 2020 Dec 10;8:616147. doi: 10.3389/fchem.2020.616147. eCollection 2020.,"Nan Wang, Gang Xie, Chao Liu, Wei Cong, Shipeng He, Yinghua Li, Li Fan, Hong-Gang Hu ","Design, Synthesis, and Antitumor Activities Study of Stapled A4K14-Citropin 1.1 Peptides",Stapled AMP,,,,,
DRAMP29010,GLFAVIKKⓍASVⓍKGL,GLFAVIKKXASVXKGL,GLFAVIKKVASVIKGL,16,A4K14-citropin1.1-Sp4,No entry found,,Synthetic construct,"Antimicrobial, Anticancer",,"Helicity = 85.3% in 50% 2,2,2-trifluoroethanol (TFE) aqueous solution (0.1mg/mL)","[Ref.33363118] ①CD analysis indicates that the helicity of intial A4K14-citropin 1.1 was 61.5% and that of the stapled peptides ranged from 13.6 to 89.8%.②Among them, A4K14-citropin 1.1-Sp1 and A4K14-citropin 1.1-Sp4 displayed the top 2 degrees of helicity (89.8 and 85.3%, respectively) in the aqueous solution and acquired 1.46- and 1.38-fold improvements compared to A4K14-citropin 1.1, respectively.",Not found,"Function: Antitumor activity against A549, HCT116 and HepG2 cancer cells.
The hydrolysis enzyme (α-chymotrypsin-mediated) degradation half-life of A4K14-citropin1.1-Sp1  is over 10 hours. A4K14-citropin1.1-Sp1 and A4K14-citropin1.1-Sp4 are much more stable than other A4K14-citropin1.1 stapling derivatives in Ref.33363118.","[Ref.33363118] Cancer cell lines: C4-2B (IC50 = 8.90 μM), A549 (IC50 = 10.51 μM), U87 (IC50 = 7.277 μM), MCF-7 (10.49 μM)",No hemolytic activity information found.,Cyclic (Stapled),Acetylation,Amidation,① The Ⓧ (position: 9 and 13) in sequence indicate (S)-2-(4-pentenyl)alanine. ② Ⓧ (9) and Ⓧ (13) are cross-linked by ring-closing metathesis through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,33363118,Front Chem. 2020 Dec 10;8:616147. doi: 10.3389/fchem.2020.616147. eCollection 2020.,"Nan Wang, Gang Xie, Chao Liu, Wei Cong, Shipeng He, Yinghua Li, Li Fan, Hong-Gang Hu ","Design, Synthesis, and Antitumor Activities Study of Stapled A4K14-Citropin 1.1 Peptides",Stapled AMP,,,,,
DRAMP29011,GLFAVIKKVAⓍVIKⓍL,GLFAVIKKVAXVIKXL,GLFAVIKKVASVIKGL,16,A4K14-citropin1.1-Sp5,No entry found,,Synthetic construct,"Antimicrobial, Anticancer",,"Helicity = 49.4% in 50% 2,2,2-trifluoroethanol (TFE) aqueous solution (0.1mg/mL)",[Ref.33363118] CD analysis indicates that the helicity of intial A4K14-citropin 1.1 was 61.5% and that of the stapled peptides ranged from 13.6 to 89.8%.,Not found,"Function: Antitumor activity against A549, HCT116 and HepG2 cancer cells.","[Ref.33363118] Cancer cell lines: C4-2B (IC50 = 11.90 μM), A549 (IC50 = 9.899 μM), U87 (IC50 = 8.229 μM), MCF-7 (12.42 μM)",No hemolytic activity information found.,Cyclic (Stapled),Acetylation,Amidation,① The Ⓧ (position: 11 and 15) in sequence indicate (S)-2-(4-pentenyl)alanine. ② Ⓧ (11) and Ⓧ (15) are cross-linked by ring-closing metathesis through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,33363118,Front Chem. 2020 Dec 10;8:616147. doi: 10.3389/fchem.2020.616147. eCollection 2020.,"Nan Wang, Gang Xie, Chao Liu, Wei Cong, Shipeng He, Yinghua Li, Li Fan, Hong-Gang Hu ","Design, Synthesis, and Antitumor Activities Study of Stapled A4K14-Citropin 1.1 Peptides",Stapled AMP,,,,,
DRAMP29012,GⓏFAVIKKⓍASVIKGL,GZFAVIKKXASVIKGL,GLFAVIKKVASVIKGL,16,A4K14-citropin1.1-Sp6,No entry found,,Synthetic construct,"Antimicrobial, Anticancer",,"Helicity = 34.9% in 50% 2,2,2-trifluoroethanol (TFE) aqueous solution (0.1mg/mL)",[Ref.33363118] CD analysis indicates that the helicity of intial A4K14-citropin 1.1 was 61.5% and that of the stapled peptides ranged from 13.6 to 89.8%.,Not found,"Function: Antitumor activity against A549, HCT116 and HepG2 cancer cells.","[Ref.33363118] Cancer cell lines: C4-2B (IC50 = 35.84 μM), A549 (IC50 = 30.19 μM), U87 (IC50 = 34.49 μM), MCF-7 (23.78 μM)",No hemolytic activity information found.,Cyclic (Stapled),Acetylation,Amidation,① The Ⓩ (position: 2) in sequence indicates (R)-2-(7-octenyl)alanine. ② The Ⓧ (position: 9) in sequence indicates (S)-2-(4-pentenyl)alanine. ③ Ⓩ and Ⓧ are cross-linked by ring-closing metathesis through a undec-4-enyl staple.,L,No cytotoxicity information found in the reference,33363118,Front Chem. 2020 Dec 10;8:616147. doi: 10.3389/fchem.2020.616147. eCollection 2020.,"Nan Wang, Gang Xie, Chao Liu, Wei Cong, Shipeng He, Yinghua Li, Li Fan, Hong-Gang Hu ","Design, Synthesis, and Antitumor Activities Study of Stapled A4K14-Citropin 1.1 Peptides",Stapled AMP,,,,,
DRAMP29013,GLFAVⓏKKVASVⓍKGL,GLFAVZKKVASVXKGL,GLFAVIKKVASVIKGL,16,A4K14-citropin1.1-Sp7,No entry found,,Synthetic construct,"Antimicrobial, Anticancer",,"Helicity = 13.6% in 50% 2,2,2-trifluoroethanol (TFE) aqueous solution (0.1mg/mL)",[Ref.33363118] CD analysis indicates that the helicity of intial A4K14-citropin 1.1 was 61.5% and that of the stapled peptides ranged from 13.6 to 89.8%.,Not found,"Function: Antitumor activity against A549, HCT116 and HepG2 cancer cells.","[Ref.33363118] Cancer cell lines: C4-2B (IC50 = 10.23 μM), A549 (IC50 = 16.37 μM), U87 (IC50 = 14.72 μM), MCF-7 (12.1 μM)",No hemolytic activity information found.,Cyclic (Stapled),Acetylation,Amidation,① The Ⓩ (position: 6) in sequence indicates (R)-2-(7-octenyl)alanine. ② The Ⓧ (position: 13) in sequence indicates (S)-2-(4-pentenyl)alanine. ③ Ⓩ and Ⓧ are cross-linked by ring-closing metathesis through a undec-4-enyl staple.,L,No cytotoxicity information found in the reference,33363118,Front Chem. 2020 Dec 10;8:616147. doi: 10.3389/fchem.2020.616147. eCollection 2020.,"Nan Wang, Gang Xie, Chao Liu, Wei Cong, Shipeng He, Yinghua Li, Li Fan, Hong-Gang Hu ","Design, Synthesis, and Antitumor Activities Study of Stapled A4K14-Citropin 1.1 Peptides",Stapled AMP,,,,,
DRAMP29015,IKLSPⓍTKDⓍLKKVLKGAIKGAIAVAKMV,IKLSPXTKDXLKKVLKGAIKGAIAVAKMV,IKLSPETKDNLKKVLKGAIKGAIAVAKMV,29,H-2,No entry found,,Synthetic construct,"Antimicrobial, Anticancer",,α-helical (most likely),No detailed structure description found.,Not found,"Function: Anticancer activity. 
Ref.30789695 does not include results of antimicrobial, hemolysis and other biological assays","[Ref.30789695] Cancer cell lines: A549 (IC50 = 4.26 ± 0.52 μM), HCT116 (IC50 = 3.54 ± 0.72 μM), HepG2 (IC50 = 1.60 ± 0.24 μM)",No hemolytic activity information found.,Cyclic (Stapled),Free,Amidation,① The Ⓧ (position: 6 and 10) in sequence indicate (S)-N-Fmoc-2-(4'-pentenyl)alanine. ② Ⓧ (6) and Ⓧ (10) are cross-linked by ring-closing metathesis through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,30789695,ACS Chem Biol. 2019 Mar 15;14(3):516-525. doi: 10.1021/acschembio.9b00046. Epub 2019 Mar 1.,"Yulei Li, Yihan Zhang, Minghao Wu, Qi Chang, Honggang Hu, Xia Zhao","Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy",Stapled AMP,,,,,
DRAMP29016,IKLSPETKDNLKKVLKGⓍIKGⓍIAVAKMV,IKLSPETKDNLKKVLKGXIKGXIAVAKMV,IKLSPETKDNLKKVLKGAIKGAIAVAKMV,29,H-5,No entry found,,Synthetic construct,"Antimicrobial, Anticancer",,α-helical (most likely),No detailed structure description found.,Not found,"Function: Anticancer activity. 
Ref.30789695 does not include results of antimicrobial, hemolysis and other biological assays","[Ref.30789695] Cancer cell lines: A549 (IC50 = 7.35 ± 0.22 μM), HCT116 (IC50 = 4.16 ± 0.21 μM), HepG2 (IC50 = 2.82 ± 0.23 μM)",No hemolytic activity information found.,Cyclic (Stapled),Free,Amidation,① The Ⓧ (position: 18 and 22) in sequence indicate (S)-N-Fmoc-2-(4'-pentenyl)alanine. ② Ⓧ (18) and Ⓧ (22) are cross-linked by ring-closing metathesis through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,30789695,ACS Chem Biol. 2019 Mar 15;14(3):516-525. doi: 10.1021/acschembio.9b00046. Epub 2019 Mar 1.,"Yulei Li, Yihan Zhang, Minghao Wu, Qi Chang, Honggang Hu, Xia Zhao","Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy",Stapled AMP,,,,,
DRAMP29017,IKLSPⓍTKDⓍLKKVLKGⓍIKGⓍIAVAKMV,IKLSPXTKDXLKKVLKGXIKGXIAVAKMV,IKLSPETKDNLKKVLKGAIKGAIAVAKMV,29,H-10,No entry found,,Synthetic construct,"Antimicrobial, Anticancer",,α-helical (most likely),No detailed structure description found.,Not found,"Function: Anticancer activity. 
Ref.30789695 does not include results of antimicrobial, hemolysis and other biological assays","[Ref.30789695] Cancer cell lines: A549 (IC50 = 3.59 ± 0.12 μM), HCT116 (IC50 = 3.51 ± 0.37 μM), HepG2 (IC50 = 1.50 ± 0.21 μM)",No hemolytic activity information found.,Cyclic (Stapled),Free,Amidation,"① The Ⓧ (position: 6, 10, 18 and 22) in sequence indicate (S)-N-Fmoc-2-(4'-pentenyl)alanine. ② Ⓧ (6) and Ⓧ (10), Ⓧ (18) and Ⓧ (22) are cross-linked by ring-closing metathesis through an oct-4-enyl hydrocarbon staple, respectively.",L,No cytotoxicity information found in the reference,30789695,ACS Chem Biol. 2019 Mar 15;14(3):516-525. doi: 10.1021/acschembio.9b00046. Epub 2019 Mar 1.,"Yulei Li, Yihan Zhang, Minghao Wu, Qi Chang, Honggang Hu, Xia Zhao","Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy",Stapled AMP,,,,,
DRAMP29019,IKLSKⓍTKDⓍLKKVLKGAIKGAIAVAKMV,IKLSKXTKDXLKKVLKGAIKGAIAVAKMV,IKLSPETKDNLKKVLKGAIKGAIAVAKMV,29,H-15,No entry found,,Synthetic construct,"Antimicrobial, Anticancer",,α-helical (most likely),No detailed structure description found.,Not found,"Function: Anticancer activity. 
Ref.30789695 does not include results of antimicrobial, hemolysis and other biological assays","[Ref.30789695] Cancer cell lines: A549 (IC50 = 2.26 ± 0.24 μM), HCT116 (IC50 = 2.95 ± 0.25 μM), HepG2 (IC50 = 2.20 ± 0.27 μM)",No hemolytic activity information found.,Cyclic (Stapled),Free,Amidation,① The Ⓧ (position: 6 and 10) in sequence indicate (S)-N-Fmoc-2-(4'-pentenyl)alanine. ② Ⓧ (6) and Ⓧ (10) are cross-linked by ring-closing metathesis through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,30789695,ACS Chem Biol. 2019 Mar 15;14(3):516-525. doi: 10.1021/acschembio.9b00046. Epub 2019 Mar 1.,"Yulei Li, Yihan Zhang, Minghao Wu, Qi Chang, Honggang Hu, Xia Zhao","Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy",Stapled AMP,,,,,
DRAMP29020,IKLSPⓍTKKⓍLKKVLKGAIKGAIAVAKMV,IKLSPXTKKXLKKVLKGAIKGAIAVAKMV,IKLSPETKDNLKKVLKGAIKGAIAVAKMV,29,H-16,No entry found,,Synthetic construct,"Antimicrobial, Anticancer",,α-helical (most likely),No detailed structure description found.,Not found,"Function: Anticancer activity. 
Ref.30789695 does not include results of antimicrobial, hemolysis and other biological assays","[Ref.30789695] Cancer cell lines: A549 (IC50 = 1.85 ± 0.31 μM), HCT116 (IC50 = 2.65 ± 0.35 μM), HepG2 (IC50 = 3.14 ± 0.46 μM)",No hemolytic activity information found.,Cyclic (Stapled),Free,Amidation,① The Ⓧ (position: 6 and 10) in sequence indicate (S)-N-Fmoc-2-(4'-pentenyl)alanine. ② Ⓧ (6) and Ⓧ (10) are cross-linked by ring-closing metathesis through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,30789695,ACS Chem Biol. 2019 Mar 15;14(3):516-525. doi: 10.1021/acschembio.9b00046. Epub 2019 Mar 1.,"Yulei Li, Yihan Zhang, Minghao Wu, Qi Chang, Honggang Hu, Xia Zhao","Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy",Stapled AMP,,,,,
DRAMP29021,IKLSKⓍTKKⓍLKKVLKGAIKGAIAVAKMV,IKLSKXTKKXLKKVLKGAIKGAIAVAKMV,IKLSPETKDNLKKVLKGAIKGAIAVAKMV,29,H-17,No entry found,,Synthetic construct,"Antimicrobial, Anticancer",,α-helical (most likely),No detailed structure description found.,Not found,"Function: Anticancer activity. 
Ref.30789695 does not include results of antimicrobial, hemolysis and other biological assays","[Ref.30789695] Cancer cell lines: A549 (IC50 = 0.96 ± 0.33 μM), HCT116 (IC50 = 1.49 ± 0.45 μM), HepG2 (IC50 = 1.64 ± 0.47 μM)",No hemolytic activity information found.,Cyclic (Stapled),Free,Amidation,① The Ⓧ (position: 6 and 10) in sequence indicate (S)-N-Fmoc-2-(4'-pentenyl)alanine. ② Ⓧ (6) and Ⓧ (10) are cross-linked by ring-closing metathesis through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,30789695,ACS Chem Biol. 2019 Mar 15;14(3):516-525. doi: 10.1021/acschembio.9b00046. Epub 2019 Mar 1.,"Yulei Li, Yihan Zhang, Minghao Wu, Qi Chang, Honggang Hu, Xia Zhao","Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy",Stapled AMP,,,,,
DRAMP29022,IKLSKKTKKNLKKVLKGⓍIKGⓍIAVAKMV,IKLSKKTKKNLKKVLKGXIKGXIAVAKMV,IKLSPETKDNLKKVLKGAIKGAIAVAKMV,29,H-18,No entry found,,Synthetic construct,"Antimicrobial, Anticancer",,α-helical (most likely),No detailed structure description found.,Not found,"Function: Anticancer activity. 
Ref.30789695 does not include results of antimicrobial, hemolysis and other biological assays","[Ref.30789695] Cancer cell lines: A549 (IC50 = 0.89 ± 0.21 μM), HCT116 (IC50 = 1.11 ± 0.21 μM), HepG2 (IC50 = 1.61 ± 0.21 μM)","[Ref.30789695] It has -1.5%, 3.8%, 12.8%, 18.2%, 13.8%, 30.2%, 65.2%, 90.8% and 83.5% hemolysis against fresh rabbit blood cells at 0.010, 0.25, 0.5, 1.0, 2.0, 5.0, 10.0, 20.0 and 25.0 μM.",Cyclic (Stapled),Free,Amidation,① The Ⓧ (position: 18 and 22) in sequence indicate (S)-N-Fmoc-2-(4'-pentenyl)alanine. ② Ⓧ (18) and Ⓧ (22) are cross-linked by ring-closing metathesis through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,30789695,ACS Chem Biol. 2019 Mar 15;14(3):516-525. doi: 10.1021/acschembio.9b00046. Epub 2019 Mar 1.,"Yulei Li, Yihan Zhang, Minghao Wu, Qi Chang, Honggang Hu, Xia Zhao","Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy",Stapled AMP,,,,,
DRAMP29023,IKLSKETKKNLKKVLKGⓍIKGⓍIAVAKMV,IKLSKETKKNLKKVLKGXIKGXIAVAKMV,IKLSPETKDNLKKVLKGAIKGAIAVAKMV,29,H-19,No entry found,,Synthetic construct,"Antimicrobial, Anticancer",,α-helical (most likely),No detailed structure description found.,Not found,"Function: Anticancer activity. 
Ref.30789695 does not include results of antimicrobial, hemolysis and other biological assays","[Ref.30789695] Cancer cell lines: A549 (IC50 = 1.00 ± 0.36 μM), HCT116 (IC50 = 1.78 ± 0.35 μM), HepG2 (IC50 = 1.64 ± 0.36 μM)","[Ref.30789695] It has 1.8%, 11.5%, 22.2%, 20.5%, 16.2%, 39.5%, 69.2%, 94.8% and 102.5% hemolysis against fresh rabbit blood cells at 0.010, 0.25, 0.5, 1.0, 2.0, 5.0, 10.0, 20.0 and 25.0 μM.",Cyclic (Stapled),Free,Amidation,① The Ⓧ (position: 18 and 22) in sequence indicate (S)-N-Fmoc-2-(4'-pentenyl)alanine. ② Ⓧ (18) and Ⓧ (22) are cross-linked by ring-closing metathesis through an oct-4-enyl hydrocarbon staple.,L,No cytotoxicity information found in the reference,30789695,ACS Chem Biol. 2019 Mar 15;14(3):516-525. doi: 10.1021/acschembio.9b00046. Epub 2019 Mar 1.,"Yulei Li, Yihan Zhang, Minghao Wu, Qi Chang, Honggang Hu, Xia Zhao","Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy",Stapled AMP,,,,,
DRAMP29024,IKLSPⓍTKKⓍLKKVLKGⓍIKGⓍIAVAKMV,IKLSPXTKKXLKKVLKGXIKGXIAVAKMV,IKLSPETKDNLKKVLKGAIKGAIAVAKMV,29,H-20,No entry found,,Synthetic construct,"Antimicrobial, Anticancer",,α-helical (most likely),No detailed structure description found.,Not found,"Function: Anticancer activity. 
Ref.30789695 does not include results of antimicrobial, hemolysis and other biological assays","[Ref.30789695] Cancer cell lines: A549 (IC50 = 2.10 ± 0.32 μM), HCT116 (IC50 = 2.63 ± 0.35 μM), HepG2 (IC50 = 4.93 ± 0.53 μM)",No hemolytic activity information found.,Cyclic (Stapled),Free,Amidation,"① The Ⓧ (position: 6, 10, 18 and 22) in sequence indicate (S)-N-Fmoc-2-(4'-pentenyl)alanine. ② Ⓧ (6) and Ⓧ (10), Ⓧ (18) and Ⓧ (22) are cross-linked by ring-closing metathesis through an oct-4-enyl hydrocarbon staple, respectively.",L,No cytotoxicity information found in the reference,30789695,ACS Chem Biol. 2019 Mar 15;14(3):516-525. doi: 10.1021/acschembio.9b00046. Epub 2019 Mar 1.,"Yulei Li, Yihan Zhang, Minghao Wu, Qi Chang, Honggang Hu, Xia Zhao","Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy",Stapled AMP,,,,,
DRAMP29025,IKLSKⓍTKKⓍLKKVLKGⓍIKGⓍIAVAKMV,IKLSKXTKKXLKKVLKGXIKGXIAVAKMV,IKLSPETKDNLKKVLKGAIKGAIAVAKMV,29,H-21,No entry found,,Synthetic construct,"Antimicrobial, Anticancer",,α-helical (most likely),No detailed structure description found.,Not found,"Function: Anticancer activity. 
Ref.30789695 does not include results of antimicrobial, hemolysis and other biological assays","[Ref.30789695] Cancer cell lines: A549 (IC50 = 3.26 ± 0.36 μM), HCT116 (IC50 = 3.05 ± 0.21 μM), HepG2 (IC50 = 1.50 ± 0.28 μM)",No hemolytic activity information found.,Cyclic (Stapled),Free,Amidation,"① The Ⓧ (position: 6, 10, 18 and 22) in sequence indicate (S)-N-Fmoc-2-(4'-pentenyl)alanine. ② Ⓧ (6) and Ⓧ (10), Ⓧ (18) and Ⓧ (22) are cross-linked by ring-closing metathesis through an oct-4-enyl hydrocarbon staple, respectively.",L,No cytotoxicity information found in the reference,30789695,ACS Chem Biol. 2019 Mar 15;14(3):516-525. doi: 10.1021/acschembio.9b00046. Epub 2019 Mar 1.,"Yulei Li, Yihan Zhang, Minghao Wu, Qi Chang, Honggang Hu, Xia Zhao","Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy",Stapled AMP,,,,,
DRAMP29026,IKLSKETKKNLKKVLKGⓍIKGⓍIAVAKMV,IKLSKETKKNLKKVLKGXIKGXIAVAKMV,IKLSPETKDNLKKVLKGAIKGAIAVAKMV,29,H-57,No entry found,,Synthetic construct,"Antimicrobial, Anticancer",,α-helical (most likely),No detailed structure description found.,Not found,"Function: Anticancer activity. 
Ref.30789695 does not include results of antimicrobial, hemolysis and other biological assays","[Ref.30789695] Cancer cell lines: A549 (IC50 = 1.10 ± 0.31 μM), HCT116 (IC50 = 1.65 ± 0.28 μM), HepG2 (IC50 = 2.71 ± 0.05 μM)","[Ref.30789695] It has -1.2%, 1.8%, 2.8%, 5.5%, 14.5%, 25.8%, 42.8%, 68.8% and 58.2% hemolysis against fresh rabbit blood cells at 0.010, 0.25, 0.5, 1.0, 2.0, 5.0, 10.0, 20.0 and 25.0 μM.",Cyclic (Stapled),Free,Amidation,"① The S (position: 4), T (position: 7) and N (position: 10) in sequence are linked with N-acetylglucosamine (GlcNAc), respectively. ② The Ⓧ (position: 18 and 22) indicate (S)-N-Fmoc-2-(4'-pentenyl)alanine. ③ Ⓧ (18) and Ⓧ (22) are cross-linked by ring-closing metathesis through an oct-4-enyl hydrocarbon staple, respectively.",L,No cytotoxicity information found in the reference,30789695,ACS Chem Biol. 2019 Mar 15;14(3):516-525. doi: 10.1021/acschembio.9b00046. Epub 2019 Mar 1.,"Yulei Li, Yihan Zhang, Minghao Wu, Qi Chang, Honggang Hu, Xia Zhao","Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy",Stapled AMP,,,,,
DRAMP29027,IKLSKKTKKNLKKVLKGⓍIKGⓍIAVAKMV,IKLSKKTKKNLKKVLKGXIKGXIAVAKMV,IKLSPETKDNLKKVLKGAIKGAIAVAKMV,29,H-58,No entry found,,Synthetic construct,"Antimicrobial, Anticancer",,α-helical (most likely),No detailed structure description found.,Not found,"Function: Anticancer activity. 
Ref.30789695 does not include results of antimicrobial, hemolysis and other biological assays","[Ref.30789695] Cancer cell lines: A549 (IC50 = 0.62 ± 0.12 μM), HCT116 (IC50 = 1.29 ± 0.08 μM), HepG2 (IC50 = 2.13 ± 0.07 μM)","[Ref.30789695] It has 0.8%, -0.5%, 0.8%, 8.8%, 13.2%, 20.8%, 37.8%, 61.8% and 54.5% hemolysis against fresh rabbit blood cells at 0.010, 0.25, 0.5, 1.0, 2.0, 5.0, 10.0, 20.0 and 25.0 μM.",Cyclic (Stapled),Free,Amidation,"① The S (position: 4), T (position: 7) and N (position: 10) in sequence are linked with N-acetylglucosamine (GlcNAc), respectively. ② The Ⓧ (position: 18 and 22) indicate (S)-N-Fmoc-2-(4'-pentenyl)alanine. ③ Ⓧ (18) and Ⓧ (22) are cross-linked by ring-closing metathesis through an oct-4-enyl hydrocarbon staple, respectively.",L,No cytotoxicity information found in the reference,30789695,ACS Chem Biol. 2019 Mar 15;14(3):516-525. doi: 10.1021/acschembio.9b00046. Epub 2019 Mar 1.,"Yulei Li, Yihan Zhang, Minghao Wu, Qi Chang, Honggang Hu, Xia Zhao","Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy",Stapled AMP,,,,,
DRAMP29032,KLLKKAGKLLKKⓏGKLLKKⓍG,KLLKKAGKLLKKZGKLLKKXG,KLLKKAGKLLKKAGKLLKKAG,21,Stripe-based foldamer peptide 4,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,"α-Helix content = 39% in 20 mM phosphate buffered saline (PBS) solution (pH 7.4), with 1% sodium dodecyl sulfate","[Ref.33369262] As shown in Figure 2, peptides 2, 3, 4 and 5 showed negative maxima at around 208 and 222nm, which suggests that they formed stable α-helical structures, similar to Stripe.",Not found,"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.
It is a helical foldmer peptide based on ""Stripe"" (an AMP manually designed) by introducing a hydrocarbon stapling. The peptide showed weaker activity than Stripe.","[Ref.33369262] Gram-positive bacteria: Staphylococcus aureus NBRC13276 (MIC = 25 μM) ;##Gram-negative bacteria: Escherichia coli DH5α (MIC = 6.25 μM), Pseudomonas aeruginosa NBRC13275 (MIC = 50 μM), multidrug-resistant Pseudomonas aeruginosa ATCCBAA-2111 (MDRP) (MIC = 25 μM)",[Ref.33369262] It exhibits hemolysis at 0.78 μM agasint human red blood cells.,Cyclic (Stapled),Free,Free,①The Ⓩ (position: 13) in sequence denotes (R)-(7-octenyl)alanine. ②The Ⓧ (position: 20) in sequence denotes (S)-(4-pentenyl)alanine. ③ Ⓩ (13) and Ⓧ (20) are cross-linked by side-stapling through a undec-4-enyl staple.,L,No cytotoxicity information found in the reference,33369262,Chempluschem. 2020 Dec;85(12):2731-2736. doi: 10.1002/cplu.202000749.,"Motoharu Hirano, Chihiro Saito, Chihiro Goto, Hidetomo Yokoo, Ryuji Kawano, Takashi Misawa, Yosuke Demizu","Rational Design of Helix-Stabilized Antimicrobial Peptide Foldamers Containing α,α-Disubstituted Amino Acids or Side-Chain Stapling",Stapled AMP,,,,,
DRAMP29033,KLLKKⓏGKLLKKⓍGKLLKKAG,KLLKKZGKLLKKXGKLLKKAG,KLLKKAGKLLKKAGKLLKKAG,21,Stripe-based foldamer peptide 5,No entry found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",,"α-Helix content = 34% in 20 mM phosphate buffered saline (PBS) solution (pH 7.4), with 1% sodium dodecyl sulfate","[Ref.33369262] As shown in Figure 2, peptides 2, 3, 4 and 5 showed negative maxima at around 208 and 222nm, which suggests that they formed stable α-helical structures, similar to Stripe.",Not found,"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.
It is a helical foldmer peptide based on ""Stripe"" (an AMP manually designed) by introducing a hydrocarbon stapling. The peptide showed weaker activity than Stripe.","[Ref.33369262] Gram-positive bacteria: Staphylococcus aureus NBRC13276 (MIC = 25 μM) ;##Gram-negative bacteria: Escherichia coli DH5α (MIC = 6.25 μM), Pseudomonas aeruginosa NBRC13275 (MIC = 12.5 μM), multidrug-resistant Pseudomonas aeruginosa ATCCBAA-2111 (MDRP) (MIC = 25 μM)",[Ref.33369262] It exhibits hemolysis at 1.56 μM agasint human red blood cells.,Cyclic (Stapled),Free,Free,①The Ⓩ (position: 6) in sequence denotes (R)-(7-octenyl)alanine. ②The Ⓧ (position: 13) in sequence denotes (S)-(4-pentenyl)alanine. ③ Ⓩ (6) and Ⓧ (13) are cross-linked by side-stapling through a undec-4-enyl staple.,L,No cytotoxicity information found in the reference,33369262,Chempluschem. 2020 Dec;85(12):2731-2736. doi: 10.1002/cplu.202000749.,"Motoharu Hirano, Chihiro Saito, Chihiro Goto, Hidetomo Yokoo, Ryuji Kawano, Takashi Misawa, Yosuke Demizu","Rational Design of Helix-Stabilized Antimicrobial Peptide Foldamers Containing α,α-Disubstituted Amino Acids or Side-Chain Stapling",Stapled AMP,,,,,
DRAMP29235,TIEEQAKTⓍLDKⓍNHEAEDLFYQⓍSLAⓍWN,TIEEQAKTXLDKXNHEAEDLFYQXSLAXWN,TIEEQAKTFLDKFNHEAEDLFYQSSLASWN,30,NYBSP-1,No entry found,,Synthetic construct,"Antimicrobial, Antiviral(SARS-CoV-2)",,94% α-helical content in 10 mM phosphate-buffered saline (PBS),No other descriptive information about the structure found in the literature,Not found,"Mechanism of action:The stapled peptide designed based on the ACE2 helix, which is expected to bind to SARS-CoV-2 and prevent the binding of the virus to the ACE2 receptor and disrupt the infection.",[Ref.33310780]Virus:##SARS-CoV-2:Inhibition of infection in HT1080/ACE2 cells(IC50=4.1 ± 0.26 μM);Inhibition of infection in A549/ACE2 cells(IC50=2.2 ± 0.14 μM);Inhibition of virus-induced cytopathic effect (CPE) in Vero E6 cells(IC100=17.2 μM);##VSV-G:Inhibition of infection in HT1080/ACE2 cells(IC50>27.5 μM);Inhibition of infection in A549/ACE2 cells(IC50>27.5 μM).,No hemolytic activity information found.,Cyclic (Stapled),Acylation,Amidation,"①The Ⓧ (position: 9,13,24 and 28) in sequence indicate S-2-(4'-pentenyl) alanine.② Ⓧ(9) and Ⓧ(13), Ⓧ(24) and Ⓧ(28) are cross-linked by hydrocarbon stapling.",L,[Ref.33310780]HT1080/ACE2 cells:CC50>27.5 μM(Less than 10% toxicity at this dose);A549/ACE2 cells:CC50>27.5 μM(Less than 10% toxicity at this dose).,33310780,mBio. 2020 Dec 11;11(6):e02451-20.,"Curreli F, Victor SMB, Ahmed S, Drelich A, Tong X, Tseng CK, Hillyer CD, Debnath AK.",Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection In Vitro.,Stapled AMP,,,,,
DRAMP29236,TIEEQⓏKTFLDKⓍNHEAEDLⓏYQSSLAⓍWN,TIEEQZKTFLDKXNHEAEDLZYQSSLAXWN,TIEEQAKTFLDKFNHEAEDLFYQSSLASWN,30,NYBSP-2,No entry found,,Synthetic construct,"Antimicrobial, Antiviral(SARS-CoV-2)",,61% α-helical content in 10 mM phosphate-buffered saline (PBS),No other descriptive information about the structure found in the literature,Not found,"Mechanism of action:The stapled peptide designed based on the ACE2 helix, which is expected to bind to SARS-CoV-2 and prevent the binding of the virus to the ACE2 receptor and disrupt the infection.",[Ref.33310780]Virus:##SARS-CoV-2:Inhibition of infection in HT1080/ACE2 cells(IC50=2.9 ± 0.27 μM);Inhibition of infection in A549/ACE2 cells(IC50=2.68 ± 0.14 μM);Inhibition of virus-induced cytopathic effect (CPE) in Vero E6 cells(IC100=33.5 μM);##VSV-G:Inhibition of infection in HT1080/ACE2 cells(IC50>26.8 μM);Inhibition of infection in A549/ACE2 cells(IC50>26.8 μM).,No hemolytic activity information found.,Cyclic (Stapled),Acylation,Amidation,"①The Ⓧ(position: 13 and 28) in sequence indicate S-2-(4'-pentenyl) alanine.②The Ⓩ(position: 6 and 21) indicate 2-(7'-octenyl) alanine in the R configuration.③ Ⓩ(6) and Ⓧ(13), Ⓩ(21) and Ⓧ(28) are cross-linked by hydrocarbon stapling.",L,[Ref.33310780]HT1080/ACE2 cells:CC50>26.8 μM(Less than 10% toxicity at this dose);A549/ACE2 cells:CC50>26.8 μM(Less than 10% toxicity at this dose).,33310780,mBio. 2020 Dec 11;11(6):e02451-20.,"Curreli F, Victor SMB, Ahmed S, Drelich A, Tong X, Tseng CK, Hillyer CD, Debnath AK.",Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection In Vitro.,Stapled AMP,,,,,
DRAMP29237,TIEEQAKTⓍLDKⓍNHEAEDLⓏYQSSLAⓍWN,TIEEQAKTXLDKXNHEAEDLZYQSSLAXWN,TIEEQAKTFLDKFNHEAEDLFYQSSLASWN,30,NYBSP-3,No entry found,,Synthetic construct,"Antimicrobial, Antiviral(SARS-CoV-2)",,50% α-helical content in 10 mM phosphate-buffered saline (PBS),No other descriptive information about the structure found in the literature,Not found,"Mechanism of action:The stapled peptide designed based on the ACE2 helix, which is expected to bind to SARS-CoV-2 and prevent the binding of the virus to the ACE2 receptor and disrupt the infection.",[Ref.33310780]Virus:##SARS-CoV-2:Inhibition of infection in HT1080/ACE2 cells(IC50=12.9 ± 0.35 μM);Inhibition of infection in A549/ACE2 cells(IC50~25 μM);##VSV-G:Inhibition of infection in HT1080/ACE2 cells(IC50>27.6 μM);Inhibition of infection in A549/ACE2 cells(IC50>27.6 μM).,No hemolytic activity information found.,Cyclic (Stapled),Acylation,Amidation,"①The Ⓧ (position: 9,13 and 28) in sequence indicate S-2-(4'-pentenyl) alanine.②The Ⓩ (position: 21) indicates 2-(7'-octenyl) alanine in the R configuration.③ Ⓧ(9) and Ⓧ(13), Ⓩ(21) and Ⓧ(28) are cross-linked by hydrocarbon stapling.",L,[Ref.33310780]HT1080/ACE2 cells:CC50>27.6 μM(Less than 10% toxicity at this dose);A549/ACE2 cells:CC50>27.6 μM(Less than 10% toxicity at this dose).,33310780,mBio. 2020 Dec 11;11(6):e02451-20.,"Curreli F, Victor SMB, Ahmed S, Drelich A, Tong X, Tseng CK, Hillyer CD, Debnath AK.",Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection In Vitro.,Stapled AMP,,,,,
DRAMP29238,TIEEQⓏKTFLDKⓍNHEAEDLFYQⓍSLAⓍWN,TIEEQZKTFLDKXNHEAEDLFYQXSLAXWN,TIEEQAKTFLDKFNHEAEDLFYQSSLASWN,30,NYBSP-4,No entry found,,Synthetic construct,"Antimicrobial, Antiviral(SARS-CoV-2)",,80% α-helical content in 10 mM phosphate-buffered saline (PBS),No other descriptive information about the structure found in the literature,Not found,"Mechanism of action:Proteolytic stability of NYBSP-4 in human plasma(half-life (T1/2) of NYBSP-4 was >289 min).The stapled peptide designed based on the ACE2 helix, which is expected to bind to SARS-CoV-2 and prevent the binding of the virus to the ACE2 receptor and disrupt the infection.",[Ref.33310780]Virus:##SARS-CoV-2:Inhibition of infection in HT1080/ACE2 cells(IC50=1.97 ± 0.14 μM);Inhibition of infection in A549/ACE2 cells(IC50=2.8 ± 0.08 μM);Inhibition of virus-induced cytopathic effect (CPE) in Vero E6 cells(IC100=33 μM);##VSV-G:Inhibition of infection in HT1080/ACE2 cells(IC50>26.6 μM);Inhibition of infection in A549/ACE2 cells(IC50>26.6 μM).,No hemolytic activity information found.,Cyclic (Stapled),Acylation,Amidation,"①The Ⓧ (position: 13,24 and 28) in sequence indicate S-2-(4'-pentenyl) alanine.②The Ⓩ (position: 6) indicates 2-(7'-octenyl) alanine in the R configuration.③  Ⓩ(6) and Ⓧ(13), Ⓧ(24) and Ⓧ(28) are cross-linked by hydrocarbon stapling.",L,[Ref.33310780]HT1080/ACE2 cells:CC50>26.6 μM(Less than 10% toxicity at this dose);A549/ACE2 cells:CC50>26.6 μM(Less than 10% toxicity at this dose).,33310780,mBio. 2020 Dec 11;11(6):e02451-20.,"Curreli F, Victor SMB, Ahmed S, Drelich A, Tong X, Tseng CK, Hillyer CD, Debnath AK.",Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection In Vitro.,Stapled AMP,,,,,
DRAMP29239,IEEQAKTFLDKFNHEⓀEDLⒺYQSSLASWNYNTNIT,IEEQAKTFLDKFNHEKEDLEYQSSLASWNYNTNIT,IEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNIT,35,hACE2(21-55)A36K-F40E,No entry found,,Synthetic construct,"Antimicrobial, Antiviral(SARS-CoV-2)",,①52% α-helical content in 10 mM PBS at pH 7.4 with 30% TFE at 298 K.②6-13% α-helical content in 10 mM PBS at pH 7.4 and 298 K.,"Low helicity for stapled hACE2 peptides in absence of TFE, with predictors of helicity averaging to 6-13% helical content. In the presence of TFE, α-helical structures can be observed for various synthetic hACE2 peptides with predictors averaging from 11 to 52% helical content",Not found,"Mechanism of action:The stapled peptide inhibit the RBD-hACE2 complex formation, and hACE2 α1-helix-based peptidomimetics could potentially prevent SARS-CoV-2 from entering the human cells through hACE2 and thus inhibit subsequent viral replication. ",[Ref.33651072]Virus:SARS-CoV-2:inhibition of SARS-CoV-2 Spike protein-hACE2 complex formation(IC50=3.6 μM).,No hemolytic activity information found.,Cyclic (Stapled),Free,Free,Ⓚ (16) and Ⓔ (20) are corss-linked by lactam stapling.,L,No cytotoxicity information found in the reference(s) presented,33651072,Chem Commun (Camb). 2021 Apr 4;57(26):3283-3286.,"Maas MN , Hintzen JCJ , Löffler PMG , Mecinović J . ",Targeting SARS-CoV-2 spike protein by stapled hACE2 peptides.,Stapled AMP,,,,,
DRAMP29240,IEEQAKTFLDKⓀNHEⒺEDLFYQSSLASWNYNTNIT,IEEQAKTFLDKKNHEEEDLFYQSSLASWNYNTNIT,IEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNIT,35,hACE2(21-55)F32K-A36E,No entry found,,Synthetic construct,"Antimicrobial, Antiviral(SARS-CoV-2)",,①6-13% α-helical content in 10 mM PBS at pH 7.4 and 298 K.②11-52% α-helical content in 10 mM PBS at pH 7.4 with 30% TFE at 298 K.,"Low helicity for stapled hACE2 peptides in absence of TFE, with predictors of helicity averaging to 6-13% helical content. In the presence of TFE, α-helical structures can be observed for various synthetic hACE2 peptides with predictors averaging from 11 to 52% helical content",Not found,"Mechanism of action:The stapled peptide inhibit the RBD-hACE2 complex formation, and hACE2 α1-helix-based peptidomimetics could potentially prevent SARS-CoV-2 from entering the human cells through hACE2 and thus inhibit subsequent viral replication. ",[Ref.33651072]Virus:SARS-CoV-2:inhibition of SARS-CoV-2 Spike protein-hACE2 complex formation(IC50=28.4 μM).,No hemolytic activity information found.,Cyclic (Stapled),Free,Free,Ⓚ (12) and Ⓔ (16) are corss-linked by lactam stapling.,L,No cytotoxicity information found in the reference(s) presented,33651072,Chem Commun (Camb). 2021 Apr 4;57(26):3283-3286.,"Maas MN , Hintzen JCJ , Löffler PMG , Mecinović J . ",Targeting SARS-CoV-2 spike protein by stapled hACE2 peptides.,Stapled AMP,,,,,
DRAMP29241,IEEQAKTⓀLDKⒺNHEAEDLFYQSSLASWNYNTNIT,IEEQAKTKLDKENHEAEDLFYQSSLASWNYNTNIT,IEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNIT,35,hACE2(21-55)F28K-F32E,No entry found,,Synthetic construct,"Antimicrobial, Antiviral(SARS-CoV-2)",,①6-13% α-helical content in 10 mM PBS at pH 7.4 and 298 K.②11-52% α-helical content in 10 mM PBS at pH 7.4 with 30% TFE at 298 K.,"Low helicity for stapled hACE2 peptides in absence of TFE, with predictors of helicity averaging to 6-13% helical content. In the presence of TFE, α-helical structures can be observed for various synthetic hACE2 peptides with predictors averaging from 11 to 52% helical content",Not found,"Mechanism of action:The stapled peptide inhibit the RBD-hACE2 complex formation, and hACE2 α1-helix-based peptidomimetics could potentially prevent SARS-CoV-2 from entering the human cells through hACE2 and thus inhibit subsequent viral replication. ",[Ref.33651072]Virus:SARS-CoV-2:inhibition of SARS-CoV-2 Spike protein-hACE2 complex formation(IC50=46.8 μM).,No hemolytic activity information found.,Cyclic (Stapled),Free,Free,Ⓚ (8) and Ⓔ (12) are corss-linked by lactam stapling.,L,No cytotoxicity information found in the reference(s) presented,33651072,Chem Commun (Camb). 2021 Apr 4;57(26):3283-3286.,"Maas MN , Hintzen JCJ , Löffler PMG , Mecinović J . ",Targeting SARS-CoV-2 spike protein by stapled hACE2 peptides.,Stapled AMP,,,,,
